Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3023199	pf-leuk	e6/l (e6/l)	3083	4375	0.00%
3023199	pf-leuk	— (—)	1352	1884	100.00%	Distribution not available
3023199	pf-leuk	e9/l (e6/l)	47	49	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Non-ischemic cardiomyopathy

665

999

5.69

321.38

1.6

1.4

3425.63

3451.50

e6/l

0.01

483

723

Asthma, excluding more controls

546

315

9.33

320.40

1.5

1.2

2517.35

3582.92

e6/l

0.52

402

212

Renal tubulo-interstitial diseases

1221

2737

3.48

318.08

1.6

1.4

2621.68

3369.78

e6/l

0.54

872

2002

Other medical care

819

1737

4.76

307.65

1.5

1.4

1977.19

2770.96

e6/l

0.91

634

1254

Pleural effusion

1724

435

54.11

307.65

1.7

1.2

2496.47

2396.31

e6/l

0.05

1322

285

Heart failure, strict

1337

1794

5.58

307.65

1.6

1.4

2456.48

3421.88

e6/l

0.55

982

1306

Dyspnoea

1350

2784

3.79

307.65

1.6

1.4

2998.71

3218.79

e6/l

0.12

1033

1978

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

606

759

7.04

307.65

1.4

1.5

2746.90

2671.30

e6/l

0.04

443

564

Influenza and pneumonia

1595

2109

5.07

307.65

1.5

1.4

4402.71

2870.40

e6/l

1.02

1169

1508

Bacterial infection, other or unspecified

1009

2034

4.61

307.65

1.6

1.4

3868.05

2688.31

e6/l

0.57

756

1476

Other diseases of pleura

2398

1196

19.89

307.65

1.7

1.2

2730.95

4184.08

e6/l

0.67

1875

779

Pneumonias (Asthma/COPD co-morbidities)

1597

2162

5.23

307.65

1.5

1.4

4453.39

2828.62

e6/l

1.13

1172

1545

COPD differential diagnosis

829

535

7.86

307.65

1.5

1.2

2420.22

2469.49

e6/l

0.03

608

348

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1470

1819

5.17

307.65

1.5

1.4

4464.74

2567.95

e6/l

1.33

1084

1288

Asthma, unspecified (mode), excluding more controls

442

293

12.00

307.65

1.5

1.2

2864.99

2660.50

e6/l

0.11

325

195

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1593

2191

5.22

307.65

1.5

1.4

4468.08

2810.72

e6/l

1.16

1172

1566

1470

1819

5.17

307.65

1.5

1.4

4464.74

2567.95

e6/l

1.33

1084

1288

Suppurative and necrotic conditions of lower respiratory tract

393

235

20.53

307.65

1.6

1.4

16647.58

1468.57

e6/l

4.30

287

170

All pneumoniae

1597

2158

5.22

307.65

1.5

1.4

4422.36

2832.84

e6/l

1.09

1171

1543

Other pulmonary diagnosis

850

537

8.03

307.65

1.5

1.2

2530.50

2466.45

e6/l

0.03

626

350

Pyothorax

357

191

24.13

307.65

1.6

1.5

17027.12

1523.45

e6/l

3.91

259

134

Lung cancer and mesothelioma

720

262

25.49

307.65

1.5

1.2

2583.92

1144.23

e6/l

5.20

546

160

Pneumonia, organism unspecified

1509

2073

5.39

307.65

1.5

1.4

4477.29

2766.05

e6/l

1.15

1122

1482

Other bacterial diseases

1429

2526

3.99

307.65

1.6

1.4

3723.45

3055.39

e6/l

0.35

1040

1817

Excluding asthma or asthma-COPD overlap

832

537

7.86

307.65

1.5

1.2

2441.19

2466.45

e6/l

0.01

609

350

Heart failure,strict

1230

1352

6.85

307.65

1.6

1.4

2585.80

3470.59

e6/l

0.43

900

976

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

765

858

7.97

307.65

1.5

2634.36

2657.26

e6/l

0.01

576

635

All-cause Heart Failure

1298

1765

5.51

307.65

1.6

1.4

2510.64

3438.50

e6/l

0.51

952

1284

COPD (mode)

488

378

10.55

307.65

1.4

1.2

3127.12

1444.02

e6/l

1.49

371

237

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

787

1333

5.36

307.65

1.4

1.5

1880.55

3609.43

e6/l

1.42

588

985

Heart failure, not strict

1380

1737

5.64

307.65

1.6

1.4

2735.63

3963.38

e6/l

0.72

1017

1252

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

483

591

8.22

307.65

1.4

1.5

2501.31

3000.42

e6/l

0.28

354

437

Heart failure and antihypertensive medication

588

478

8.46

307.65

1.6

1.4

3764.55

4415.13

e6/l

0.14

437

348

ILD differential diagnosis

829

535

7.86

307.65

1.5

1.2

2420.22

2469.49

e6/l

0.03

608

348

Other pleural conditions

1004

284

46.56

307.65

1.8

1.2

2063.20

1792.82

e6/l

0.23

829

193

Malignant neoplasm of respiratory system and intrathoracic organs

643

1145

5.47

307.09

1.5

2586.38

2321.79

e6/l

0.23

506

814

Renal failure

917

2167

4.00

303.03

1.6

1.4

1979.93

2781.48

e6/l

0.70

666

1589

Abnormal findings on diagnostic imaging of lung

913

2320

3.95

302.87

1.6

1.4

3299.25

2919.26

e6/l

0.20

714

1663

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1043

2782

3.56

294.72

1.6

1.4

3135.58

3012.98

e6/l

0.06

815

1992

Asthma, unspecified (mode)

462

502

7.39

285.54

1.5

1.2

3399.05

1893.42

e6/l

1.14

338

325

Persons encountering health services for specific procedures and health care

1299

2517

3.24

284.21

1.5

1.4

3466.48

3534.52

e6/l

0.03

952

1805

Asthma (only as main-diagnosis), excluding more controls

462

315

8.81

280.12

1.5

1.2

2537.07

3582.92

e6/l

0.49

346

212

Bacterial Sepsis

840

1911

4.02

279.04

1.6

1.4

4326.00

2807.96

e6/l

0.59

635

1408

Oxycodone

694

1548

4.47

271.34

1.5

1.4

2060.91

2702.09

e6/l

0.64

545

1111

Heart failure and bmi 25plus

651

895

5.19

267.25

1.6

1.4

3140.80

3829.08

e6/l

0.17

481

665

Later onset COPD, excluding more controls

356

303

9.49

261.16

1.5

1.2

2263.34

1111.96

e6/l

2.03

270

187

Abnormalities of breathing

1081

1882

3.46

257.35

1.6

1.4

2747.11

3280.97

e6/l

0.34

813

1321

Non-small cell lung cancer

483

873

5.89

256.38

1.4

1.5

2501.31

1617.66

e6/l

1.62

354

610

Implicit Sepsis

1042

2473

3.34

255.27

1.5

1.4

3850.02

2973.21

e6/l

0.36

772

1799

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1223

2939

3.02

250.48

1.5

2978.63

3053.02

e6/l

0.03

890

2129

Implicit bacterial Sepsis

752

1773

4.01

250.40

1.6

1.4

4576.35

2816.90

e6/l

0.63

576

1304

Dialysis, with operation codes

353

481

7.81

246.43

1.7

1.4

1507.84

1960.69

e6/l

0.61

270

360

Other heart diseases, wide

929

1585

3.68

245.62

1.5

1.4

2523.75

4243.30

e6/l

1.43

672

1154

Other heart diseases

512

566

6.06

243.90

1.6

1.3

2400.78

5638.02

e6/l

1.53

375

419

Diseases of the respiratory system

596

508

5.94

243.05

1.5

1.2

2356.28

2437.82

e6/l

0.04

436

336

Septicaemia

710

1743

4.02

241.78

1.6

1.4

4141.31

2737.39

e6/l

0.44

525

1273

Asthma

575

532

5.85

239.97

1.5

1.2

2778.30

2473.59

e6/l

0.17

427

347

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

243

212

12.70

239.51

1.5

2796.34

1561.92

e6/l

1.55

187

151

Bacterial pneumoniae

637

1318

4.38

237.51

1.5

1.4

4413.31

2209.21

e6/l

0.78

474

941

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

154

37.20

237.39

2.0

1.5

1910.13

1977.89

e6/l

0.04

126

Explicit Sepsis

720

1833

3.86

231.69

1.6

1.4

4107.06

2751.33

e6/l

0.43

532

1351

Bacterial pneumonia, not elsewhere classified

616

1269

4.40

230.91

1.5

1.4

4500.65

2199.46

e6/l

0.79

459

900

Mesothelioma, excluding all cancers (controls excluding all cancers)

143

46.07

230.07

2.0

1.3

1669.80

2265.56

e6/l

0.42

118

Valvular heart disease excluding rheumatic fever

661

1143

4.31

226.92

1.6

1.4

2545.83

3511.24

e6/l

0.53

491

846

Non-rheumatic valve diseases

655

1139

4.29

222.93

1.6

1.4

2488.15

3522.97

e6/l

0.58

488

842

Anaemias

240

17.43

222.61

1.6

1.4

3544.69

4832.55

e6/l

0.28

170

Nephropathy related operations

335

496

7.18

216.98

1.7

1.4

1184.09

2011.78

e6/l

2.38

252

365

Acute renal failure

467

962

5.07

213.08

1.7

1.4

2609.57

2462.31

e6/l

0.06

342

699

Asthma (mode)

529

535

5.48

210.41

1.5

1.2

2770.09

2469.49

e6/l

0.17

402

348

Chronic kidney disease

618

1594

4.00

209.06

1.7

1.4

1795.84

2658.60

e6/l

0.59

456

1170

Mesothelioma

143

32.77

205.45

2.0

1.3

1669.80

1920.84

e6/l

0.20

118

Asthma (only as main-diagnosis)

485

532

5.55

204.39

1.5

1.2

3049.92

2473.59

e6/l

0.28

360

347

Malignant neoplasm of heart, mediastinum and pleura

136

37.19

204.36

2.0

1.3

1786.32

1856.74

e6/l

0.04

117

Other septicaemia

623

1613

3.89

203.86

1.6

1.4

4450.98

2743.30

e6/l

0.48

464

1179

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

216

202

11.59

202.61

1.8

1.5

1457.16

1720.58

e6/l

0.45

166

141

Other diseases of pericardium

164

18.45

200.08

1.6

1.2

1692.96

3239.58

e6/l

1.29

125

Condition for Implicit Sepsis (Organ dysfunction codes)

1020

2562

2.93

199.00

1.5

1.4

3909.04

3061.41

e6/l

0.34

747

1859

COPD/asthma/ILD related infections

1077

1819

2.99

193.78

1.6

1.4

3434.67

2567.95

e6/l

0.57

805

1288

COPD/asthma related infections

1077

1819

2.99

193.78

1.6

1.4

3434.67

2567.95

e6/l

0.57

805

1288

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

899

1702

3.16

186.69

1.5

2410.63

4281.45

e6/l

1.65

641

1241

Malignant neoplasm, wide definition for exclusion

899

1703

3.16

186.53

1.5

2410.63

4281.45

e6/l

1.65

641

1241

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

898

1702

3.15

186.18

1.5

2413.11

4281.45

e6/l

1.65

640

1241

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

334

578

6.01

184.61

1.4

1.5

1703.74

2753.00

e6/l

1.03

254

417

Malignant neoplasm of bronchus and lung

485

1075

4.42

182.61

1.4

1.5

2745.67

2007.62

e6/l

0.80

374

756

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

396

817

5.02

179.84

1.4

1.5

2079.87

2476.14

e6/l

0.34

297

597

Non-small cell lung cancer, adenocarcinoma

243

313

8.56

179.59

1.5

1.4

2796.34

2030.34

e6/l

0.72

187

218

Non-small cell lung cancer, adenocarcinoma, helper endpoint

243

313

8.56

179.59

1.5

1.4

2796.34

2030.34

e6/l

0.72

187

218

Atrial fibrillation and flutter

394

458

5.72

176.44

1.6

1.3

1411.72

5165.89

e6/l

2.06

286

340

GASTRO-related operations

718

999

3.64

172.80

1.5

1.4

2413.99

5127.51

e6/l

1.80

526

679

Any gastric operation

718

999

3.64

172.80

1.5

1.4

2413.99

5127.51

e6/l

1.80

526

679

Continuous positive airway pressure

317

453

6.21

172.37

1.5

1.4

2609.89

3465.40

e6/l

0.29

238

325

Malignant neoplasm

911

1843

2.96

170.95

1.5

2465.25

3975.83

e6/l

1.32

661

1328

Early onset COPD, excluding more controls

217

255

8.67

169.89

1.4

1.2

5474.96

1447.59

e6/l

1.27

161

160

Care involving dialysis

207

247

8.91

161.68

1.7

1.4

1014.57

1920.51

e6/l

1.20

155

178

Cardiomyopathy

300

538

5.76

159.40

1.6

1.3

4389.20

3040.07

e6/l

0.16

205

392

Atrial fibrillation and flutter with reimbursement

355

402

5.78

159.10

1.6

1.3

1497.21

5200.49

e6/l

1.64

257

297

Fever of other and unknown origin

676

2031

3.13

157.66

1.5

1.4

4451.35

2811.76

e6/l

0.49

508

1463

Diseases of arteries, arterioles and capillaries (FINNGEN)

323

386

5.97

155.35

1.6

1.3

2185.20

5269.17

e6/l

1.11

228

289

Malignant neoplasm of mesothelium and soft tissue

181

204

9.90

149.30

1.8

1.4

1527.29

1639.85

e6/l

0.17

142

150

Non-invasive ventilation

286

479

5.73

149.02

1.5

1.4

3705.04

3196.31

e6/l

0.16

247

340

Any event in cancer register

873

1882

2.78

146.51

1.5

2887.80

4071.47

e6/l

0.75

645

1343

Bacterial pneumonia (organism specified)

666

2051

3.01

144.18

1.5

4232.82

2601.90

e6/l

0.54

499

1477

Ascites

204

289

7.54

137.89

1.6

1.4

1840.83

1887.27

e6/l

0.02

157

213

Pneumothorax

156

158

10.40

137.75

1.7

1.2

6369.93

1510.51

e6/l

0.88

122

100

Aplastic and other anaemias

680

2301

2.86

134.96

1.5

3599.43

2628.12

e6/l

0.27

481

1687

Cardiac arrhythmias

528

1006

3.50

133.86

1.5

1.4

2217.01

4553.95

e6/l

1.64

390

731

Heart failure and coronary heart disease

630

1594

3.03

129.45

1.6

1.5

1407.65

2377.89

e6/l

0.80

468

1158

First line medication for Crohn's disease

1085

2537

2.35

127.79

1.6

1.4

2478.53

3768.30

e6/l

1.34

799

1810

Cardiomyopathy (excluding other)

219

379

5.98

121.03

1.5

1.3

5581.65

3105.03

e6/l

0.24

154

270

Cardiomyopathies, Primary/intrinsic

212

368

5.96

116.81

1.5

1.3

5719.48

3297.44

e6/l

0.23

150

262

Other anaemias

616

2193

2.76

115.30

1.5

3853.08

2645.10

e6/l

0.31

431

1609

Other and unspecified anaemias

609

2175

2.76

113.95

1.5

3893.24

2660.53

e6/l

0.31

425

1596

Erysipelas

633

2159

2.71

113.64

1.5

1.4

3640.11

2943.75

e6/l

0.18

462

1561

Presence of cardiac and vascular implants and grafts

675

2008

2.59

105.38

1.6

1.5

1343.57

3316.76

e6/l

2.67

508

1442

Extracorporeal dialysis

162

240

7.21

105.22

1.7

1.4

622.00

1674.75

e6/l

5.85

122

174

Malaise and fatigue

578

1775

2.75

104.52

1.5

1.4

2939.06

2284.10

e6/l

0.33

420

1273

Primary_lymphoid and hematopoietic malignant neoplasms

320

851

3.85

104.24

1.6

1.5

2729.85

2902.37

e6/l

0.08

235

623

Certain infectious and parasitic diseases

889

1892

2.37

104.03

1.6

1.4

2310.57

3330.00

e6/l

1.05

636

1367

Valvular operations

223

456

5.03

102.45

1.6

1.3

3890.63

2787.29

e6/l

0.24

161

334

Bleeding

911

3004

2.23

102.25

1.5

3826.87

2898.95

e6/l

0.36

665

2176

ILD medications: prednisolone, methylprednisolone, prednisone

1052

2787

2.15

101.77

1.6

1.4

2556.51

3541.14

e6/l

1.00

779

2013

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

903

2762

2.24

101.23

1.5

2295.92

3670.57

e6/l

1.51

680

1974

Diseases of arteries, arterioles and capillaries

828

2723

2.30

100.19

1.5

1793.53

3060.43

e6/l

1.81

583

2004

Benign neoplasm of colon, rectum, anus and anal canal

521

1298

2.90

100.01

1.5

1.4

1892.43

4478.16

e6/l

1.97

362

953

Oral corticosteroids

1036

2969

2.13

99.53

1.6

1.4

2654.36

3458.83

e6/l

0.79

783

2143

Cardiovascular diseases (excluding rheumatic etc)

381

601

3.68

99.25

1.5

1.3

3215.04

6156.37

e6/l

1.34

263

440

Glomerular disorders in diseases classified elsewhere

223

481

4.82

96.50

1.7

1.4

1330.07

1949.47

e6/l

0.69

165

350

Haemorrhage from respiratory passages

442

1393

2.99

95.53

1.5

1.4

2836.94

2626.53

e6/l

0.10

323

979

AV-block

250

526

4.42

95.47

1.6

1.4

1184.66

3038.05

e6/l

2.92

188

392

Complications of surgical and medical care, not elsewhere classified

958

3263

2.12

95.32

1.5

3507.09

3057.57

e6/l

0.16

697

2370

Glomerular diseases

295

796

3.81

94.49

1.6

1.5

1257.24

2213.80

e6/l

1.65

218

579

ILD medications

1056

2797

2.09

94.28

1.6

1.4

2682.46

3538.23

e6/l

0.79

772

2018

Other disorders of fluid, electrolyte and acid-base balance

426

1393

3.01

93.41

1.6

1.4

4518.95

2801.99

e6/l

0.36

327

1010

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

108

113

9.95

93.00

1.3

1.5

1497.30

2641.53

e6/l

0.51

Conduction disorders

334

793

3.56

92.90

1.6

1.4

1177.97

3552.78

e6/l

2.19

245

589

COPD

628

2117

2.49

92.27

1.4

1.5

2995.84

2349.92

e6/l

0.44

466

1530

Benign neoplasm: Colon

474

1273

2.89

92.08

1.5

1.4

1945.08

3710.09

e6/l

1.30

334

937

Tramadol

733

2012

2.36

91.52

1.6

1.4

2602.83

3264.57

e6/l

0.56

516

1439

Hypertensive heart and/or renal disease

397

986

3.19

90.71

1.5

1.4

1365.15

4415.02

e6/l

1.90

294

719

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

214

471

4.67

90.04

1.6

1.5

1592.40

2974.76

e6/l

1.35

162

348

Metabolic disorders

917

2688

2.14

89.67

1.5

1.4

3391.39

3344.48

e6/l

0.01

656

1965

General symptoms and signs

970

2290

2.14

89.65

1.5

1.4

4610.96

3028.22

e6/l

0.65

718

1641

Other chronic obstructive pulmonary disease

607

2063

2.49

89.36

1.4

1.5

2907.17

2378.49

e6/l

0.33

454

1490

Non-allergic asthma (mode), excluding more controls

117

140

8.36

89.22

1.6

1.2

3432.25

1940.32

e6/l

0.73

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

198

402

4.94

89.18

1.3

1.5

1384.74

2145.72

e6/l

1.01

136

297

Inflammatory bowel disease treatment related agents

1060

2990

2.03

88.61

1.6

1.4

2515.17

3527.09

e6/l

1.12

774

2154

Implicit viral Sepsis

272

727

3.83

88.19

1.6

1.4

1284.58

2145.40

e6/l

1.55

198

536

Viral Sepsis

272

727

3.83

88.19

1.6

1.4

1284.58

2145.40

e6/l

1.55

198

536

Hypertensive diseases (excluding secondary)

347

566

3.59

87.45

1.5

1.3

2102.21

5643.07

e6/l

2.13

253

417

Unspecified kidney failure

203

441

4.80

87.24

1.6

1.4

1339.07

1703.58

e6/l

0.35

142

331

Cerebrovascular diseases (FINNGEN)

265

462

4.15

87.17

1.6

1.3

4041.24

4934.46

e6/l

0.17

201

341

Diabetic nephropathy, excluding more controls

243

488

4.30

86.44

1.6

1.5

1290.11

3386.89

e6/l

1.46

182

335

Acute tubulo-interstitial nephritis

623

2333

2.39

86.26

1.5

1.4

3500.00

3177.60

e6/l

0.12

449

1721

L01XE Protein kinase inhibitors

143

232

6.56

85.16

1.4

1.5

1693.25

1788.80

e6/l

0.12

113

163

Other arrhythmias

497

1429

2.69

84.70

1.6

1.4

2816.17

4128.88

e6/l

0.80

361

1048

Transplanted organ and tissue status

162

299

5.61

83.77

1.6

1.4

1952.09

2002.91

e6/l

0.02

115

209

Pulmonary heart disease, diseases of pulmonary circulation

444

1643

2.76

83.48

1.4

1.5

2048.07

2788.25

e6/l

0.77

323

1178

Pericarditis

12.56

82.10

1.4

1.2

2081.93

1938.02

e6/l

0.11

Other chronic obstructive pulmonary disease, including avohilmo

676

2516

2.27

81.08

1.4

1.5

3031.55

2813.13

e6/l

0.11

508

1830

Opioids

833

2053

2.14

78.83

1.5

1.4

2117.85

3335.44

e6/l

1.67

605

1466

Symptoms and signs involving the circulatory and respiratory systems

812

1883

2.17

78.54

1.5

1.4

2548.75

3280.97

e6/l

0.62

604

1321

COPD, early/later onset

616

2282

2.32

77.75

1.4

1.5

3329.91

2832.53

e6/l

0.23

460

1659

COPD, hospital admissions

611

2268

2.32

77.26

1.5

3361.58

2832.25

e6/l

0.24

455

1651

Respiratory insufficiency

102

127

8.23

76.32

1.5

1.3

3584.34

985.66

e6/l

1.37

Complications of procedures, not elsewhere classified

761

3170

2.09

75.92

1.5

3758.06

3064.42

e6/l

0.22

569

2302

Neoplasms

533

1120

2.57

75.35

1.5

1.4

2917.75

5315.61

e6/l

1.27

374

822

Peripheral artery disease

610

2176

2.29

74.53

1.5

1330.39

3121.00

e6/l

2.49

433

1615

Dental caries

311

996

3.14

74.51

1.6

1.4

5264.68

2263.03

e6/l

0.48

220

721

Dentinal caries

288

886

3.29

74.50

1.6

1.4

5482.00

2204.77

e6/l

0.48

202

643

Paroxysmal tachycardia

194

372

4.46

74.14

1.6

1.3

1467.11

4850.55

e6/l

1.35

144

281

Any reimbursement code in KELA

309

433

3.59

73.82

1.5

1.3

3005.36

5686.50

e6/l

1.01

212

313

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

294

539

3.48

73.45

1.5

1.3

5491.38

5504.79

e6/l

0.00

212

396

Pacemaker

490

1967

2.47

73.26

1.6

1.5

1268.14

2715.56

e6/l

2.53

355

1427

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

14.00

73.21

1.4

1240.04

1616.71

e6/l

0.40

Pulmonary embolism

394

1471

2.73

72.89

1.4

1.5

2200.28

2817.58

e6/l

0.53

284

1056

Pulmonary heart disease

394

1481

2.71

71.93

1.4

1.5

2200.28

2799.00

e6/l

0.51

284

1065

All influenza

257

758

3.44

71.69

1.6

1.4

1342.79

2247.80

e6/l

1.89

193

540

COPD related to multimorbidity

549

2018

2.33

70.26

1.5

3431.49

1948.02

e6/l

1.04

409

1462

Asthma-related pneumonia

444

1798

2.50

69.23

1.5

2514.76

2453.02

e6/l

0.04

324

1292

Asthma-related pneumonia or sepsis

444

1800

2.50

69.06

1.5

2514.76

2453.02

e6/l

0.04

324

1292

Asthma, hospital admissions 3, pneumonia

444

1800

2.50

69.06

1.5

2514.76

2453.02

e6/l

0.04

324

1292

Ulcer of lower limb, not elsewhere classified

237

686

3.56

68.64

1.6

1.5

2257.16

1851.17

e6/l

0.20

159

511

Hypertensive Heart Disease

336

951

2.95

68.44

1.5

1.4

1475.69

4275.39

e6/l

1.55

252

690

Other CVD (FINNGEN)

145

211

5.54

68.28

1.6

1.3

11341.23

5612.72

e6/l

0.35

112

159

Venous thromboembolism

610

2770

2.16

67.59

1.5

3359.22

2574.07

e6/l

0.31

439

2012

Infections, IBD-co-morbidities

217

407

3.95

67.21

1.6

1.4

3371.75

3329.15

e6/l

0.01

161

278

DVT of lower extremities and pulmonary embolism

507

2212

2.32

66.57

1.4

1.5

2208.58

2657.62

e6/l

0.45

364

1603

Explicit bacterial Sepsis

160

360

4.58

65.65

1.6

1.4

7354.19

1746.74

e6/l

0.46

113

268

Atherosclerosis, excluding cerebral and coronary sclerosis

573

2089

2.23

65.35

1.5

1346.73

2690.80

e6/l

2.41

406

1551

COPD, hospital admission 2, with asthma infections

459

1637

2.44

65.04

1.5

3182.34

2017.45

e6/l

0.77

340

1185

COPD, hospital admissions 3, with asthma pneumonia sepsis

415

1417

2.54

64.20

1.5

3292.04

2011.06

e6/l

0.75

304

1023

Hyperkalaemia

123

228

5.67

63.72

1.6

1.4

853.02

1789.99

e6/l

2.50

166

Cardiovascular diseases

300

510

3.22

63.34

1.5

1.3

3613.62

4246.81

e6/l

0.32

209

371

Viral pneumonia

151

334

4.62

63.17

1.6

1.3

1409.05

2081.51

e6/l

0.95

113

241

Complications of medical and surgical care

689

3285

2.01

62.70

1.5

3969.69

3004.91

e6/l

0.27

494

2400

Hypertension, essential

617

1626

2.18

62.41

1.5

1.4

1785.47

4855.44

e6/l

3.22

435

1188

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

421

1329

2.50

62.36

1.4

1.5

1707.63

3380.21

e6/l

1.27

305

977

Polyarthropathies

691

2263

2.05

62.16

1.6

1.4

2493.45

3478.58

e6/l

0.84

495

1628

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

280

577

3.20

62.06

1.3

1.4

4197.02

3548.56

e6/l

0.10

208

418

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

280

577

3.20

62.05

1.3

1.4

4197.02

3548.56

e6/l

0.10

208

418

Pleural plaque

145

317

4.72

61.75

1.4

1.2

3957.25

2635.46

e6/l

0.25

123

206

Pain in throat and chest

640

1864

2.11

60.95

1.5

1.4

4051.76

3078.43

e6/l

0.27

460

1307

Iron deficiency anaemia

459

1985

2.32

60.52

1.5

4299.85

2690.53

e6/l

0.33

337

1424

Streptococcal septicaemia

142

313

4.69

59.94

1.6

1.4

7893.61

1944.28

e6/l

0.44

104

227

Primary_lymphoid and hematopoietic malignant neoplasms

320

1194

2.73

59.48

1.6

1.5

2729.85

2575.19

e6/l

0.08

235

873

Abscess of lung

13.44

59.15

1.4

1.3

18675.63

1642.71

e6/l

1.05

Cardiomyopathy, other and unspecified

112

203

5.68

59.10

1.6

1.3

9885.66

2546.27

e6/l

0.37

146

ILD medications: immunosuppressive drugs

504

2208

2.21

59.03

1.5

1.4

3403.06

3790.55

e6/l

0.19

357

1582

Codes for special purposes

402

1678

2.42

58.74

1.6

1.5

2457.60

2594.30

e6/l

0.11

262

1225

Provisional assignment of new diseases of uncertain etiology

401

1675

2.42

58.51

1.6

1.5

2463.20

2591.50

e6/l

0.10

261

1223

Codeine

732

2032

1.99

58.12

1.5

1.4

4060.60

3291.07

e6/l

0.22

531

1451

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

10.52

57.96

1.2

1.4

1783.79

1332.94

e6/l

0.32

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

167

427

4.00

57.86

1.5

2095.29

2672.17

e6/l

0.39

119

313

Covid-19 confirmed case

307

1136

2.74

57.81

1.5

2556.99

2479.16

e6/l

0.05

191

825

Diabetic nephropathy

246

800

3.13

57.61

1.6

1.5

1283.91

3285.69

e6/l

0.92

183

561

Calcific aortic valvular stenosis

430

1829

2.35

57.56

1.6

1.5

1479.29

2225.32

e6/l

0.95

308

1333

Calcific aortic valvular stenosis, operated

430

1829

2.35

57.56

1.6

1.5

1479.29

2225.32

e6/l

0.95

308

1333

Secondary hypertension

152

6.40

57.30

1.5

1.2

869.41

2858.85

e6/l

4.94

110

Operations 2 for CAVS

428

1827

2.34

56.82

1.6

1.5

1481.06

2227.87

e6/l

0.95

307

1331

Calcific aortic valvular stenosis, diagnosis (helper)

428

1827

2.34

56.82

1.6

1.5

1481.06

2227.87

e6/l

0.95

307

1331

Insulin medication

606

2563

2.04

56.58

1.7

1.4

1573.77

3437.14

e6/l

2.89

444

1872

Dialysis

111

7.66

56.34

1.6

1.4

376.00

2337.34

e6/l

3.45

Calcific aortic valvular stenosis, including rheumatic fever

428

1832

2.33

56.34

1.6

1.5

1481.06

2223.49

e6/l

0.94

307

1334

L04AD Calcineurin inhibitors

136

304

4.59

56.27

1.7

1.5

1345.29

2739.54

e6/l

1.90

222

Type 2 diabetes, wide definition

761

2622

1.91

55.46

1.6

1.4

1701.75

3496.28

e6/l

3.47

534

1924

Adjustment and management of implanted device

257

887

2.96

55.42

1.6

1.5

1402.90

2220.37

e6/l

1.03

147

632

Parasetamol

636

1576

2.07

55.07

1.5

1.4

2724.33

2769.01

e6/l

0.03

456

1103

Non-allergic asthma (mode)

117

233

5.02

54.54

1.6

1.2

3432.25

1395.76

e6/l

1.17

151

Chronic periapical parodontitis

246

840

2.98

53.96

1.5

1.4

2648.27

2062.72

e6/l

0.35

184

610

Other diseases of the respiratory system

291

1091

2.72

53.71

1.5

4178.86

2106.84

e6/l

0.90

237

779

Other respiratory disorders and diseases

291

1091

2.72

53.71

1.5

4178.86

2106.84

e6/l

0.90

237

779

Nutritional anaemias

516

2409

2.11

53.65

1.5

3966.17

2672.89

e6/l

0.29

382

1741

Chronic periodontitis

211

665

3.25

53.31

1.6

1.5

3624.62

2160.32

e6/l

0.86

151

488

Allergic asthma (mode), excluding more controls

126

6.66

53.16

1.4

1.2

3005.50

1889.63

e6/l

0.79

Disorders of lipoprotein metabolism and other lipidaemias

763

2584

1.87

52.10

1.5

1.4

2144.18

3370.30

e6/l

1.43

534

1895

Hypertensive diseases

593

1642

2.06

51.84

1.5

1.4

1853.62

4865.81

e6/l

3.14

426

1201

Hypertension

592

1642

2.05

51.49

1.5

1.4

1857.16

4865.81

e6/l

3.13

425

1201

Preparatory care for dialysis

182

5.69

50.83

1.6

1.4

1552.78

1640.76

e6/l

0.03

127

Hypothyroidism (congenital or acquired)

110

102

6.23

50.80

1.6

1.3

1807.67

4961.08

e6/l

2.56

Other disorders of skin and subcutaneous tissue

646

3122

1.91

50.76

1.5

3431.36

2783.45

e6/l

0.23

476

2260

Amputation

168

480

3.61

49.76

1.7

1.4

2095.40

1909.64

e6/l

0.07

115

358

Undetermined asthma, excluding more controls

7.71

48.74

1.5

1.2

3996.90

1690.27

e6/l

2.13

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

564

2898

1.96

48.13

1.5

4182.75

2763.77

e6/l

0.36

413

2109

Hernia of abdominal wall, postoperative

154

425

3.67

47.72

1.5

1.4

3799.99

2995.83

e6/l

0.22

109

293

Hypothyroidism, levothyroxine purchases

106

102

6.01

47.50

1.6

1.3

1853.45

4961.08

e6/l

2.50

Hypothyroidism and >3 levothyroxin purchases

106

102

6.01

47.50

1.6

1.3

1853.45

4961.08

e6/l

2.50

Oedema, not elsewhere classified

312

1275

2.46

47.41

1.6

1.4

2087.53

2016.97

e6/l

0.04

223

910

Chronic lower respiratory diseases

964

3068

1.71

47.32

1.5

3594.97

3112.11

e6/l

0.19

708

2205

Lung transplant status

30.43

47.16

1.6

1.4

2310.39

1300.57

e6/l

—

Lung transplantation

30.42

47.15

1.6

1.4

2310.39

1300.57

e6/l

—

Other and unspecified iron deficiency

339

1458

2.35

46.55

1.6

1.5

5152.14

2883.33

e6/l

0.34

241

1060

Hypo-osmolality and hyponatraemia

216

746

2.94

46.29

1.7

1.5

3203.95

2455.52

e6/l

0.30

181

551

Hard cardiovascular diseases

713

2514

1.83

46.10

1.5

2505.00

3597.39

e6/l

0.74

533

1813

Diseases of pulp and periapical tissues

336

1448

2.35

45.90

1.5

1.4

2640.91

2976.92

e6/l

0.18

248

1039

Autoimmune diseases excluding thyroid diseases

878

2823

1.74

45.87

1.6

1.4

3033.82

3147.18

e6/l

0.06

650

2042

Autoimmune diseases excluding thyroid diseases, strict definition

853

2742

1.74

45.27

1.6

1.4

3047.62

3199.33

e6/l

0.08

631

1981

Insulin, combination of fast acting with intermediate-acting or long-acting

607

3008

1.88

45.15

1.7

1.4

1571.04

3223.25

e6/l

2.88

445

2190

Gout

379

1574

2.23

44.81

1.7

1.4

1665.21

3456.49

e6/l

1.49

270

1147

Peripheral arterial reconstruction

261

1020

2.62

44.52

1.5

1300.83

2295.89

e6/l

1.17

189

740

Benign neoplasms

460

1225

2.13

44.46

1.5

1.4

2487.97

5285.40

e6/l

1.77

335

897

In situ neoplasms

276

1048

2.54

44.44

1.5

3131.68

2633.42

e6/l

0.12

176

776

Insulin, fast-acting

359

1615

2.25

44.27

1.7

1.4

1303.22

2467.49

e6/l

2.82

264

1165

Anaemia in chronic diseases classified elsewhere

7.58

44.20

1.5

1.4

1383.41

2212.52

e6/l

0.53

Type 1 diabetes

240

898

2.70

44.18

1.6

1.5

1212.37

2483.58

e6/l

2.16

176

665

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

201

540

3.05

44.09

1.4

4509.21

3694.37

e6/l

0.10

149

390

Pure hypercholesterolaemia

673

2489

1.83

43.51

1.5

1.4

2196.93

3326.10

e6/l

1.16

480

1827

Asthma-related infections

510

2592

1.95

43.25

1.5

2532.61

2831.35

e6/l

0.26

378

1864

Asthma, hospital admission 2, infections

510

2592

1.95

43.25

1.5

2532.61

2831.35

e6/l

0.26

378

1864

Later onset COPD

406

1501

2.16

43.03

1.5

2159.91

1884.13

e6/l

0.28

304

1085

Endocarditis

8.15

42.82

1.6

1.2

8739.42

2907.11

e6/l

0.34

Gout, FINNGEN

379

1772

2.17

42.77

1.7

1.4

1665.21

2129.29

e6/l

0.62

270

1293

Insulin, intermediate and long-acting

540

2803

1.91

42.66

1.7

1.4

1438.38

3324.33

e6/l

3.28

399

2037

Diseases of oesophagus, stomach and duodenum

868

3129

1.69

42.53

1.5

1.4

4063.78

2942.59

e6/l

0.46

628

2274

Other dialysis

102

6.95

42.50

1.7

1.4

452.82

2467.97

e6/l

2.94

STROKE

483

1670

2.02

42.46

1.5

1.4

1966.51

3601.10

e6/l

2.19

369

1205

Secondary uncertain malignant neoplasm

186

624

3.06

42.42

1.6

1.5

1648.42

1727.64

e6/l

0.12

146

458

Depression medications

113

109

5.24

41.82

1.6

1.4

2651.41

5530.01

e6/l

2.05

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

230

390

2.97

41.76

1.4

1.3

1990.69

4441.67

e6/l

0.98

160

272

Coronary atherosclerosis

655

2344

1.82

41.17

1.5

2196.15

3666.60

e6/l

1.18

480

1693

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

429

1416

2.09

40.84

1.4

1.5

2154.19

3559.08

e6/l

1.00

296

1040

Hypothyroidism, drug reimbursement

7.20

40.73

1.6

1.2

2599.12

5205.10

e6/l

0.89

Care involving use of rehabilitation procedures

477

2332

1.95

40.61

1.4

5463.53

3324.04

e6/l

0.49

353

1672

530

2613

1.88

39.61

1.5

8037.63

2480.95

e6/l

1.61

392

1893

Insulin, fast-acting or short human

361

1704

2.14

39.52

1.7

1.5

1299.34

2497.37

e6/l

2.99

265

1232

Peripheral artery operations in Hilmo

188

667

2.88

38.73

1.6

1.5

1998.38

1814.16

e6/l

0.09

130

491

Serous carcinoma of ovary

106

6.43

38.53

1.2

1.3

1783.79

1637.93

e6/l

0.09

Cardiodefibrillation

427

2166

2.00

38.46

1.6

1.5

1584.31

3042.71

e6/l

1.65

303

1579

Amputation of toe

123

341

3.74

38.35

1.6

1.4

2570.76

1627.95

e6/l

0.37

243

Chronic periodontitis, complicated

132

383

3.54

38.29

1.6

1.5

5477.27

1814.41

e6/l

1.61

274

Substance abuse, excluding more controls

494

2289

1.90

38.23

1.5

9288.87

2205.88

e6/l

2.08

375

1638

L04AA Selective immunosuppressants

199

733

2.75

38.03

1.7

1.5

3214.90

2232.06

e6/l

0.51

134

531

Type 1 diabetes, wide definition, subgroup 1

186

661

2.84

37.92

1.6

1.5

1347.73

2491.60

e6/l

1.31

135

487

Alcohol use disorder, Swedish definition

507

2532

1.87

37.78

1.5

8118.60

2512.59

e6/l

1.53

376

1832

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

141

430

3.35

37.73

1.5

1374.36

2372.41

e6/l

0.94

310

Major coronary heart disease event

688

2666

1.74

37.39

1.5

2631.07

3521.25

e6/l

0.51

508

1933

malignant neoplasm of female genital organs

159

526

3.08

37.11

1.3

1.4

1276.86

3799.91

e6/l

1.32

115

390

Benign neoplasm: Colon, unspecified

219

853

2.59

37.06

1.5

1376.81

2641.78

e6/l

1.72

154

628

Antihypertensive medication - note that there are other indications

295

677

2.39

36.92

1.5

1.4

2819.62

4566.33

e6/l

1.41

200

485

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

187

681

2.81

36.74

1.8

1.5

10752.53

1927.59

e6/l

0.81

132

490

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

125

361

3.54

36.46

1.5

1488.57

2416.34

e6/l

0.69

262

538

2666

1.82

36.42

1.5

7912.42

2510.89

e6/l

1.59

400

1931

Fall on same level

873

3007

1.63

36.36

1.5

1.4

3738.10

3223.62

e6/l

0.17

634

2169

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

183

4.75

36.16

1.4

1626.35

1560.89

e6/l

0.07

127

Diseases of the digestive system

459

2432

1.90

36.13

1.6

1.5

4748.44

2547.57

e6/l

0.53

351

1758

Disorders of lens

616

2205

1.77

35.85

1.5

2721.66

3476.55

e6/l

0.38

433

1616

Other bacterial intestinal infections

201

769

2.66

35.75

1.6

1.5

3088.22

2034.59

e6/l

0.24

161

569

Diabetes mellitus

778

2803

1.66

35.71

1.5

1.4

2617.70

3476.03

e6/l

0.64

539

2053

Kidney transplant status

139

5.34

35.63

1.7

1.4

814.55

2308.86

e6/l

2.43

Diabetes, varying definitions

777

2804

1.66

35.63

1.5

1.4

2610.17

3477.53

e6/l

0.65

541

2051

Mental and behavioural disorders due to psychoactive substance use

507

2626

1.83

35.53

1.5

9065.21

2502.34

e6/l

1.92

386

1900

Myocardial infarction

524

2057

1.85

35.50

1.5

2596.74

3802.59

e6/l

0.57

391

1489

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

385

1308

2.05

35.07

1.4

1.5

2171.01

3499.47

e6/l

0.82

257

959

Malignant neoplasm of ovary

145

5.22

35.06

1.2

1.3

1504.02

1630.58

e6/l

0.09

105

Major coronary heart disease event excluding revascularizations

642

2577

1.73

35.05

1.5

2626.90

3432.05

e6/l

0.42

475

1863

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

501

2759

1.83

35.05

1.5

4290.32

2749.32

e6/l

0.35

365

2007

Gout, strict definition

240

1011

2.42

34.98

1.7

1.5

1573.92

2278.38

e6/l

0.68

167

737

COPD-related respiratory insufficiency

174

628

2.84

34.87

1.4

1.5

3956.54

1749.44

e6/l

0.57

134

447

Non-follicular lymphoma, hilmo, excluding all cancers

110

301

3.74

34.81

1.6

1.5

2074.92

1504.96

e6/l

0.87

215

Enlarged lymph nodes

156

530

2.98

34.70

1.5

1989.17

2339.26

e6/l

0.43

114

371

Disorders resulting from impaired renal tubular function

125

5.61

34.58

1.7

1.4

728.96

2153.31

e6/l

2.19

ILD, hospital admissions 3, with pneumonia sepsis

108

294

3.77

34.49

1.7

1.4

5865.58

1621.51

e6/l

0.70

216

Substance abuse

494

2598

1.83

34.43

1.5

9288.87

2475.39

e6/l

1.95

375

1880

Type 1 diabetes, wide definition

195

749

2.63

34.23

1.6

1.5

1380.94

2389.33

e6/l

1.16

140

551

Enterocolitis due to Clostridium difficile

147

488

3.08

34.23

1.7

1.4

3752.02

2161.55

e6/l

0.27

116

353

Gout, idiopatic and unspecified

307

1447

2.16

34.10

1.7

1.5

1531.16

2423.26

e6/l

1.25

213

1060

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

387

1324

2.02

33.99

1.4

1.5

2182.83

3468.29

e6/l

0.80

263

973

Cerebrovascular diseases

696

2995

1.68

33.98

1.5

2787.76

3174.11

e6/l

0.20

514

2175

ILD, hospital admission 2, with pulmonary infections

115

331

3.55

33.76

1.7

1.3

5747.80

1689.63

e6/l

0.68

240

Ischemic heart diseases

671

2485

1.70

33.75

1.5

2933.98

3618.72

e6/l

0.31

497

1796

Diseases of liver

309

1471

2.12

33.28

1.7

1.5

7666.80

2309.94

e6/l

0.83

223

1067

Iron deficiency anaemia secondary to blood loss (chronic)

185

707

2.66

33.06

1.4

1.5

1756.81

2164.15

e6/l

0.28

149

513

Other diseases of the digestive system

358

1807

2.01

32.92

1.6

1.5

5226.74

2368.82

e6/l

0.55

275

1290

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

380

1317

2.00

32.56

1.4

1.5

2218.44

3482.53

e6/l

0.76

253

966

GI-bleeding

361

1837

1.99

32.44

1.6

1.5

5164.35

2360.94

e6/l

0.55

279

1311

Disorders of choroid and retina

717

3201

1.64

32.41

1.5

3419.69

2996.09

e6/l

0.12

520

2330

Bacterial intestinal infections, IBD co-morbidities

198

790

2.54

32.36

1.6

1.5

3136.82

2032.72

e6/l

0.25

158

583

Ischaemic heart disease, wide definition

661

2468

1.69

32.22

1.5

2978.67

3588.66

e6/l

0.27

487

1786

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

742

2781

1.64

32.21

1.5

1.4

1879.95

3489.08

e6/l

2.92

519

2039

Intestinal infectious diseases

714

3421

1.63

32.05

1.5

1.4

2521.00

3463.72

e6/l

0.68

535

2457

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

269

3.77

31.72

1.6

1.5

969.79

1533.33

e6/l

1.46

192

Allergic asthma (mode)

202

4.15

31.53

1.4

1.3

3005.50

1411.45

e6/l

1.39

132

Glucagon-like peptide-1 (GLP-1) analogues

541

2569

1.75

31.43

1.6

1.4

1892.36

3406.60

e6/l

1.77

399

1882

Type 2 diabetes

751

2766

1.62

31.08

1.5

1.4

2633.20

3487.11

e6/l

0.62

525

2029

Benign neoplasm of colon, rectum, anus and anal canal

582

3121

1.70

30.89

1.5

1798.88

3003.46

e6/l

1.88

407

2303

Infections of the skin and subcutaneous tissue

431

2350

1.84

30.79

1.6

1.5

4507.86

3301.01

e6/l

0.23

324

1691

COPD, hospital admissions 1, only main diagnosis

407

1858

1.89

30.53

1.4

1.5

2890.21

2068.90

e6/l

0.53

303

1351

Endocrine, nutritional and metabolic diseases

546

1572

1.77

30.49

1.6

1.4

2528.50

3897.55

e6/l

1.22

390

1140

Cirrhosis of liver, NAS

206

4.18

30.35

1.9

1.4

1349.25

1686.81

e6/l

0.44

150

Gout, unspecified

252

1157

2.22

30.02

1.7

1.5

1590.83

2386.05

e6/l

0.85

182

838

Other diseases of blood and blood-forming organs, wide

215

923

2.36

29.95

1.5

6170.60

2227.28

e6/l

0.50

172

658

Lymphoid leukaemia

167

4.50

29.58

1.7

1.5

5210.93

1971.91

e6/l

0.77

118

Nonischemic cardiomyopathy

201

4.15

29.54

1.5

1.4

14752.13

2613.77

e6/l

0.46

145

Fibrosis and cirrhosis of liver

105

312

3.46

29.49

1.8

1.4

1453.49

1651.61

e6/l

0.27

228

Diabetes, insulin treatment (Kela reimbursement)

788

3069

1.58

29.49

1.5

1.4

1832.49

3692.52

e6/l

3.16

550

2238

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

139

343

3.03

29.42

1.6

1.4

5109.88

3430.86

e6/l

0.21

233

Diabetes medication

767

2955

1.58

29.21

1.5

1.4

2589.50

3725.13

e6/l

0.86

539

2157

Codeine or tramadol medication

883

3188

1.54

29.18

1.5

4012.96

2986.44

e6/l

0.40

646

2315

Secondary and unspecified malignant neoplasm of lymph nodes

113

354

3.27

29.13

1.8

1.4

1761.13

1788.43

e6/l

0.03

255

Other retinal disorders

587

2844

1.67

28.92

1.5

2070.37

2636.04

e6/l

0.54

432

2070

Diarrhoea and gastroenteritis of presumed infectious origin

518

2760

1.71

28.83

1.5

2184.32

3669.23

e6/l

1.69

385

1960

Coronary artery bypass grafting

351

1381

1.96

28.83

1.5

1185.37

3339.48

e6/l

2.38

254

1006

Diabetic retinopathy, excluding more controls

236

571

2.36

28.69

1.5

4703.18

3219.95

e6/l

0.15

178

396

Undetermined asthma

150

4.57

28.61

1.5

1.3

3996.90

1006.38

e6/l

3.38

100

Other CVD

230

1038

2.25

28.56

1.6

1.5

7698.98

2087.51

e6/l

0.69

176

754

Senile cataract

573

2112

1.69

28.39

1.5

1977.31

2949.93

e6/l

0.97

398

1543

Other acute lower respiratory infections

448

2431

1.77

28.11

1.5

4642.66

2609.29

e6/l

0.75

332

1767

Examination and observation for other reasons

477

1639

1.78

28.03

1.5

1.4

4125.37

2774.71

e6/l

0.33

372

1108

Injuries to the head

813

3447

1.54

27.96

1.5

4362.39

3020.59

e6/l

0.49

606

2484

Vocal cord dysfunction

108

310

3.27

27.77

1.5

1.4

2543.09

2600.08

e6/l

0.03

220

867

3002

1.53

27.65

1.5

1.4

2772.84

3279.68

e6/l

0.34

650

2152

Fungal Sepsis

128

4.95

27.57

1.7

1.4

1973.98

1428.00

e6/l

0.47

Chronic lymphocytic leukaemia, helper endpoint

5.94

27.49

1.7

1.5

1952.61

1711.25

e6/l

0.15

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

5.94

27.49

1.7

1.5

1952.61

1711.25

e6/l

0.15

Use of hypnotics and sedatives

820

3092

1.54

27.36

1.5

3983.10

3075.71

e6/l

0.32

609

2241

Mental and behavioural disorders due to alcohol

430

2390

1.76

26.71

1.5

9174.98

2542.12

e6/l

1.59

324

1730

Osteopathies and chondropathies

434

2364

1.75

26.33

1.5

2735.41

2836.90

e6/l

0.06

322

1681

Amiodarone users

140

524

2.74

26.32

1.5

1137.94

1707.25

e6/l

0.83

100

383

Myocardial infarction, without ST-elevation

445

2376

1.75

26.31

1.4

1.5

1805.69

2562.50

e6/l

0.55

333

1727

Disorders of gallbladder, biliary tract and pancreas

782

3299

1.53

26.24

1.5

3159.59

3043.82

e6/l

0.03

577

2389

Pain, not elsewhere classified

195

850

2.31

26.20

1.5

1.4

4974.38

2206.22

e6/l

1.59

140

597

Mental and behavioural disorders due to alcohol, excluding acute intoxication

384

2137

1.81

26.10

1.5

9951.77

2680.67

e6/l

1.52

286

1538

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

159

4.33

25.92

1.3

1.5

1414.18

1465.43

e6/l

0.05

116

Syncope and collapse

370

1801

1.83

25.81

1.6

1.4

6322.27

2167.31

e6/l

0.82

273

1299

Cardiomyopathy, Hypertrophic obstructive

9.50

25.79

1.6

1.1

713.82

1683.71

e6/l

1.05

Other abnormalities of plasma proteins

7.53

25.78

2.0

1.2

1761.14

1903.47

e6/l

0.07

Symptoms and signs involving the urinary system

642

3145

1.59

25.74

1.5

3203.45

3143.20

e6/l

0.03

467

2287

Direct fill therapy

124

439

2.86

25.74

1.6

1.5

3633.47

2278.28

e6/l

0.33

322

Hodgkin lymphoma

7.26

25.56

1.9

1.3

1500.10

2314.38

e6/l

0.73

Heart failure and hypertrophic cardiomyopathy

6.35

25.49

1.9

1.3

686.14

1716.43

e6/l

2.01

Invasive ventilation

292

3.33

25.32

1.5

1.4

962.74

1738.00

e6/l

2.96

211

Glomerulonephritis

113

385

2.99

25.24

1.5

1.4

1151.00

2031.59

e6/l

1.68

287

Benign neoplasm: Colon

493

2911

1.67

25.23

1.5

1887.20

2988.94

e6/l

1.41

349

2131

Other disorders of kidney and ureter

145

566

2.61

25.00

1.6

1.4

1339.82

2136.64

e6/l

0.89

416

Myocardial infarction, strict

461

1975

1.72

24.82

1.5

1382.28

3603.29

e6/l

2.91

339

1430

Bronchitis

788

3450

1.50

24.23

1.5

2922.07

3200.97

e6/l

0.17

591

2488

Early onset COPD

217

1023

2.15

24.20

1.4

1.5

5474.96

2040.44

e6/l

1.00

161

731

Sub-endpoint used in defining T1D endpoints

260

1286

2.00

24.19

1.6

1.5

1189.95

2249.37

e6/l

1.93

191

921

Acute peritonitis

256

3.44

24.15

1.6

1.4

1206.59

1642.61

e6/l

0.49

185

Benign neoplasm: Rectum, anus and anal canal

161

671

2.43

24.07

1.5

1494.19

2542.93

e6/l

1.27

106

498

All influenza (not pneumonia)

109

373

2.95

24.05

1.6

1.4

1626.42

2089.02

e6/l

0.40

276

Other disorders of glucose regulation and pancreatic internal secretion

287

3.27

23.89

1.6

1.4

13372.27

1704.05

e6/l

0.55

210

Hypertensive Renal Disease

153

4.26

23.78

1.6

1.4

494.28

1919.43

e6/l

4.53

116

Implicit fungal Sepsis

116

4.82

23.77

1.6

1.4

2007.86

1224.74

e6/l

0.71

Benign neoplasm: Sigmoid colon

149

603

2.50

23.76

1.6

1.5

2160.86

2585.43

e6/l

0.26

103

445

Hypokalaemia

115

409

2.86

23.75

1.4

9570.43

2514.72

e6/l

0.45

298

Cough

278

1380

1.94

23.70

1.5

1.4

1995.81

2613.42

e6/l

0.51

224

965

Malignant neoplasm of breast

320

1232

1.89

23.59

1.4

3910.09

2861.01

e6/l

0.22

234

887

Stroke, including SAH

587

2754

1.59

23.45

1.5

1921.24

3022.69

e6/l

1.43

436

1991

Convulsions, not elsewhere classified

173

745

2.31

23.23

1.5

11206.14

2535.32

e6/l

0.83

125

530

Abnormal findings on examination of blood, without diagnosis

444

2488

1.68

23.22

1.6

1.5

2082.62

2854.60

e6/l

0.74

317

1834

Coronary revascularization (ANGIO or CABG)

460

1917

1.69

23.10

1.5

1457.52

3602.04

e6/l

2.79

333

1385

Agranulocytosis

114

412

2.81

22.89

1.5

1.4

9304.95

2191.06

e6/l

0.48

297

Malignant neoplasm of breast, HER2-negative

313

1233

1.88

22.86

1.4

3988.93

2850.35

e6/l

0.23

228

889

Benign neoplasm: Ascending colon

115

418

2.79

22.82

1.8

1.5

1292.06

2805.79

e6/l

1.51

306

Benign neoplasm: Transverse colon

316

3.09

22.81

1.4

1.6

1981.46

2373.19

e6/l

0.25

227

Autoimmune diseases

821

2830

1.49

22.79

1.6

1.4

3724.89

3147.74

e6/l

0.20

605

2046

Benign neoplasm: Rectum

143

581

2.49

22.64

1.5

1324.62

2716.34

e6/l

1.69

427

Alcoholic liver disease

119

443

2.74

22.63

1.7

1.4

15996.72

2059.39

e6/l

0.83

314

Other disorders of teeth and supporting structures

192

886

2.19

22.62

1.6

1.4

3652.54

2103.32

e6/l

0.58

140

642

Used for control exclusion in common control thyroid runs

780

2645

1.50

22.59

1.6

1.4

3726.96

3216.89

e6/l

0.16

572

1913

Viral hepatitis, IBD co-morbidity

5.07

22.34

1.5

1.4

26622.23

2358.31

e6/l

0.57

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

131

492

2.58

22.23

1.4

2644.57

2923.39

e6/l

0.09

358

Gastroduodenal ulcer

286

1531

1.88

22.13

1.4

1.5

6008.47

2287.45

e6/l

0.58

217

1100

Symptoms and signs involving the digestive system and abdomen

774

2603

1.50

22.02

1.5

3012.99

3563.24

e6/l

0.36

567

1891

Unspecified acute lower respiratory infection

139

565

2.49

22.01

1.4

1.5

7133.76

2074.32

e6/l

0.72

101

407

Emergency coronary revascularization (for ACS)

566

2594

1.58

22.01

1.5

1332.30

3150.13

e6/l

3.35

411

1895

Malignant neoplasm of other and unspecified female genital organs

7.35

21.94

1.5

1.2

1369.31

1283.12

e6/l

0.08

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

8.43

21.94

1.6

1.2

781.29

2049.84

e6/l

1.33

Oesophageal varices

154

4.09

21.87

2.0

1.5

941.00

1731.62

e6/l

1.69

105

Pain in limb

577

2675

1.57

21.85

1.5

1.4

2519.61

3002.12

e6/l

0.44

405

1922

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

141

4.23

21.84

1.4

1.5

1294.28

1613.63

e6/l

0.42

101

Other soft tissue disorders, not elsewhere classified

670

2728

1.52

21.73

1.5

1.4

2650.76

3037.02

e6/l

0.32

475

1963

Intestinal stricture

292

1590

1.85

21.58

1.4

1.5

2530.28

2287.60

e6/l

0.13

206

1145

Asthma (diagnoses ohter than nonallergic)

626

3528

1.52

21.50

1.5

3180.63

3200.95

e6/l

0.01

459

2556

Abnormalities of heart beat

240

1214

1.97

21.48

1.6

1.4

2514.56

2631.42

e6/l

0.05

183

846

Symptoms and signs concerning food and fluid intake

103

365

2.86

21.41

1.4

1718.57

2102.04

e6/l

0.44

262

Other cataract

387

1760

1.71

21.13

1.5

2694.95

2441.24

e6/l

0.12

290

1281

Cellulitis

186

872

2.15

21.09

1.6

1.5

6597.16

2426.43

e6/l

0.43

144

622

Fracture of femur

280

1379

1.87

21.04

1.4

1.5

4891.62

2031.23

e6/l

0.40

201

998

Diseases of the skin and subcutaneous tissue

755

2557

1.49

20.88

1.6

1.4

2254.51

2961.40

e6/l

1.07

546

1861

Osteomyelitis

260

3.23

20.86

1.7

1.4

2953.49

1770.67

e6/l

0.41

187

Polyneuropathies and other disorders of the peripheral nervous system

219

1099

2.02

20.76

1.6

1.5

1679.93

2458.48

e6/l

0.98

161

803

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

121

4.42

20.72

1.4

1.6

1843.27

1733.25

e6/l

0.08

Pneumonia derived septicemia

117

4.50

20.72

1.3

1.4

1666.97

1682.95

e6/l

0.01

Nephrotic syndrome

4.90

20.71

1.6

1.4

1695.00

2405.37

e6/l

0.33

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

134

4.22

20.66

1.7

1.5

2165.29

1839.39

e6/l

0.25

Diffuse large B-cell lymphoma, helper endpoint

134

4.22

20.66

1.7

1.5

2165.29

1839.39

e6/l

0.25

Medical observation and evaluation for suspected diseases and conditions

525

1681

1.61

20.63

1.5

1.4

2338.28

2724.46

e6/l

0.39

418

1140

Hyperlipidaemia, other/unspecified

357

1975

1.72

20.55

1.5

1.4

1537.60

2746.80

e6/l

2.03

244

1448

Hypoglycaemia, other or unspecified

227

3.37

20.52

1.6

1.4

14547.14

1695.70

e6/l

0.48

168

Symptoms and signs involving cognition, perception, emotional state and behaviour

707

3361

1.48

20.48

1.5

4468.12

2834.57

e6/l

0.57

525

2426

Need for other prophylactic measures

181

3.67

20.24

1.5

1.4

2659.73

1741.15

e6/l

0.59

131

Pneumococcal septicemia

111

4.56

20.24

1.3

1603.42

1615.67

e6/l

0.01

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

732

3259

1.47

20.11

1.6

1.5

3053.38

3239.43

e6/l

0.05

531

2372

Chronic pancreatitis

128

525

2.48

19.98

1.6

1.4

9590.01

2264.60

e6/l

0.50

375

Hypotension

186

893

2.11

19.94

1.5

9273.37

2016.59

e6/l

0.73

141

656

Nausea and vomiting

213

1055

2.00

19.85

1.5

3697.22

2534.98

e6/l

0.25

160

755

Idiopathic gout

118

469

2.57

19.78

1.8

1.5

2479.44

1778.55

e6/l

0.29

346

Alcohol use disorder, ICD-based

340

1986

1.72

19.78

1.6

1.5

10237.98

2665.09

e6/l

1.34

252

1428

Substance use, excluding alcohol

136

576

2.38

19.68

1.4

1.5

17372.58

2752.53

e6/l

1.32

108

412

Stroke, excluding SAH

553

2682

1.54

19.57

1.5

1780.39

2922.02

e6/l

1.56

411

1934

Conotruncal defects

14.32

19.44

1.6

1.5

4770.17

2411.13

e6/l

—

Asthma/COPD (KELA code 203)

644

3062

1.49

19.21

1.5

4661.88

3111.82

e6/l

0.48

485

2200

Coagulation defects, purpura and other haemorrhagic conditions

165

767

2.17

19.19

1.4

1.5

3562.84

2271.02

e6/l

0.34

134

564

Left ventricular outflow tract obstruction (LVOTO), broad definition

321

2.88

19.17

1.5

6687.66

2646.16

e6/l

0.46

232

Other diseases of intestines

726

2896

1.46

19.17

1.5

1.4

2532.01

3774.89

e6/l

1.36

527

2099

Volume depletion

105

400

2.67

19.14

1.5

1.4

1260.76

1935.21

e6/l

1.07

297

Other (not insulin) diabetes medications

701

2892

1.47

18.94

1.5

1.4

2731.56

3721.99

e6/l

0.65

491

2118

Asthma and allergy, excluding more controls

6.22

18.93

1.8

1.2

3948.48

2069.09

e6/l

0.51

Insulin, fast-acting (human)

111

436

2.57

18.93

1.5

1.4

902.00

2384.09

e6/l

4.10

320

Cardiac arrest

147

3.69

18.82

1.6

1.3

2179.56

2936.11

e6/l

0.23

110

Unspecified privation

105

404

2.64

18.74

1.6

1.4

2662.36

1928.07

e6/l

0.44

298

Fentanyl

108

423

2.59

18.58

1.6

1.5

1852.77

1987.87

e6/l

0.08

312

Paralytic ileus and intestinal obstruction

243

1313

1.87

18.47

1.5

2893.53

2738.90

e6/l

0.06

171

940

Amputation of foot

120

4.27

18.44

1.6

1.5

842.07

1739.53

e6/l

2.17

Sequelae of external causes of morbidity and mortality

214

1112

1.94

18.36

1.6

1.5

2028.36

2123.55

e6/l

0.08

148

805

Chronic viral hepatitis

4.89

18.27

1.6

1.3

30532.30

1832.21

e6/l

0.59

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

156

3.75

18.26

1.7

1.5

1014.29

1665.10

e6/l

0.96

110

Non-small cell lung cancer, squamous, helper endpoint

293

2.95

18.24

1.4

1.5

1626.35

1980.08

e6/l

0.35

211

Non-small cell lung cancer, squamous

293

2.95

18.24

1.4

1.5

1626.35

1980.08

e6/l

0.35

211

Other and unspecified polyneuropathies, also in other diseases

193

972

2.01

18.20

1.6

1.5

1641.60

2140.99

e6/l

0.52

140

703

Type 2 diabetes, strict (exclude DM1)

674

2755

1.47

18.16

1.5

1.4

2907.49

3464.86

e6/l

0.32

464

2022

Type 2 diabetes, definitions combined

669

2732

1.47

18.07

1.5

1.4

2936.41

3475.86

e6/l

0.30

462

2006

Injuries to the thorax

373

2289

1.64

18.03

1.5

4233.88

3270.39

e6/l

0.31

278

1664

Diabetic retinopathy

313

1134

1.76

17.99

1.5

4098.58

2384.33

e6/l

0.25

232

806

Falls/tendency to fall

760

2653

1.44

17.96

1.5

1.4

2529.47

3120.25

e6/l

0.41

551

1922

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

119

479

2.43

17.87

1.8

1.5

1847.21

2405.79

e6/l

0.50

342

Factors influencing health status and contact with health services

244

638

1.93

17.84

1.4

1854.87

4007.92

e6/l

2.28

178

437

Hodgkin lymphoma, hilmo

5.01

17.67

1.9

1.3

1500.10

1854.98

e6/l

0.32

Ischaemic Stroke, excluding all haemorrhages

524

2618

1.52

17.63

1.4

1.5

1745.32

3029.25

e6/l

1.74

389

1890

L04AX Other immunosuppressants

366

2247

1.64

17.62

1.5

3114.69

3096.05

e6/l

0.01

257

1627

Fracture of rib(s), sternum and thoracic spine

262

1473

1.79

17.55

1.5

4298.21

2457.07

e6/l

0.62

195

1077

Acute bronchitis

334

1966

1.67

17.51

1.5

3376.96

2574.92

e6/l

0.28

249

1418

Hypertrophic cardiomyopathy

166

3.60

17.45

1.8

1.4

724.74

1726.74

e6/l

3.20

117

Misadventures to patients during surgical and medical care

125

540

2.34

17.42

1.7

1.4

2530.04

2295.49

e6/l

0.07

398

Cytomegaloviral disease

6.19

17.41

1.5

1.4

725.05

2859.67

e6/l

1.11

Gastric ulcer

188

953

2.00

17.41

1.4

1.5

3430.48

1873.21

e6/l

0.46

141

685

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

116

4.16

17.41

1.4

1.5

1536.47

1870.95

e6/l

0.29

Myocarditis

4.88

17.31

1.4

1.2

2334.46

3183.37

e6/l

0.22

Lymphoid leukaemia

243

3.08

17.19

1.7

1.4

5210.93

1722.13

e6/l

0.86

175

Non-follicular lymphoma

110

454

2.47

17.06

1.6

1.4

2074.92

1828.57

e6/l

0.28

328

Chronic ulcer of skin, not elsewhere classified

304

2.82

17.00

1.6

1.4

2124.31

1643.50

e6/l

0.18

221

Other viral hepatitis

109

4.18

16.99

1.6

1.4

27505.87

2414.26

e6/l

0.57

Hernia

671

3173

1.44

16.89

1.5

2076.23

3479.62

e6/l

2.00

475

2307

Colorectal cancer, excluding all cancers (controls excluding all cancers)

205

1044

1.91

16.83

1.4

1.5

1052.54

2537.34

e6/l

3.21

150

770

Persons encountering health services for specific procedures, not carried out

179

3.40

16.83

1.7

1.3

25687.47

1984.37

e6/l

0.57

125

Viral pneumonia (known virus, not influenza)

4.81

16.72

1.4

1.3

1265.54

2015.58

e6/l

0.51

Intracranial trauma

387

1805

1.61

16.66

1.5

1.4

3719.87

3250.40

e6/l

0.15

290

1249

Gastrointestinal diseases

367

1109

1.66

16.62

1.5

1.4

2428.52

4108.63

e6/l

1.28

265

804

Aortic valve malfunction, age under 60 years

296

2.81

16.62

1.5

1.4

7114.92

2772.14

e6/l

0.43

214

Pneumonia due to other infectious organisms, not elsewhere classified

4.92

16.44

1.6

1.3

2695.45

1510.70

e6/l

0.81

Other symptoms and signs involving the circulatory and respiratory systems

172

3.42

16.44

1.6

1.3

3538.95

1928.64

e6/l

0.74

121

Cytomegalovirus infection, IBD co-morbidity

5.85

16.44

1.5

1.3

725.05

3263.50

e6/l

1.49

Second line medication for Crohn's disease

368

2303

1.61

16.43

1.5

3108.76

3054.07

e6/l

0.03

258

1667

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

6.54

16.42

1.4

1.3

1238.90

2128.06

e6/l

0.66

Immunodeficiency with predominantly antibody defects

5.81

16.41

1.7

1.3

1888.28

1933.37

e6/l

0.02

Secondary right heart disease

198

3.28

16.40

1.4

835.61

1488.42

e6/l

2.41

145

Other/unspecified cytomegaloviral diseases

6.51

16.40

1.4

1.3

595.32

3266.71

e6/l

1.34

L02BA Anti-estrogens

114

486

2.37

16.36

1.4

1461.46

2441.74

e6/l

1.36

355

Other disorders of skin and subcutaneous tissue, not elsewhere classified

132

601

2.22

16.27

1.5

4414.55

2166.48

e6/l

0.43

105

446

Pneumonia due to Streptococcus pneumoniae

100

4.28

16.27

1.3

1.4

21709.06

1554.04

e6/l

0.50

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

4.86

16.20

1.6

1.5

8791.14

2565.47

e6/l

0.67

Purpura and other haemorrhagic conditions

123

546

2.28

16.13

1.5

1.4

2295.75

2223.66

e6/l

0.03

102

400

Type 2 diabetes, definitions combined, including avohilmo

659

2722

1.44

16.13

1.5

1.4

2945.34

3506.25

e6/l

0.31

454

1994

Open wound of lower leg

119

521

2.31

16.10

1.5

1.4

2661.15

2279.52

e6/l

0.24

385

Decubitus ulcer and pressure area

278

2.83

15.71

1.6

1.4

1167.44

1539.90

e6/l

0.67

210

Artificial opening status

203

3.17

15.71

1.6

1.3

4778.50

1849.41

e6/l

0.46

142

Unspecified haematuria

385

2101

1.58

15.69

1.5

2585.57

2755.74

e6/l

0.09

279

1545

Constipation

660

3342

1.42

15.58

1.5

3160.02

2975.92

e6/l

0.08

488

2426

Biguanides

688

3007

1.41

15.54

1.5

1.4

2801.61

3593.08

e6/l

0.48

480

2197

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

336

2.62

15.48

1.4

1.5

3835.74

2344.60

e6/l

0.42

240

Medicines for HER+ breast cancer

220

1187

1.82

15.45

1.4

4174.12

3018.85

e6/l

0.16

163

853

Diseases of peritoneum

103

432

2.42

15.43

1.5

1.4

1222.84

2071.98

e6/l

1.11

316

Injuries to the hip and thigh

395

2331

1.56

15.40

1.5

3875.64

2647.66

e6/l

0.21

282

1685

Immunodeficiencies

127

3.77

15.35

1.7

1.3

1910.35

1700.80

e6/l

0.15

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

385

2.51

15.34

1.6

1.4

2901.58

1996.93

e6/l

0.29

276

Other or unspecified ileus, impaction or obstruction

180

940

1.93

15.32

1.5

1351.87

2215.94

e6/l

1.59

125

670

Congenital malformations of heart and great arteries

354

2.54

15.32

1.8

1.5

2294.43

2066.71

e6/l

0.14

253

Retention of urine

339

1782

1.62

15.30

1.6

1.5

3585.82

2745.23

e6/l

0.28

240

1318

Deposits [accretions] on teeth

208

3.06

15.27

1.5

4402.44

2061.32

e6/l

0.53

157

Hepatic failure, not elsewhere classified

133

3.71

15.18

1.9

1.3

1510.39

1660.10

e6/l

0.09

276

1630

1.69

15.06

1.4

2325.97

2802.59

e6/l

0.44

204

1174

Charcot foot

5.96

15.05

1.7

1.2

4328.42

1328.59

e6/l

0.39

Other diseases of intestine

121

551

2.23

14.97

1.6

1.5

1999.43

1993.39

e6/l

0.00

395

Mycoses

203

1111

1.84

14.94

1.5

3532.69

2296.68

e6/l

0.32

149

799

Chronic lymphocytic leukaemia

145

3.58

14.86

1.7

1.4

1952.61

1566.67

e6/l

0.29

104

Other pulmonary heart/vessel disease

221

3.02

14.84

1.4

939.84

1573.99

e6/l

2.03

161

Other respiratory diseases principally affecting the interstitium

184

982

1.90

14.74

1.5

3939.88

2146.65

e6/l

0.42

128

724

Malignant neoplasm of kidney, except renal pelvis

105

455

2.35

14.68

1.4

1.5

1572.83

1869.92

e6/l

0.34

328

Malignant melanoma, excluding all cancers (controls excluding all cancers)

125

581

2.17

14.67

1.6

1.5

1668.53

2697.29

e6/l

1.03

426

Malignant neoplasm of urinary organs

115

519

2.25

14.61

1.4

1.5

1444.82

1820.42

e6/l

0.53

377

Sequelae with surgical and medical care as external cause

169

879

1.94

14.60

1.6

1.4

1901.05

2157.88

e6/l

0.22

113

640

Diverticular disease of intestine

568

2626

1.44

14.50

1.5

2536.45

3469.14

e6/l

0.72

407

1914

Abnormal results of function studies

245

2.85

14.47

1.5

1.4

1926.12

1799.73

e6/l

0.11

171

Diabetic retinopathy, strict definition

164

739

1.97

14.46

1.6

1.5

1343.41

2798.51

e6/l

1.08

121

512

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

101

4.08

14.44

1.5

1039.18

1742.08

e6/l

0.99

Emphysema

337

2.57

14.44

1.4

1.5

3534.54

1596.22

e6/l

1.03

236

Cutaneous abscess, furuncle and carbuncle

176

931

1.90

14.41

1.7

1.5

2939.99

2322.12

e6/l

0.18

135

671

Other or ill-defined heart diseases

4.07

14.26

1.4

1.2

1598.04

2646.94

e6/l

0.69

Congenital malformations of cardiac septa

133

3.53

14.25

2.1

1.3

2105.30

1893.72

e6/l

0.08

Bronchiectasis

352

2.52

14.16

1.4

2145.00

2098.08

e6/l

0.03

250

Benign neoplasms

681

2730

1.40

14.11

1.5

1.4

2376.54

3914.55

e6/l

1.71

494

1993

Certain disorders involving the immune mechanism

146

731

2.02

14.08

1.6

1.4

1897.45

2314.24

e6/l

0.60

109

536

Persons encountering health services in other circumstances, wide

856

3304

1.35

14.04

1.6

1.4

3744.52

3131.88

e6/l

0.21

601

2416

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

4.08

13.99

1.4

12102.11

2391.04

e6/l

0.75

Amyloidosis, other/unspecified

4.78

13.92

1.4

1.3

688.82

1199.10

e6/l

0.87

Other special examinations and investigations of persons without complaint or reported diagnosis

492

1681

1.49

13.90

1.6

1.4

2342.17

2724.46

e6/l

0.36

379

1140

Asthma and opportunity respiratory infection

208

3.01

13.87

1.4

2458.55

1640.64

e6/l

0.61

151

Exposure to unspecified factor

641

3581

1.39

13.85

1.5

1.4

4180.83

3195.20

e6/l

0.25

434

2623

Drug-induced neutropenia

263

2.75

13.81

1.5

1.4

2525.08

1969.27

e6/l

0.33

182

Injuries to the abdomen, lower back, lumbar spine and pelvis

295

1817

1.62

13.81

1.5

6588.98

2624.51

e6/l

0.65

225

1305

Vascular disorders of the intestines

310

2.60

13.72

1.5

1.4

1750.09

1744.97

e6/l

0.00

220

Carcinoma in situ of skin of other and unspecified parts of face

287

2.66

13.69

1.7

1.5

691.66

2038.77

e6/l

1.10

208

Benign neoplasm of other and ill-defined parts of digestive system

114

526

2.19

13.65

1.6

1.5

1596.73

2620.56

e6/l

1.16

384

Missing teeth due to accident, extraction or parodontitis

106

478

2.25

13.48

1.6

1.5

4419.87

2090.26

e6/l

0.53

355

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

120

3.66

13.46

1.4

1.5

1034.64

1869.63

e6/l

1.82

Congenital malformations of the circulatory system

408

2.32

13.37

1.8

1.4

2170.94

2412.73

e6/l

0.14

292

Viral hepatitis

160

3.22

13.27

1.6

1.4

25057.33

2189.91

e6/l

0.57

111

Carcinoma in situ of skin

263

2.70

13.25

1.5

1187.97

2184.79

e6/l

0.61

190

Amyloidosis

4.16

13.23

1.4

692.65

1257.95

e6/l

1.17

Other external causes of accidental injury

586

2071

1.42

13.16

1.5

1.4

2089.44

2747.08

e6/l

1.12

425

1499

Vitreous haemorrhage

420

2.32

13.15

1.4

1.5

2000.34

1767.24

e6/l

0.08

305

Benzodiazepine use

686

3579

1.37

13.13

1.5

4944.08

2925.53

e6/l

0.74

511

2589

Chronic periodontitis, including avohilmo

625

3345

1.39

13.09

1.5

4325.16

3036.23

e6/l

0.53

432

2452

Sulfasalazine

188

1048

1.80

13.07

1.5

1.4

3117.03

2940.83

e6/l

0.07

126

744

Disorders of thyroid, IBD co-morbidities

119

405

2.15

12.98

1.6

1.4

2103.32

3398.81

e6/l

0.35

280

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

367

2.41

12.97

1.8

1.4

3116.91

1712.07

e6/l

0.42

272

Parodontitis or operation codes

627

3349

1.38

12.93

1.5

4323.77

3034.20

e6/l

0.54

433

2455

Dermatitis

420

2858

1.48

12.91

1.5

1.4

4255.76

3143.61

e6/l

0.32

307

2065

Accidents

584

2071

1.42

12.89

1.6

1.4

2095.80

2747.08

e6/l

1.10

425

1499

Parodontitis

626

3348

1.38

12.88

1.5

4323.77

3034.20

e6/l

0.54

433

2455

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

142

729

1.96

12.80

1.4

1.5

1166.44

2723.42

e6/l

2.02

109

531

Tobacco use

134

3.41

12.77

1.5

1.4

2252.18

1668.71

e6/l

0.27

Mental and behavioural disorders due to use of other stimulants, including caffeine

7.14

12.73

1.6

1.3

54577.92

2444.81

e6/l

0.48

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

120

3.56

12.69

1.5

3266.20

1663.87

e6/l

0.26

Superficial injury of head

163

878

1.87

12.69

1.5

8384.49

2466.13

e6/l

0.57

127

636

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

4.98

12.65

1.4

954.57

2175.66

e6/l

1.27

Seropositive rheumatoid arthritis, wide

205

1185

1.74

12.63

1.5

3653.18

2621.14

e6/l

0.48

150

850

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

199

1141

1.76

12.62

1.5

3729.01

2538.23

e6/l

0.56

145

821

Open wound of head

387

2567

1.49

12.54

1.5

2897.42

3014.12

e6/l

0.04

286

1854

Malignant neoplasm of skin

540

2895

1.41

12.52

1.5

1870.97

2907.16

e6/l

1.29

383

2114

Atrial septal defect

4.41

12.52

2.1

1.3

1520.30

1869.84

e6/l

0.23

Osteoporosis

207

1146

1.74

12.49

1.5

1.4

2727.81

2533.46

e6/l

0.09

160

827

L02BG Aromatase inhibitors

182

1020

1.80

12.48

1.4

4736.94

2813.58

e6/l

0.24

132

746

Seropositive rheumatoid arthritis

205

1189

1.73

12.38

1.5

1.4

3653.18

2882.38

e6/l

0.31

150

842

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

109

515

2.14

12.37

1.5

913.54

2784.58

e6/l

1.74

376

Rheumatoid arthritis

260

1458

1.63

12.35

1.5

1.4

3638.02

2974.31

e6/l

0.30

190

1047

Abdominal and pelvic pain

703

2603

1.36

12.30

1.5

2781.11

3563.24

e6/l

0.60

518

1891

Reimbursement for rheumatic diseases

382

2574

1.49

12.23

1.5

2984.34

2830.83

e6/l

0.09

270

1866

Systemic lupus erythematosus, unspecified

4.68

12.17

1.6

1.2

4641.45

1721.05

e6/l

0.89

Haemorrhage, not elsewhere classified

154

3.19

12.15

1.5

1.4

954.79

1622.97

e6/l

1.61

110

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

124

3.47

12.13

1.5

1254.37

1529.56

e6/l

0.29

Viral pneumonia (unknown virus, not influenza)

191

2.92

12.08

1.7

1.4

1963.75

1714.71

e6/l

0.23

136

Systemic connective tissue disorders

249

1537

1.63

11.98

1.5

2179.90

2585.11

e6/l

0.30

164

1115

Failure and rejection of transplanted organs and tissues

7.63

11.91

1.3

10781.82

4434.07

e6/l

0.31

Malignant neoplasm of breast, HER-positive

200

1151

1.72

11.89

1.4

4520.76

3036.68

e6/l

0.20

148

827

Systemic lupus erythematosus

4.12

11.89

1.6

1.3

4346.55

1648.08

e6/l

0.91

SLE (Finngen)

4.12

11.89

1.6

1.3

4346.55

2268.04

e6/l

0.63

Hydronephrosis

452

2.19

11.85

1.5

1.4

923.61

1918.35

e6/l

3.84

339

Other other unspecified disorders of the circulatory system

141

3.27

11.85

1.8

1.3

1326.39

1772.13

e6/l

0.56

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

4.23

11.85

1.5

1.3

1387.29

2424.16

e6/l

0.92

Clear cell adenocarcinoma of kidney

211

2.82

11.79

1.4

1.5

1294.28

1626.19

e6/l

0.51

152

Injury of other and unspecified intrathoracic organs

245

2.66

11.74

1.5

1.4

2213.89

1544.41

e6/l

0.81

180

ILD medications: azathioprine

421

2.23

11.74

1.6

1.4

2624.19

2439.14

e6/l

0.10

303

In situ neoplasms

276

1756

1.58

11.73

1.5

3131.68

2671.41

e6/l

0.11

176

1277

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

4.55

11.72

1.6

1.4

4298.44

2101.47

e6/l

0.26

Acute pancreatitis

164

910

1.82

11.69

1.5

7575.86

2050.90

e6/l

0.50

122

656

Other/unspecified seropositive rheumatoid arthritis

199

1168

1.72

11.65

1.5

3729.01

2645.10

e6/l

0.50

145

840

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

108

3.60

11.64

1.2

1.5

2718.07

1719.75

e6/l

0.37

385

2.28

11.61

1.6

1.4

6552.33

2336.27

e6/l

0.42

282

Multiple myeloma, excluding all cancers (controls excluding all cancers)

153

3.13

11.60

1.4

1.5

911.91

1663.75

e6/l

1.55

109

SLE, ICD10

4.24

11.57

1.6

1.3

4516.33

1739.45

e6/l

0.89

SLE, strict definition

4.24

11.57

1.6

1.3

4516.33

1739.45

e6/l

0.89

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

4.94

11.50

1.6

1.3

4708.44

2164.51

e6/l

0.26

Other embolism and thrombosis

114

564

2.04

11.49

1.6

1.5

8854.91

2440.49

e6/l

0.40

414

Multiple myeloma and malignant plasma cell neoplasms

154

3.11

11.48

1.4

1.5

941.53

1663.75

e6/l

1.47

109

Statin medication

423

1625

1.46

11.47

1.5

1.4

2020.25

4721.51

e6/l

2.52

313

1215

Other nutritional deficiencies

361

2386

1.48

11.46

1.5

5545.86

3192.20

e6/l

0.41

269

1721

Asthma and allergy

3.96

11.40

1.8

1.3

3948.48

1614.11

e6/l

0.68

Elevated blood glucose level

302

2.45

11.39

1.6

1.4

1270.08

1665.81

e6/l

0.66

226

ILD, hospital admissions

146

789

1.87

11.39

1.6

1.5

4924.08

1854.56

e6/l

0.62

572

Other interstitial pulmonary diseases

148

804

1.86

11.35

1.6

1.5

4878.97

1826.83

e6/l

0.62

100

585

Fracture of lumbar spine and pelvis

183

1057

1.74

11.33

1.5

8103.89

2180.08

e6/l

0.64

143

771

Interstitial lung disease endpoints

148

806

1.86

11.27

1.6

1.5

4878.97

1826.59

e6/l

0.62

100

585

Interstitial lung disease

148

806

1.86

11.27

1.6

1.5

4878.97

1826.59

e6/l

0.62

100

585

Rheumatoid arthritis, including avohilmo

273

1750

1.57

11.24

1.5

3676.52

2501.22

e6/l

0.74

202

1256

Other disorders of white blood cells

211

2.75

11.19

1.6

1.4

3146.56

1951.97

e6/l

0.74

148

Benign neoplasm: Colon, unspecified

219

1338

1.65

11.08

1.5

1376.81

2329.78

e6/l

2.30

154

971

Vascular diseases of the intestine

163

3.01

11.05

1.3

1.4

2128.35

1773.21

e6/l

0.15

120

Left bundle-branch block

190

2.82

11.02

1.4

1.3

1084.00

2555.00

e6/l

2.18

133

External causes of morbidity and mortality

451

1573

1.44

11.01

1.6

1.4

2085.65

2515.92

e6/l

0.70

334

1120

Other gastritis (incl. Duodenitis)

186

1091

1.72

10.96

1.7

1.5

2478.89

1990.41

e6/l

0.39

131

782

Other and unspecified dermatitis

334

2252

1.49

10.86

1.5

4930.86

3316.42

e6/l

0.39

247

1608

Diffuse large B-cell lymphoma

204

2.76

10.81

1.7

1.4

2165.29

1636.34

e6/l

0.50

148

Basal cell carcinoma

488

2801

1.39

10.77

1.4

1.5

1917.25

2339.74

e6/l

0.47

333

2059

Disorders of magnesium metabolism

8.70

10.72

1.4

1.3

528.50

1696.08

e6/l

—

Fracture of lower leg, including ankle

357

2437

1.46

10.68

1.5

4339.90

3505.14

e6/l

0.17

249

1758

Other and unspecified types of non-Hodgkin lymphoma, hilmo

189

2.81

10.62

1.4

1843.27

1683.12

e6/l

0.14

137

Chronic nephritic syndrome

135

3.17

10.62

1.7

1.4

651.65

1663.16

e6/l

3.17

Erosion of teeth

7.12

10.62

1.7

1.3

723.70

3469.12

e6/l

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

466

2.10

10.60

1.6

1.5

1636.49

2855.29

e6/l

1.01

344

Genitourinary diseases

406

1401

1.46

10.55

1.5

1.4

2118.78

4499.02

e6/l

1.83

286

1004

Systemic sclerosis

4.57

10.54

1.7

1.3

2519.67

1734.22

e6/l

0.31

Other disorders involving the immune mechanism, not elsewhere classified

3.86

10.53

1.5

1.3

1387.29

2291.74

e6/l

0.82

Persons encountering health services for examination and investigation

473

1681

1.41

10.50

1.5

1.4

2806.39

2724.46

e6/l

0.06

358

1140

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

128

680

1.89

10.47

1.5

8654.50

2418.94

e6/l

0.96

101

484

Chronic gastritis

236

1489

1.60

10.47

1.5

8135.69

2325.91

e6/l

0.77

167

1072

Injury, poisoning and certain other consequences of external causes

368

1247

1.48

10.46

1.5

1.4

2059.90

2407.62

e6/l

0.50

272

884

Problems related to lifestyle

290

2.40

10.41

1.5

1.4

3158.13

2428.97

e6/l

0.31

206

Azathioprine

443

2.11

10.39

1.6

1.4

2624.19

2464.49

e6/l

0.09

320

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

297

2.39

10.38

1.5

1.4

3394.87

1761.51

e6/l

0.36

214

Malignant neoplasm of digestive organs

346

2337

1.47

10.35

1.4

1.5

1750.38

2532.30

e6/l

0.77

259

1698

Aortic aneurysm

225

1384

1.61

10.33

1.4

1.5

2409.25

2324.54

e6/l

0.04

158

1028

Systemic sclerosis, icd10

4.63

10.29

1.7

1.2

2691.79

1567.78

e6/l

0.46

General examination and investigation of persons without complaint and reported diagnosis

445

1671

1.42

10.29

1.5

1.4

2746.93

2738.52

e6/l

0.00

362

1132

Viral infections characterized by skin and mucous membrane lesions

259

1675

1.55

10.26

1.5

4767.38

3136.10

e6/l

0.40

181

1212

Weight loss

401

2.17

10.20

1.5

1.4

2720.67

1827.39

e6/l

0.43

291

Benign neoplasm: Stomach

251

2.50

10.16

1.5

1404.07

2159.75

e6/l

0.69

183

Other malignant neoplasms of skin (=non-melanoma skin cancer)

475

2717

1.39

10.15

1.4

1.5

1881.97

2347.43

e6/l

0.53

333

1979

Dysphagia

190

1147

1.67

10.09

1.4

1.5

1724.37

2413.86

e6/l

0.54

136

818

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

4.93

10.08

1.2

1.4

967.54

1887.76

e6/l

0.75

Volvulus

104

3.45

10.07

1.3

4474.86

1146.09

e6/l

0.57

Mental and behavioural disorders due to opioids

4.84

10.02

1.6

1.2

3724.73

2326.16

e6/l

0.45

Acute pancreatitis (for exclusion)

164

955

1.73

9.98

1.5

7575.86

2165.47

e6/l

0.48

122

695

Restrictive cardiomyopathy

8.99

9.93

1.8

1.4

480.00

1101.91

e6/l

—

Parodontitis and operation codes

569

3305

1.34

9.93

1.5

4485.98

3085.86

e6/l

0.53

391

2420

Basal cell carcinoma, including avohilmo

491

2830

1.37

9.87

1.4

1.5

1932.73

2337.53

e6/l

0.45

335

2077

Obesity related asthma

213

1331

1.61

9.85

1.6

1.5

2154.35

2893.05

e6/l

0.64

155

968

Osteonecrosis

208

2.64

9.85

1.3

1.4

3980.44

1758.28

e6/l

0.76

151

Other viral diseases

147

830

1.77

9.83

1.5

2761.43

2585.62

e6/l

0.09

595

Primary biliary cholangitis (PBC)

4.79

9.81

1.4

1.2

1729.87

1895.38

e6/l

0.08

Other arthritis (FG)

210

1309

1.61

9.81

1.5

1.4

3541.13

2660.96

e6/l

0.38

153

939

Poisoning by drugs, medicaments and biological substances

122

653

1.88

9.80

1.4

8672.25

2542.95

e6/l

0.82

479

Covid-19 suspected case

103

521

1.99

9.79

1.7

1.5

2227.52

2370.07

e6/l

0.12

375

Angina pectoris

459

2238

1.39

9.78

1.6

1.5

2114.04

3637.50

e6/l

1.48

334

1614

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

136

755

1.81

9.75

1.4

1.5

1032.56

2655.34

e6/l

2.27

103

546

Psychiatric diseases

744

2869

1.30

9.73

1.5

5829.91

2124.63

e6/l

1.66

560

2042

Benign neoplasm: Transverse colon

478

2.04

9.62

1.4

1.5

1981.46

1728.20

e6/l

0.24

345

Congenital malformations, deformations and chromosomal abnormalities

291

1873

1.49

9.62

1.6

1.5

4127.52

2869.74

e6/l

0.25

217

1336

Seropositive rheumatoid arthritis, strict definition

110

575

1.93

9.55

1.5

4432.55

1862.34

e6/l

1.01

418

Amputation of ankle bones

103

3.41

9.54

1.5

1.4

687.00

1381.51

e6/l

1.54

Septal defects

130

3.04

9.51

2.0

1.4

1673.13

2140.53

e6/l

0.30

Parodontitis or/and operation codes

369

1525

1.44

9.50

1.5

5023.59

3200.32

e6/l

0.43

247

1148

Acquired haemolytic anaemia

3.77

9.50

1.6

1.3

784.86

1514.31

e6/l

1.17

Other antidepressants

735

2963

1.30

9.46

1.5

4209.89

2566.15

e6/l

0.64

533

2154

Thoracic aortic aneurysm

124

677

1.85

9.45

1.3

1.5

3335.61

2620.34

e6/l

0.26

493

Myeloid leukaemia

4.02

9.37

1.6

1.3

2168.85

1807.57

e6/l

0.21

Candidiasis

469

2.02

9.34

1.7

1.4

5410.63

1869.81

e6/l

0.49

345

Fracture of shoulder and upper arm

245

1604

1.53

9.25

1.5

5679.79

2724.95

e6/l

0.37

184

1145

Sulfonylureas

355

1987

1.43

9.25

1.6

1.5

1747.26

2521.34

e6/l

0.74

265

1468

Late syphilis

5.17

9.17

1.7

1.4

6843.18

1412.87

e6/l

0.40

Abnormal findings on diagnostic imaging of other body structures

425

2.07

9.17

1.8

1.4

2045.45

1883.20

e6/l

0.09

305

Other and unspecified disorders of white blood cells

159

2.82

9.12

1.7

1.3

1910.57

1540.81

e6/l

0.26

113

Unspecified fall

331

2291

1.44

9.11

1.5

5123.51

2717.11

e6/l

0.39

237

1650

Follicular lymphoma

116

3.16

9.10

1.4

1.5

1975.12

1786.70

e6/l

0.13

Thyrotoxicosis

150

875

1.72

9.09

1.6

1.5

1827.63

2942.58

e6/l

0.73

112

634

Benign neoplasm of other and unspecified endocrine glands

309

2.25

9.05

1.6

1.5

1271.32

3167.39

e6/l

1.41

225

Zoster [herpes zoster]

139

797

1.76

8.99

1.6

1.5

4879.28

2043.59

e6/l

0.51

582

Thyrotoxicosis, other and/or unspecified

119

652

1.84

8.94

1.6

1.5

1874.20

3129.44

e6/l

0.61

478

Drug-induced hypoglycaemia without coma

4.44

8.94

1.5

1.3

5947.56

1774.38

e6/l

0.47

Obesity due to excess calories

244

1610

1.52

8.91

1.5

3317.94

3118.33

e6/l

0.05

189

1159

Other infectious diseases

338

2.19

8.88

1.8

1.4

2805.23

1878.17

e6/l

0.33

245

ILD, hospital admissions 1, main diag only

127

713

1.80

8.87

1.6

1.5

5608.34

1625.05

e6/l

0.70

515

Carcinoma in situ of skin of scalp and neck

3.51

8.85

1.6

1.5

1032.06

1796.42

e6/l

0.76

Other diseases of arteries and capillaries

358

2.15

8.84

1.6

1.4

982.07

2116.51

e6/l

3.33

264

L01XX Other antineoplastic agents

257

2.38

8.81

1.4

2056.50

1525.02

e6/l

0.53

185

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

193

1213

1.60

8.77

1.5

1841.49

2963.92

e6/l

1.09

143

879

Asthma, including avohilmo

767

3508

1.27

8.75

1.5

1.4

3026.75

3358.43

e6/l

0.22

568

2537

Disorders of mineral metabolism

295

2.26

8.74

1.5

1.4

1387.91

2371.92

e6/l

0.94

212

Diseases of the myoneural junction and muscle

101

530

1.93

8.73

1.5

19467.71

2041.47

e6/l

1.15

384

Protozoal diseases

3.45

8.68

1.7

1.3

2369.08

1655.58

e6/l

0.36

Thrombocytopenia, unspecified

271

2.32

8.67

1.5

1.4

1222.38

1609.13

e6/l

0.66

192

Arthropathies in other diseases classified elsewhere

125

3.01

8.66

1.6

1.3

4150.31

1647.66

e6/l

0.46

Autoimmune diseases related-to ILD

530

3530

1.32

8.66

1.5

5296.24

2960.19

e6/l

0.63

384

2567

Diagnoses used for exclusion with ILD

202

1290

1.58

8.61

1.5

1782.75

2287.29

e6/l

0.75

148

934

Cholelithiasis, broad definition with cholecystitis

599

3149

1.31

8.61

1.5

3554.44

2820.32

e6/l

0.19

441

2286

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

278

2.29

8.60

1.2

1.5

2691.96

1471.83

e6/l

0.79

203

Concussion

298

1778

1.45

8.59

1.5

4267.99

3220.13

e6/l

0.32

231

1230

Other symptoms and signs involving cognitive functions and awareness

350

2337

1.41

8.59

1.5

4227.07

2429.82

e6/l

0.63

244

1694

Disorder of lipoprotein metabolism, unspecified

117

647

1.83

8.59

1.5

1387.99

2125.35

e6/l

1.07

470

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

205

2.52

8.57

1.6

1.5

683.59

1559.42

e6/l

3.24

146

Other complications of surgical and medical care, not elsewhere classified

317

2.20

8.55

1.6

1.4

1320.60

2273.48

e6/l

1.13

231

Persons encountering health services for other counselling and medical advice, not elsewhere classified

726

3245

1.28

8.54

1.6

1.4

3698.02

3169.65

e6/l

0.15

514

2369

Attention to artificial openings

137

2.90

8.53

1.3

4427.59

1762.80

e6/l

0.59

Mixed connective tissue disease

188

2.58

8.50

1.4

1.3

4341.40

2523.75

e6/l

0.49

131

Diaphragmatic hernia

268

1823

1.48

8.50

1.6

1.5

2694.95

2711.25

e6/l

0.01

182

1306

Gangrene, not elsewhere classified

6.06

8.42

1.9

1.2

1315.29

1819.53

e6/l

—

Other specified/unspecified systemic involvement of connective tissue

166

2.68

8.40

1.3

4780.32

2578.89

e6/l

0.50

112

Dizziness and giddiness

509

3121

1.33

8.40

1.4

1.5

2081.78

2540.20

e6/l

0.60

389

2262

Intracranial and intraspinal abscess and granuloma

5.96

8.39

1.5

2729.40

2226.75

e6/l

—

Other and unspecified local infections of skin and subcutaneous tissue

333

2.15

8.37

1.7

1.4

1995.24

1925.15

e6/l

0.04

247

Benign neoplasm: Ascending colon

115

639

1.82

8.34

1.8

1.5

1292.06

1825.20

e6/l

1.09

471

Finngen Rheumatological endpoints

610

2675

1.30

8.33

1.5

1.4

2654.74

3868.24

e6/l

1.11

445

1931

Other/unspecified rheumatoid arthritis

103

553

1.88

8.32

1.5

3662.23

2265.61

e6/l

0.51

402

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

208

2.48

8.32

1.3

1.5

1290.53

1409.58

e6/l

0.15

148

DVT of lower extremities

155

937

1.67

8.30

1.4

1.5

2157.43

2366.25

e6/l

0.10

107

669

Other diseases of pancreas

328

2.16

8.30

1.4

1952.63

1830.88

e6/l

0.09

238

Non-Hodgkin lymphoma, all

215

2.47

8.30

1.8

1.4

1882.45

1520.29

e6/l

0.39

157

Rare circulating lymphoid malignancy

123

2.99

8.29

1.6

1.4

8791.14

2063.11

e6/l

0.75

Any mental disorder

754

2977

1.27

8.29

1.4

1.5

6580.26

2092.02

e6/l

2.04

573

2127

Abnormal findings in nipple discharge synovial fluid wound secretions

5.13

8.19

1.3

1.2

695.70

2297.75

e6/l

—

Duodenal ulcer

107

585

1.85

8.18

1.4

1.5

9597.30

1845.01

e6/l

0.49

431

Melanocytic naevi of trunk

265

2.28

8.17

1.5

1.6

1021.78

2547.76

e6/l

1.94

194

Unstable angina pectoris

334

1969

1.41

8.15

1.5

2048.07

3321.07

e6/l

0.94

241

1428

Other viral diseases, not elsewhere classified

105

569

1.85

8.14

1.5

1.4

3435.90

2334.82

e6/l

0.56

419

Malignant immunoproliferative diseases

5.78

8.10

1.9

1.2

739.90

2949.58

e6/l

—

Sequelae of cerebrovascular disease

311

1923

1.43

8.08

1.4

1.5

1766.75

2517.09

e6/l

0.72

240

1402

Benign neoplasm: Sigmoid colon

149

899

1.67

8.07

1.6

1.5

2160.86

2076.13

e6/l

0.06

103

652

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

293

2.21

8.03

1.6

1.4

1087.40

1804.10

e6/l

1.56

209

Disorders of calcium metabolism

224

2.40

8.02

1.4

1574.82

1579.35

e6/l

0.00

163

Acute posthaemorrhagic anaemia

142

2.80

8.01

1.1

1.3

1583.32

1322.59

e6/l

0.26

101

Leiomyoma of uterus

151

501

1.70

7.99

1.4

1914.67

3849.05

e6/l

1.01

107

364

Congenital malformations of the urinary system

159

2.67

7.98

1.7

1.3

900.06

2086.88

e6/l

1.70

112

Phlebitis and thrombophlebitis (not including DVT)

159

978

1.64

7.97

1.5

2572.22

3118.00

e6/l

0.23

112

705

Systemic sclerosis (FG)

3.65

7.89

1.7

1.3

2519.67

2013.09

e6/l

0.18

Coronary angioplasty

322

1755

1.42

7.87

1.5

1347.97

3561.14

e6/l

2.51

235

1278

Diseases of pulp and periapical tissues, including avohilmo

736

3029

1.26

7.86

1.5

2284.88

3051.88

e6/l

0.94

533

2195

Diseases of the eye and adnexa

470

1754

1.34

7.85

1.5

2677.93

3529.48

e6/l

0.77

350

1266

Intracranial injury

376

2660

1.37

7.85

1.5

3474.86

2926.76

e6/l

0.19

286

1920

Other (seronegative) rheumatoid arthritis, wide

136

807

1.70

7.84

1.5

4379.72

2000.12

e6/l

1.10

103

592

Exposure to other specified factors

417

2908

1.35

7.83

1.5

7824.11

2761.82

e6/l

1.10

309

2101

Other renal tubulo-interstitial diseases

4.11

7.83

1.4

1.2

1901.79

1548.63

e6/l

0.15

Alcohol dependence

195

1264

1.55

7.83

1.6

1.5

9142.71

2412.56

e6/l

0.79

146

899

IgA nephropathy (IgA glomerulonephritis)

3.71

7.78

1.5

1.4

789.26

1846.46

e6/l

1.62

Injury of intra-abdominal organs

4.23

7.76

1.4

2099.93

1920.09

e6/l

0.09

Complications of internal orthopaedic prosthetic devices, implants and grafts

171

1079

1.60

7.74

1.4

1.5

2125.74

2918.38

e6/l

0.50

103

782

Pain (limb, back, neck, head abdominally)

528

2011

1.32

7.71

1.5

2705.02

3440.75

e6/l

0.49

373

1466

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

5.07

7.68

1.3

1.1

761.73

1178.42

e6/l

0.50

Malignant neoplasm of retroperitoneum and peritoneum

6.97

7.68

1.7

1.2

576.43

1240.82

e6/l

—

Obesity and other hyperalimentation

326

2318

1.40

7.67

1.6

1.5

3158.89

3634.38

e6/l

0.14

245

1674

Presence of other functional implants

419

2204

1.35

7.66

1.5

2080.71

3342.39

e6/l

0.91

308

1582

Other disorders of veins

240

1631

1.48

7.66

1.5

1837.31

3155.02

e6/l

1.64

166

1177

Other benign neoplasms of skin

186

1177

1.56

7.60

1.4

1.5

1775.92

2553.41

e6/l

0.72

143

859

Poisoning by medicine

102

562

1.82

7.59

1.4

1.5

9868.78

2592.85

e6/l

0.83

409

ILD-related respiratory insufficiency

164

2.62

7.59

1.5

1.4

9729.19

1507.51

e6/l

0.52

118

Other local infections of skin and subcutaneous tissue

360

2.05

7.58

1.7

1.4

1932.42

1867.30

e6/l

0.03

268

Dental pulpitis 1

734

3035

1.26

7.57

1.5

2280.84

3054.38

e6/l

0.95

532

2198

Obesity

324

2309

1.39

7.56

1.6

1.5

3163.64

3639.89

e6/l

0.14

244

1666

Mental and behavioural disorders due to cannabinoids

5.65

7.55

1.4

1.3

16975.22

2811.57

e6/l

—

Benign neoplasm of ovary

347

2.06

7.53

1.3

1.5

3047.31

2140.34

e6/l

0.30

258

Congenital malformations of aortic and mitral valves

108

3.00

7.52

1.5

2208.96

1804.66

e6/l

0.23

Anorexia

5.29

7.48

1.5

1.2

8340.30

1520.74

e6/l

—

Suicide or other Intentional self-harm

124

727

1.71

7.47

1.4

8555.03

2521.16

e6/l

0.88

528

Cholecystitis

118

684

1.74

7.44

1.4

1.5

8588.84

2325.54

e6/l

0.39

491

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

3.25

7.44

1.2

1.4

2906.41

1519.27

e6/l

0.42

Exclusions for E4_PCOS_CONSORTIUM

334

1501

1.40

7.43

1.4

2325.00

3663.67

e6/l

1.15

238

1086

Umbilical hernia

185

1202

1.55

7.38

1.4

1.5

3365.92

3968.40

e6/l

0.19

130

875

Dental pulpitis 4

732

3035

1.26

7.37

1.5

2282.34

3053.16

e6/l

0.95

531

2199

Other specified/unspecified arthritis

180

1163

1.56

7.36

1.5

1.4

3896.50

3080.85

e6/l

0.28

128

840

Acidosis

3.68

7.35

1.6

1.4

2489.53

1366.12

e6/l

0.26

Asthma, hospital admissions , main diagnosis only

503

3471

1.30

7.34

1.5

3096.25

3202.83

e6/l

0.05

374

2503

Soft tissue disorders

672

2760

1.27

7.34

1.5

1.4

2855.07

3021.00

e6/l

0.10

482

1990

Open wound of ankle and foot

331

2.07

7.33

1.6

1.4

3045.61

1777.67

e6/l

0.37

235

Haemolytic anaemias

110

2.96

7.31

1.6

1.3

800.13

1804.77

e6/l

1.90

Melanocytic naevi

121

709

1.71

7.31

1.5

2156.73

2718.43

e6/l

0.24

514

Dissection of aorta

138

2.74

7.30

1.5

1.4

5110.74

1833.27

e6/l

0.67

103

Delirium, not induced by alcohol and other psychoactive substances

107

607

1.78

7.27

1.5

5344.84

1515.17

e6/l

0.85

439

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

4.41

7.27

1.6

1.3

2588.08

2372.58

e6/l

0.07

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

128

763

1.68

7.26

1.5

1.4

8654.50

2669.44

e6/l

0.90

101

554

Intestinal malabsorption

116

2.88

7.23

2.1

1.2

1157.54

1970.61

e6/l

0.80

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

5.14

7.23

1.3

15858.43

2157.58

e6/l

—

Neurological diseases, wide definition

154

468

1.66

7.21

1.4

2495.29

4056.32

e6/l

0.49

107

325

Injuries to the knee and lower leg

749

3448

1.25

7.20

1.5

3079.97

3368.82

e6/l

0.12

540

2500

Pyogenic arthritis

294

2.13

7.18

1.4

1931.98

1813.40

e6/l

0.07

218

Abnormal weight loss

375

2.00

7.17

1.5

1.4

1655.54

1843.00

e6/l

0.16

267

Benign neoplasm: Rectum

143

883

1.63

7.13

1.5

1324.62

2114.94

e6/l

1.63

642

Postmenopausal atrophic vaginitis

661

0.46

7.12

1.3

1.4

1818.21

3723.60

e6/l

0.84

468

Malignant neoplasm of head and neck

390

1.97

7.11

1.3

1.5

3121.92

1789.51

e6/l

0.49

285

Thyrotoxicosis with toxic multinodular goitre

237

2.27

7.11

1.8

1.4

1652.19

1618.14

e6/l

0.03

170

Degeneration of macula and posterior pole

393

2423

1.34

7.10

1.4

1.5

1885.80

2418.55

e6/l

0.41

286

1761

Diseases of oral cavity, salivary glands and jaws

647

2624

1.27

7.08

1.5

1.4

2678.90

2809.57

e6/l

0.09

459

1920

Benign neoplasm: Rectum, anus and anal canal

161

1026

1.58

7.04

1.5

1494.19

2262.61

e6/l

1.24

106

744

Osteonecrosis due to drugs

4.51

7.02

1.3

3341.33

1542.82

e6/l

0.29

Benign neoplasm: Adrenal gland

182

2.44

7.01

1.8

1.5

1146.88

2709.24

e6/l

1.06

129

Benign neoplasm: Caecum

324

2.06

6.98

1.6

1.5

2969.92

2048.95

e6/l

0.21

229

Smoking dependency

285

2.13

6.92

1.3

1.5

8236.09

2381.10

e6/l

0.65

203

Cystic kidney disease

3.09

6.92

1.7

1.4

1118.68

1883.02

e6/l

0.72

Unspecified misadventure during surgical and medical care

196

2.38

6.90

1.7

1.4

876.56

1793.06

e6/l

2.94

141

Syphilis

3.31

6.87

1.6

1.4

5232.18

2112.02

e6/l

0.36

Other noninfective gastroenteritis and colitis

154

977

1.58

6.83

1.4

1.5

3617.04

2224.57

e6/l

0.46

103

716

Mental and behavioural disorders due to tobacco

287

2.11

6.81

1.3

1.5

8236.09

2376.25

e6/l

0.65

206

Malignant neoplasm, without specification of site

156

2.55

6.73

1.4

1478.47

1386.33

e6/l

0.07

109

Tubulo-interstitial nephritis, not specified as acute or chronic

249

2.19

6.73

1.5

1.4

1998.85

1865.72

e6/l

0.09

184

Use of disulfiram, acamprosate or naltrexone

243

2.20

6.69

1.7

1.5

4620.00

2238.54

e6/l

0.87

170

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

548

1.78

6.68

1.3

1.5

1061.46

2895.86

e6/l

1.80

406

Need for immunization against other single viral diseases

3.78

6.68

1.5

1.4

1014.83

1918.08

e6/l

1.00

Supplementary factors related to causes of morbidity and mortality classified elsewhere

180

1191

1.52

6.65

1.5

6313.80

2433.72

e6/l

0.41

149

855

Sequelae of other external causes

187

2.38

6.64

1.6

1.4

1443.44

1629.36

e6/l

0.16

129

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

218

2.26

6.64

1.3

1.5

955.24

2001.50

e6/l

1.04

164

Carcinoma in situ of other and unspecified digestive organs

3.40

6.59

1.5

1.4

529.58

2113.09

e6/l

2.42

Other and unspecified vascular occlusions

465

1.85

6.59

1.5

1214.53

1979.58

e6/l

1.55

338

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

3.37

6.57

1.3

1678.93

1772.26

e6/l

0.07

Chronic diseases of tonsils and adenoids

239

2145

0.70

6.55

1.5

1.4

3428.96

3677.27

e6/l

0.11

178

1554

Retinal vascular disorders

108

635

1.72

6.55

1.4

1.5

1094.43

1811.86

e6/l

2.13

461

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

170

2.43

6.51

1.4

1.5

2943.66

2617.54

e6/l

0.07

129

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

381

1.92

6.50

1.4

13599.76

2755.23

e6/l

0.87

267

Personality disorders, excluding more controls

102

591

1.73

6.47

1.5

1.4

16305.84

2400.18

e6/l

0.84

418

Other and unspecified myopathies

390

1.92

6.45

1.5

1.4

21073.16

1784.89

e6/l

0.95

285

Other symptoms and signs involving the digestive system and abdomen

563

1.75

6.43

1.5

1.4

1841.71

3191.58

e6/l

0.52

401

Abscess of anal and rectal regions

254

2.14

6.41

1.3

1.4

2282.23

1876.60

e6/l

0.33

174

Left ventricular outflow tract obstruction, narrow definition

130

2.65

6.40

1.5

2148.59

1898.72

e6/l

0.14

Alcohol-induced chronic pancreatitis

248

2.16

6.39

1.6

1.5

20510.31

1656.82

e6/l

0.48

181

Diabetic neuropathy

101

585

1.74

6.35

1.6

1.5

709.48

2309.47

e6/l

4.51

414

Retinal vascular occlusion

106

626

1.71

6.34

1.4

1.5

1114.22

1826.26

e6/l

2.05

455

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

330

1.99

6.30

1.4

1.5

832.02

2119.43

e6/l

1.23

237

Other noninfective disorders of lymphatic vessels and lymph nodes

103

2.86

6.28

1.7

1.3

1514.68

1711.93

e6/l

0.14

Other and unspecified acquired haemolytic anaemias

4.83

6.27

1.8

1.2

630.11

1704.14

e6/l

—

Other functional intestinal disorders

300

2100

1.36

6.22

1.5

2522.54

2751.49

e6/l

0.13

224

1524

Other disorders of urethra and urinary system

448

2601

1.29

6.22

1.5

2525.14

2622.38

e6/l

0.05

323

1915

Tuberculosis, IBD comorbidity

388

1.90

6.22

1.5

1.4

1880.67

1605.37

e6/l

0.40

279

Lung diseases due to external agents

123

760

1.63

6.19

1.4

1.5

1433.44

1750.53

e6/l

0.55

555

Benign neoplasm: Descending colon

206

2.26

6.18

1.8

1.5

1362.79

1709.80

e6/l

0.55

148

Other and unspecified coagulation defects

104

2.82

6.16

1.6

1.3

1021.59

2134.66

e6/l

2.12

Abnormalities of gait and mobility

579

1.73

6.15

1.4

1.5

2555.62

1883.64

e6/l

0.24

424

Other diseases of urinary system

674

3072

1.24

6.14

1.5

2919.56

3070.94

e6/l

0.08

476

2268

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

432

1.84

6.13

1.4

1.5

868.38

2674.98

e6/l

2.15

323

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

425

1.85

6.13

1.4

1.5

1147.60

2336.48

e6/l

1.12

309

Type of accident

165

1093

1.52

6.10

1.5

6683.21

2297.57

e6/l

0.42

135

788

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

341

1.95

6.10

1.4

1.5

832.02

2088.22

e6/l

1.24

245

Shock, not elsewhere classified

4.44

6.08

1.5

1.2

770.60

1998.68

e6/l

—

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

4.38

6.06

1.5

1.1

1167.38

2549.65

e6/l

—

Childhood asthma (age<16), excluding more controls

4.58

6.04

1.5

1.3

3551.70

2581.53

e6/l

—

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

3.40

6.03

1.4

1.5

6192.67

2081.15

e6/l

0.49

Benign lipomatous neoplasm of other sites/unspecified

241

2.13

6.01

1.4

1.5

1529.69

2153.35

e6/l

0.49

175

Adenocarcinoma and ductal carcinoma of pancreas

159

2.44

6.00

1.2

1.4

2718.07

1380.19

e6/l

0.55

115

Persons with potential health hazards related to communicable diseases

146

937

1.55

5.99

1.5

1.4

13771.42

2719.42

e6/l

0.66

680

Fall involving bed

141

2.53

5.99

1.2

1.4

1410.03

1308.27

e6/l

0.08

102

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

222

942

1.45

5.99

1.5

2081.57

3891.98

e6/l

0.85

157

692

Sleep disorders (combined)

619

3276

1.24

5.97

1.5

3088.04

3452.07

e6/l

0.17

448

2374

Embolic stroke with flimmer

2.89

5.97

1.4

1.2

4890.56

1980.86

e6/l

0.43

Opening and dilatation of root channel of tooth

147

2.47

5.94

1.6

1.4

1691.46

2060.91

e6/l

0.30

102

Cholelithiasis

555

3112

1.25

5.92

1.5

2108.97

2818.39

e6/l

0.79

405

2259

Gingivitis and periodontal diseases

618

2567

1.25

5.92

1.5

1.4

3919.10

2830.99

e6/l

0.43

422

1874

Other and unspecified drugs and medicaments

297

2.00

5.89

1.6

1.4

993.13

1921.13

e6/l

2.26

214

Migraine, single triptan purchase ok & required. ICD-code if available is included

184

1809

0.69

5.87

1.5

1.4

3717.55

3431.23

e6/l

0.10

137

1295

Triptan medication for migraine, single purchase ok

184

1809

0.69

5.87

1.5

1.4

3717.55

3431.23

e6/l

0.10

137

1295

Disorders of other endocrine glands

242

1709

1.40

5.86

1.5

5797.34

2565.92

e6/l

0.78

185

1222

Carcinoma in situ of skin of upper limb, including shoulder

3.13

5.81

1.5

1.4

1847.55

1704.52

e6/l

0.05

Dependence on enabling machines and devices, not elsewhere classified

5.10

5.74

1.4

1.2

244.71

1404.13

e6/l

—

Noninfective enteritis and colitis

263

1920

1.37

5.73

1.4

1.5

2743.87

2784.28

e6/l

0.02

185

1383

Other menopausal disorders

600

0.51

5.72

1.4

3839.10

3773.34

e6/l

0.01

428

Familial hypercholesterolemia

126

800

1.59

5.70

1.7

1.5

1513.12

2079.11

e6/l

0.96

107

578

Infection of intervertebral disc (pyogenic)

3.81

5.70

2.1

1.4

3151.89

1311.38

e6/l

—

115

2.67

5.69

1.3

1608.68

1180.82

e6/l

0.29

Malignant immunoproliferative diseases

4.20

5.69

1.9

1.3

739.90

1777.24

e6/l

—

Hernia of abdominal wall

303

2270

1.34

5.65

1.4

1.5

3169.83

3450.85

e6/l

0.11

217

1651

Melanoma in situ

127

2.56

5.64

1.7

1.6

1643.05

1689.35

e6/l

0.03

Discitis, unspecified

3.48

5.63

1.3

64642.18

1336.51

e6/l

0.49

Respiratory tuberculosis, confirmed

2.99

5.62

1.3

1.2

2117.63

1355.83

e6/l

0.87

Benign neoplasm of major salivary glands

275

2.01

5.61

1.6

1.5

2241.59

2165.30

e6/l

0.04

197

Other systemic involvement of connective tissue (FG)

169

1139

1.48

5.60

1.4

2248.79

2560.52

e6/l

0.16

105

805

Mental and behavioural disorders due to sedatives or hypnotics

152

2.39

5.55

1.4

1.3

16087.00

1764.51

e6/l

0.57

106

Benign neoplasm: Duodenum

3.11

5.52

1.5

1.4

1515.94

2094.29

e6/l

0.46

Filling of root of tooth

3.10

5.51

1.5

1.3

1764.07

1811.68

e6/l

0.02

Disorders of skin appendages

234

1689

1.39

5.51

1.5

3634.28

2931.48

e6/l

0.19

177

1211

Malignant neoplasm of breast, HER-negative

113

704

1.61

5.50

1.4

3005.04

2214.00

e6/l

0.32

515

Carcinoma in situ of skin of lower limb, including hip

3.30

5.49

1.6

1.5

913.08

2020.13

e6/l

1.38

Persons encountering health services in other circumstances

206

1458

1.42

5.44

1.5

2666.33

2936.21

e6/l

0.09

156

1052

Methotrexate

510

1.72

5.39

1.4

3163.05

2243.23

e6/l

0.63

366

Essential (haemorrhagic) thrombocythaemia

2.77

5.38

1.3

1.5

1210.30

1850.49

e6/l

0.77

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

2.90

5.38

1.5

9977.42

2038.97

e6/l

0.40

Tuberculosis, wide

408

1.81

5.36

1.5

1.4

1880.67

1588.37

e6/l

0.43

293

Other neurological diseases

510

3296

1.25

5.36

1.4

1.5

1640.83

2968.55

e6/l

2.46

396

2386

Dipeptidyl peptidase 4 (DPP-4) inhibitors

588

1.66

5.33

1.8

1.5

1231.94

1692.70

e6/l

0.80

435

Transient ischemic attack

402

2608

1.28

5.33

1.4

1.5

1622.75

2936.09

e6/l

1.79

318

1883

Portal vein thrombosis

3.93

5.29

1.5

1.3

3451.25

1988.59

e6/l

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

218

928

1.41

5.29

1.5

2049.59

3918.26

e6/l

0.87

154

681

Disorders of parathyroid gland

145

954

1.51

5.29

1.5

5141.53

2824.89

e6/l

0.41

116

686

Fitting and adjustment of other devices

238

1614

1.38

5.28

1.4

1840.30

2756.41

e6/l

0.87

206

1176

Arterial embolism and thrombosis

268

2.00

5.27

1.3

1.4

1238.67

1837.67

e6/l

0.91

200

Multiple myeloma and malignant plasma cell neoplasms

228

2.09

5.26

1.4

941.53

1662.55

e6/l

1.92

167

Spondylopathies

554

2723

1.24

5.25

1.5

4476.67

2759.48

e6/l

0.46

409

1962

Alcohol abuse, main dg, excluding more controls

514

1.70

5.25

1.3

1.5

3169.87

2278.87

e6/l

0.41

364

N06DA Anticholinesterases

157

1848

0.68

5.24

1.3

1.5

2939.13

2344.68

e6/l

0.20

118

1331

Use of anticholinesterases

157

1848

0.68

5.24

1.3

1.5

2939.13

2344.68

e6/l

0.20

118

1331

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

114

2.58

5.23

1.4

1.5

2125.08

1677.49

e6/l

0.19

Sequelae of injuries of neck and trunk

2.91

5.21

1.7

1.5

1959.94

1911.82

e6/l

0.03

Other systemic involvement of connective tissue

172

1192

1.45

5.16

1.4

1.5

2200.73

2661.07

e6/l

0.27

108

863

Dental pulpitis 2

531

2188

1.25

5.15

1.5

2353.79

2686.37

e6/l

0.27

378

1600

Benign neoplasm: Parotid gland

216

2.10

5.15

1.7

1.5

2372.10

2282.84

e6/l

0.03

154

Benign neoplasm: Small intestine

115

2.55

5.14

1.7

1.5

1310.70

1709.20

e6/l

0.43

Gastro-oesophageal reflux disease

416

2913

1.27

5.13

1.5

1.4

4934.09

2872.96

e6/l

0.44

316

2119

Procreative management

123

668

1.56

5.12

1.4

2619.45

3659.24

e6/l

0.53

492

Malignant neoplasm of other connective and soft tissue

2.74

5.04

1.2

1.3

929.65

1687.66

e6/l

1.22

Exposure to other and unspecified inanimate mechanical forces

179

2.20

5.00

1.7

1.4

2186.92

1789.86

e6/l

0.23

125

Other metabolic disorders

351

1.83

5.00

1.6

1.4

1462.79

2811.02

e6/l

1.62

255

Other and unspecified nonorganic psychotic disorders

476

1.71

4.99

1.5

1.4

3547.49

2866.99

e6/l

0.26

337

Respiratory tuberculosis, bacteriologically and histologically confirmed

2.78

4.98

1.3

1.2

2117.63

1320.29

e6/l

0.96

Parodontitis, under 40 years

2.97

4.98

1.3

1.5

3583.85

3398.63

e6/l

0.07

Dental caries 3

605

2537

1.22

4.92

1.5

2432.89

2880.05

e6/l

0.40

419

1852

Noninfectious colitis NAS

494

1.69

4.91

1.3

1.5

3702.03

2249.45

e6/l

0.34

365

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

3.50

4.90

1.4

1.3

2722.30

2827.30

e6/l

—

Other necrotizing vasculopathies

311

1.88

4.90

1.6

1.5

1355.60

1574.52

e6/l

0.28

223

Parodontitis, under 40 years, or operation codes

2.93

4.86

1.3

1.5

3583.85

3398.63

e6/l

0.07

Carcinoma in situ of skin

399

1.77

4.86

1.5

1.4

1187.97

2048.19

e6/l

1.45

293

Assault

297

1.89

4.86

1.6

1.4

6942.52

2431.59

e6/l

1.15

208

Obesity, other/unspecified

153

1051

1.46

4.82

1.7

1.5

4449.09

2729.25

e6/l

0.30

110

760

Epilepsy

200

1439

1.39

4.81

1.4

1.5

2407.12

2775.95

e6/l

0.25

164

1006

Acute upper respiratory infections of multiple and unspecified sites

408

2425

1.26

4.81

1.5

2745.60

3882.19

e6/l

0.94

319

1715

Alcohol withdrawal state with delirium

285

1.91

4.79

1.5

21729.46

1649.29

e6/l

0.60

210

Corns and callosities

264

1.95

4.78

1.5

1.4

923.32

1665.89

e6/l

2.02

188

Fracture of foot, except ankle

119

778

1.54

4.78

1.5

1.4

2830.49

2474.58

e6/l

0.15

564

Other reaction to severe stress, and adjustment disorders

141

955

1.48

4.78

1.5

1.4

7163.79

3038.14

e6/l

0.63

109

679

Carbimazole or st.post thyroidectomy, condition for graves disease

103

652

1.59

4.77

1.5

1.4

1736.77

2348.66

e6/l

0.92

477

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.66

4.77

1.7

1.3

2567.75

1565.21

e6/l

0.22

Actinic keratosis

313

2297

1.30

4.73

1.5

3988.78

2206.45

e6/l

0.38

211

1675

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

151

2.27

4.73

1.5

1.6

1678.62

2799.73

e6/l

0.65

115

Childhood asthma (age<16)

3.72

4.72

1.5

1.3

3551.70

2129.95

e6/l

—

Dermatophytosis

577

1.62

4.71

1.5

1.4

1847.22

1998.70

e6/l

0.09

419

Glaucoma secondary to other eye disorders

171

2.19

4.71

1.3

1594.67

1426.64

e6/l

0.11

120

Other diseases of stomach and duodenum

273

1.92

4.69

1.7

1.4

1888.43

1592.69

e6/l

0.12

202

Use of rivastigmine

855

0.52

4.69

1.3

1.4

1264.13

1981.25

e6/l

1.17

626

Other coagulation defects

211

2.05

4.68

1.5

1.4

7480.64

1970.30

e6/l

0.41

146

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

617

1.59

4.66

1.6

1.5

8168.95

2275.59

e6/l

0.90

440

Myeloid leukaemia

103

2.57

4.66

1.6

1.3

2168.85

1565.18

e6/l

0.46

Dental caries 1

582

2448

1.22

4.62

1.5

2342.97

2886.20

e6/l

0.51

400

1791

Motorcycle rider injured in noncollision transport accidents

3.24

4.62

1.9

1.4

7027.58

2285.38

e6/l

0.75

Dental caries, including avohilmo

581

2447

1.22

4.57

1.5

2346.43

2884.63

e6/l

0.50

399

1790

Other and unspecified effects of external causes

122

811

1.51

4.56

1.5

2653.83

2410.50

e6/l

0.10

594

Dental pulpitis 2, only avohilmo

539

2257

1.22

4.54

1.5

2371.66

2643.10

e6/l

0.22

378

1652

Myeloproliferative diseases

378

1.76

4.53

1.3

1.4

1913.15

1808.73

e6/l

0.08

274

Dental caries 2 and operation codes, only avohilmo

218

1824

0.74

4.52

1.6

1.5

5458.75

3449.81

e6/l

0.29

152

1344

Other diseases of anus and rectum

201

1467

1.37

4.52

1.5

1845.18

2602.95

e6/l

0.51

157

1061

Personal history of other diseases and conditions

186

2.10

4.51

1.6

1.4

1878.15

2998.10

e6/l

0.66

126

Injuries to the elbow and forearm

377

2709

1.26

4.50

1.4

1.5

5466.26

2779.79

e6/l

0.50

278

1947

Benign neoplasm of urinary organs

123

2.38

4.49

1.3

1.5

5359.70

1820.98

e6/l

0.86

Carcinoma in situ of skin of other and unspecified parts of face

447

1.70

4.48

1.7

1.4

691.66

2003.70

e6/l

4.18

327

2409

1.28

4.48

1.5

3886.47

2175.23

e6/l

0.38

220

1758

Skin changes due to chronic exposure to nonionizing radiation

316

2335

1.29

4.44

1.5

3958.35

2187.36

e6/l

0.38

214

1702

Hyperparathyroidism

127

847

1.49

4.43

1.5

3018.62

2122.17

e6/l

0.31

608

Nerve, nerve root and plexus disorders

671

3543

1.19

4.43

1.5

2829.24

3305.16

e6/l

0.29

512

2549

Tuberculosis

352

1.78

4.40

1.4

1868.19

1619.73

e6/l

0.34

255

Disorders of eyelid, lacrimal system and orbit

536

3474

1.21

4.40

1.5

1998.47

3206.70

e6/l

2.04

386

2531

Unspecified jaundice

224

1.99

4.37

1.5

1.4

1602.08

1657.45

e6/l

0.03

161

Respiratory tuberculosis, confirmed and not-confirmed

302

1.84

4.36

1.4

1859.46

1760.33

e6/l

0.11

219

Respiratory tuberculosis

302

1.84

4.36

1.4

1859.46

1760.33

e6/l

0.11

219

Neuroendocrine tumor and carcinoma of small intestine

3.41

4.36

1.3

1.4

15858.43

1150.36

e6/l

—

254

1711

1.32

4.34

1.3

1.5

1734.36

2263.54

e6/l

0.36

187

1221

Carcinoma in situ of rectum

4.69

4.34

1.6

1.1

698.80

2710.13

e6/l

—

Diseases of the musculoskeletal system and connective tissue

323

1256

1.29

4.33

1.5

1.4

2483.33

3475.29

e6/l

0.63

233

892

Viral and other specified intestinal infections

484

1.64

4.33

1.4

1770.79

2738.81

e6/l

1.10

353

Schizophrenia or delusion, excluding more controls

141

971

1.44

4.26

1.5

5742.82

2268.88

e6/l

1.05

100

690

Dementia in Alzheimer disease

1056

0.62

4.25

1.3

1.5

1327.97

1821.28

e6/l

0.72

776

Postprocedural disorders of digestive system, not elsewhere classified

108

2.44

4.24

1.3

1.4

6598.00

1588.21

e6/l

0.41

Benign neoplasm of mouth and pharynx

283

1.85

4.22

1.5

2876.71

2193.52

e6/l

0.23

205

Retinal detachments and breaks

249

1900

1.32

4.22

1.4

1.5

5123.05

2645.94

e6/l

0.29

177

1365

Abdominal aortic aneurysm (AAA)

638

1.55

4.17

1.4

1.5

1704.60

2021.68

e6/l

0.19

474

Other inflammatory liver diseases

214

1.98

4.16

1.9

1.3

6309.87

1781.93

e6/l

0.79

148

Vitamin deficiency

167

2.12

4.14

1.3

1621.54

1638.00

e6/l

0.01

116

Vitamin deficiency, wide

167

2.12

4.14

1.3

1621.54

1638.00

e6/l

0.01

116

Urticaria and erythema

169

1219

1.39

4.13

1.5

2249.08

2876.56

e6/l

0.46

125

880

Idiopathic pulmonary fibrosis

428

1.68

4.10

1.7

1.4

7111.31

1662.66

e6/l

0.56

307

Right hemicolectomy

287

1.83

4.08

1.3

1.4

900.56

1632.52

e6/l

1.21

210

Oesophageal obstruction

155

2.16

4.08

1.4

1539.36

1626.28

e6/l

0.07

106

Neovascular glaucoma

169

2.10

4.03

1.3

1.4

1700.56

1445.38

e6/l

0.16

120

Inguinal hernia

416

2278

1.23

4.01

1.5

1856.15

3478.71

e6/l

2.03

315

1648

Carcinoma in situ of skin of scalp and neck

137

2.24

4.01

1.6

1.4

1032.06

1523.19

e6/l

0.56

100

Sleep apnoea

567

3220

1.20

4.00

1.5

2697.01

3589.47

e6/l

0.54

422

2329

Alcohol abuse, main dg

555

1.57

3.98

1.3

1.5

3169.87

2474.37

e6/l

0.30

395

Injuries to the ankle and foot

319

2303

1.26

3.97

1.5

4193.95

3865.10

e6/l

0.07

231

1656

Emotionally unstable personality disorder

183

2.03

3.97

1.9

1.4

4509.69

3319.36

e6/l

0.27

127

Colectomy operation

120

821

1.47

3.97

1.3

1.5

1834.51

2135.27

e6/l

0.28

600

Squamous cell neoplasms and carcinomas of the skin

109

732

1.50

3.97

1.5

913.54

1981.74

e6/l

2.34

535

Symptoms and signs involving the nervous and musculoskeletal systems

344

2757

1.25

3.94

1.4

1.5

4843.86

2667.31

e6/l

0.40

266

1974

Other and unspecified injuries of head

198

1.99

3.92

1.6

1.4

26768.23

1598.80

e6/l

0.47

138

Other diseases of biliary tract

373

1.70

3.89

1.4

4527.69

2316.31

e6/l

0.43

270

Other symptoms and signs involving the urinary system

473

1.62

3.88

1.7

1.5

3155.00

1769.88

e6/l

0.61

340

Intestinal adhesions without obstruction

344

1.73

3.86

1.4

4252.35

1491.83

e6/l

0.51

241

Haemangioma and lymphangioma, any site

193

1.98

3.82

1.5

1.6

2339.68

2646.19

e6/l

0.13

139

Focal epilepsy

127

885

1.44

3.81

1.4

1.5

2464.04

2388.68

e6/l

0.06

108

642

Fluid overload

12.65

3.81

2.2

1.2

575.17

1079.40

e6/l

—

Extreme obesity with alveolar hypoventilation

133

2.20

3.81

1.4

5130.74

1626.05

e6/l

0.74

Malignant neoplasm of oral cavity

140

2.17

3.79

1.4

714.19

1519.72

e6/l

2.45

Cyst of kidney

309

1.76

3.78

1.6

1.3

1531.16

1582.16

e6/l

0.04

222

Personality disorders

102

682

1.50

3.78

1.5

1.4

16305.84

2744.94

e6/l

0.81

488

Unspecific neurodegenerative disorder

226

2027

0.77

3.77

1.3

1.5

2895.09

2325.27

e6/l

0.25

170

1461

Parodontitis, under 40 years and operation codes

2.73

3.75

1.2

1.6

3987.64

3486.09

e6/l

0.18

Parodontitis, operation under 40 years and operation codes

2.73

3.75

1.2

1.6

3987.64

3486.09

e6/l

0.18

Malignant neoplasm of small intestine

2.54

3.74

1.3

1.4

12644.11

1569.07

e6/l

—

Pulmonary oedema

2.55

3.74

1.3

483.25

1451.68

e6/l

2.21

Fracture of skull and facial bones

115

790

1.46

3.74

1.4

1.5

3864.74

2452.81

e6/l

0.64

567

Follow-up examination after treatment for conditions other than malignant neoplasms

250

1263

1.30

3.73

1.5

1.4

5556.23

2327.70

e6/l

0.42

184

842

Disorders of continuity of bone

266

1.81

3.73

1.5

1.3

4125.73

2533.53

e6/l

0.38

193

Benign neoplasm: Rectosigmoid junction

115

2.28

3.72

1.4

1.5

867.67

1709.00

e6/l

1.73

Fall on and from stairs and steps

147

1059

1.39

3.68

1.6

1.5

12024.48

2320.51

e6/l

0.66

776

Bicuspidal aortic valve syndrome

103

2.35

3.68

1.6

1.5

2325.47

1742.46

e6/l

0.29

Haemangioma, any site

182

1.99

3.68

1.4

1.5

2385.08

2749.97

e6/l

0.15

130

Symptoms and signs involving the skin and subcutaneous tissue

392

3198

1.22

3.67

1.5

4160.72

2938.44

e6/l

0.35

305

2306

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

122

2.23

3.67

1.6

1.5

1610.24

3105.71

e6/l

0.72

Primary gonarthrosis, bilateral

242

2713

0.78

3.67

1.5

2005.11

3071.60

e6/l

1.14

184

1959

Renal tubulo-interstitial disorders in diseases classified elsewhere

3.76

3.67

1.5

1.2

219.17

1986.52

e6/l

—

Amputation of thigh

149

2.11

3.65

1.7

1.4

596.05

1174.99

e6/l

1.73

108

Other blood glucose lowering drugs, excl. Insulins

124

869

1.43

3.65

1.6

1.5

1135.80

2114.00

e6/l

2.34

643

Dental operations

505

2159

1.20

3.65

1.6

1.5

2499.07

2831.23

e6/l

0.24

365

1553

Gonarthrosis, primary, with knee surgery

283

2907

0.79

3.64

1.5

1743.25

3020.17

e6/l

1.97

207

2109

Carcinoma in situ of breast, intraductal

142

2.12

3.64

1.2

1.5

3782.79

2788.01

e6/l

0.21

110

Anxiety (asthma-related co-morbidities)

232

1408

1.30

3.62

1.5

4423.56

2814.23

e6/l

0.46

173

996

Dental caries 1 and operation codes

616

2683

1.18

3.59

1.6

1.5

2731.82

2871.18

e6/l

0.10

435

1966

Cerebral palsy and other paralytic syndromes

428

1.62

3.59

1.7

1.5

1991.56

1830.75

e6/l

0.14

309

Spinal stenosis

384

2464

1.22

3.56

1.5

2201.53

2411.22

e6/l

0.20

295

1783

Other skin changes

113

783

1.45

3.55

1.3

1.5

7486.68

1913.07

e6/l

0.57

563

Other specified disorders of kidney and ureter

105

2.31

3.54

1.2

1.3

2703.00

1576.09

e6/l

0.20

Other anxiety disorders

162

1056

1.36

3.53

1.6

1.4

5181.42

2718.92

e6/l

0.50

119

761

Fracture of forearm

288

2147

1.26

3.53

1.4

1.5

3391.38

2689.87

e6/l

0.19

207

1545

Abnormal serum enzyme levels

239

1839

1.29

3.53

1.5

1513.06

2725.69

e6/l

1.39

168

1361

Dermatitis and eczema

644

3618

1.17

3.50

1.5

3629.12

3248.88

e6/l

0.14

483

2608

CR(E)ST syndrome

3.39

3.49

1.4

1.3

774.17

1642.64

e6/l

—

Myocardial infarction, unclassifiable

207

1412

1.31

3.49

1.4

1.5

3197.88

2139.42

e6/l

0.23

154

1021

Respiratory conditions due to other external agents

2.51

3.49

1.4

1.3

1254.50

1334.91

e6/l

0.07

Adenocarcinoma of pancreas

132

2.16

3.48

1.2

1.3

2906.41

1369.19

e6/l

0.48

Malignant neoplasm of oesophagus

119

2.22

3.47

1.4

1071.20

1581.51

e6/l

0.60

Assault by bodily force

125

2.17

3.47

1.4

8518.00

2616.87

e6/l

0.98

Benign lipomatous neoplasm

124

877

1.42

3.47

1.5

2465.01

2458.90

e6/l

0.00

640

Benign neoplasm of other and ill-defined parts of digestive system

114

795

1.44

3.47

1.6

1.5

1596.73

2066.22

e6/l

0.85

580

Benign neoplasm of eye and adnexa

258

1.79

3.46

1.5

1.6

2056.44

2419.03

e6/l

0.21

188

Diseases of spleen

2.81

3.44

1.7

1.4

1324.18

1861.39

e6/l

0.48

Malignant neoplasm of tongue

2.70

3.42

1.4

1.3

751.89

1610.56

e6/l

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

296

2326

1.25

3.41

1.6

1.5

4433.06

3405.78

e6/l

0.33

223

1689

Other benign neoplasms of connective and other soft tissue

230

1.83

3.41

1.5

1235.35

2518.14

e6/l

1.30

167

Dental caries 3 and operation codes

627

2749

1.17

3.41

1.5

2705.01

2858.27

e6/l

0.11

441

2009

Disorders of adult personality and behaviour

105

723

1.46

3.40

1.6

1.4

16024.73

2906.19

e6/l

0.80

520

Follicular lymphoma, hilmo

188

1.94

3.40

1.4

1975.12

1724.66

e6/l

0.19

133

Benign neoplasm: Skin of other and unspecified parts of face

319

1.70

3.40

1.4

1.6

988.86

2697.40

e6/l

1.46

230

Spondyloarthritis

108

749

1.45

3.38

1.5

13557.91

2405.61

e6/l

0.67

547

Phobic anxiety disorders

209

1.87

3.38

1.4

1994.89

3916.48

e6/l

1.04

141

Low back pain

428

2743

1.20

3.37

1.4

1.5

4019.24

3030.15

e6/l

0.41

327

1974

Shoulder lesions

502

2589

1.19

3.35

1.5

1.4

3513.97

2831.67

e6/l

0.26

381

1859

Malignant neoplasm of larynx

2.52

3.33

1.3

6958.46

1432.37

e6/l

0.60

Specific personality disorders

580

1.50

3.32

1.7

1.4

4282.55

2664.73

e6/l

0.58

420

Other diseases of liver

646

1.48

3.31

1.6

1.5

1788.31

2018.53

e6/l

0.25

481

Presence of other devices

165

1235

1.34

3.29

1.4

1.5

2818.66

2817.34

e6/l

0.00

146

873

Fibroblastic disorders

171

1288

1.33

3.28

1.6

1.5

5472.11

2519.69

e6/l

0.48

129

921

Palmar fascial fibromatosis [Dupuytren]

131

947

1.39

3.28

1.5

6426.85

2008.54

e6/l

0.59

671

Neurological diseases

517

2199

1.19

3.23

1.5

1.4

2397.44

3031.73

e6/l

0.59

397

1528

Special screening examination for neoplasms

192

1.89

3.21

1.4

1002.77

1845.22

e6/l

1.46

123

Sarcoidosis

505

1.53

3.20

1.7

1.4

2084.42

2129.60

e6/l

0.04

366

Other diseases of oesophagus

442

1.57

3.19

1.9

1.4

5931.04

1650.98

e6/l

0.85

324

Cysts of oral region, not elsewhere classified

144

2.03

3.16

1.5

1692.19

1815.36

e6/l

0.09

107

Infective dermatitis

483

1.54

3.15

1.5

1.4

2384.54

2443.88

e6/l

0.03

346

Acute and transient psychotic disorders

334

1.65

3.15

1.6

1.5

9829.63

2422.06

e6/l

0.82

239

Carcinoma in situ of other and unspecified genital organs

4.55

3.12

1.9

1.1

767.56

1600.20

e6/l

—

Other and unspecified diseases of blood and blood-forming organs

2.31

3.12

1.3

985.12

1615.29

e6/l

0.84

Carcinoma in situ of skin of ear and external auricular canal

2.86

3.11

1.6

1.5

2682.00

2108.97

e6/l

—

176

1270

1.32

3.11

1.3

1.5

1875.89

2192.54

e6/l

0.14

135

899

Monoplegia

3.12

3.10

1.7

1.4

1063.86

1644.12

e6/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

155

1678

0.75

3.10

1.4

1.5

4428.81

2867.55

e6/l

0.29

121

1216

Macular pucker

106

747

1.43

3.10

1.5

1155.44

2259.81

e6/l

2.03

528

Carcinoma in situ of other and unspecified sites

125

2.10

3.10

1.5

1.6

1539.95

1794.36

e6/l

0.18

Alcohol-induced acute pancreatitis

132

2.07

3.08

1.4

1.5

1842.73

1649.55

e6/l

0.14

Behavioural syndromes associated with physiological disturbances and physical factors

126

914

1.38

3.08

1.5

4708.05

2568.13

e6/l

0.53

676

Carcinoma in situ of rectum

3.55

3.08

1.6

1.2

698.80

1917.45

e6/l

—

Cholangitis (primary sclerosing, PSC)

246

1.76

3.08

1.3

1.4

3007.03

1752.86

e6/l

0.30

175

Delivery, wide proxy

709

0.69

3.06

1.4

1755.13

4504.51

e6/l

1.52

519

Acute suppurative otitis media

498

1.50

3.05

1.4

1.5

8208.36

3014.33

e6/l

0.55

347

Acute sinusitis

234

1728

1.26

3.05

1.5

2735.79

4267.47

e6/l

0.92

179

1222

Isolated proteinuria

2.28

3.04

1.3

1.4

1416.25

1915.94

e6/l

0.29

Panic disorder

269

1.71

3.03

1.4

2038.64

3321.50

e6/l

0.78

184

Injuries to unspecified part of trunk, limb or body region

369

1.61

3.03

1.8

1.4

1686.62

1654.12

e6/l

0.02

270

Focal brain injury

262

1.73

3.03

1.4

1685.21

1919.08

e6/l

0.18

184

Coxarthrosis [arthrosis of hip](FG)

387

2334

1.20

3.02

1.5

1.4

1754.38

3328.83

e6/l

1.95

290

1692

Pregnancy, childbirth and the puerperium

657

0.68

2.99

1.4

1460.77

2934.83

e6/l

1.33

487

Lichen simplex chronicus and prurigo

256

1.73

2.98

1.6

1.4

2660.79

1894.52

e6/l

0.35

183

Barrett oesophagus

190

1.86

2.98

1.5

1.4

3300.42

2049.85

e6/l

0.34

136

Polycythaemia vera

107

2.17

2.98

1.0

1.6

2864.08

1706.20

e6/l

0.36

Granulomatous disorders of skin and subcutaneous tissue

2.66

2.97

2.2

1.3

2485.90

1612.84

e6/l

—

Dorsalgia

603

2819

1.16

2.96

1.5

3511.40

2995.06

e6/l

0.25

435

2032

Gonarthrosis,primary

470

3470

0.85

2.96

1.5

1923.01

3264.65

e6/l

2.36

352

2521

Fracture at wrist and hand level

169

1291

1.31

2.95

1.5

5134.87

2728.48

e6/l

0.35

123

926

Benign neoplasm: Duodenum

101

2.21

2.95

1.5

1.3

1515.94

1831.89

e6/l

0.25

Other arterial embolism and thrombosis

121

2.09

2.94

1.3

1622.44

1662.15

e6/l

0.02

Infections with a predominantly sexual mode of transmission

662

1.44

2.93

1.4

3545.47

2628.95

e6/l

0.39

477

severe traumatic brain injury, does not include concussion

160

1216

1.32

2.93

1.5

1413.63

2271.35

e6/l

1.77

114

886

Schizophrenia, schizotypal and delusional disorders

142

1060

1.34

2.93

1.5

1.4

5753.97

2412.12

e6/l

1.02

102

773

Carcinoma in situ of skin of trunk

108

2.16

2.92

1.6

1.5

1432.20

1611.29

e6/l

0.13

Other and unspecified tonsillitis

109

659

1.41

2.92

1.6

1.4

2991.29

4566.95

e6/l

0.72

458

Dislocation, sprain and strain of joints and ligaments of thorax

2.34

2.92

1.7

1.4

1157.46

1728.82

e6/l

0.59

Soft tissue disorders related to use, overuse and pressure

156

1183

1.32

2.90

1.5

9555.93

2555.21

e6/l

0.60

113

853

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

163

1.91

2.90

1.5

1.4

3392.81

1715.49

e6/l

0.43

112

Inflammatory diseases of the central nervous system

281

1.68

2.89

1.3

1.4

2434.92

1868.18

e6/l

0.27

200

Malignant melanoma

102

724

1.42

2.89

1.6

1.5

1727.51

2131.33

e6/l

0.47

525

Small fibre neuropathy

102

2.19

2.88

1.9

1.4

2027.00

1736.14

e6/l

0.14

Pneumonitis due to solids and liquids

422

1.55

2.88

1.4

1.5

1167.04

1893.53

e6/l

1.35

304

Schizophrenia or delusion

141

1055

1.34

2.87

1.5

1.4

5742.82

2435.21

e6/l

0.98

100

770

Ulcer of oesophagus

328

1.63

2.87

1.6

1.4

1799.72

1776.67

e6/l

0.01

234

Familial hypercholesterolemia, with ischemic heart disease

519

1.49

2.87

1.8

1.5

1442.44

2021.37

e6/l

0.60

376

Other infective otitis externa

200

1.81

2.85

1.4

2701.33

1716.23

e6/l

0.48

137

Polyuria

152

1152

1.32

2.85

1.6

1.5

2302.12

2340.56

e6/l

0.02

104

846

Background retinopathy and retinal vascular changes

2.37

2.83

1.2

1.3

1868.78

1364.00

e6/l

—

Unknown and unspecified causes of morbidity

245

1.72

2.83

1.4

1753.65

2193.51

e6/l

0.43

176

Nail disorders

245

1.72

2.83

1.8

1.4

1537.97

1991.58

e6/l

0.53

173

Sequelae of injuries, of poisoning and of other consequences of external causes

119

870

1.37

2.83

1.6

1.5

1756.38

2371.60

e6/l

1.12

639

Disorders of the thyroid gland

576

3260

1.16

2.82

1.6

1.5

4437.13

2996.68

e6/l

0.36

409

2367

Use of memantine

133

1542

0.75

2.82

1.4

1.5

1857.03

2041.12

e6/l

0.09

102

1124

Use of other anti-dementia drugs

133

1542

0.75

2.82

1.4

1.5

1857.03

2041.12

e6/l

0.09

102

1124

Injuries to the shoulder and upper arm

500

3601

1.17

2.82

1.5

5601.80

2896.90

e6/l

0.68

369

2600

Gingival hyperplasia

103

2.16

2.81

1.4

1.6

1635.31

2454.60

e6/l

0.36

Benign neoplasm: Anus and anal canal

2.42

2.81

1.5

2743.67

1895.96

e6/l

0.25

Arterial embolism and thrombosis of lower extremity artery

151

1.94

2.81

1.4

899.79

1507.12

e6/l

1.44

112

Sequelae of injuries of head

158

1.91

2.80

1.5

1.4

1814.09

1856.51

e6/l

0.02

115

Other inflammation of eyelid

489

1.50

2.80

1.4

1.5

3109.17

2041.20

e6/l

0.56

355

Visual impairment including blindness (binocular or monocular)

284

1.67

2.79

1.4

1037.97

1583.11

e6/l

1.18

211

Dissociative [conversion] disorders

2.66

2.79

1.6

1.1

2516.93

1814.41

e6/l

0.30

Other and unspecified vasculitis limited to skin

2.29

2.79

1.4

1670.33

1489.00

e6/l

0.09

Hydrocele

102

730

1.40

2.77

1.5

1307.03

1908.01

e6/l

0.79

514

Contraceptive management

748

0.68

2.77

1.7

1.4

4377.84

4618.25

e6/l

0.04

542

Subjective visual disturbances

128

950

1.35

2.77

1.4

1.5

1813.25

2738.52

e6/l

0.67

690

Other follicular disorders

173

1.86

2.77

1.6

1.4

3003.21

1866.67

e6/l

0.47

119

Visual disturbances and blindness

288

2368

1.22

2.75

1.4

1.5

1584.08

3013.91

e6/l

2.10

211

1713

Carcinoma in situ, bladder

118

2.06

2.73

1.5

1428.39

1843.24

e6/l

0.29

Collagenous colitis

333

1.60

2.71

1.5

1584.19

1845.88

e6/l

0.26

242

Localized swelling, mass and lump of skin and subcutaneous tissue

177

1380

1.29

2.71

1.5

3617.67

2399.24

e6/l

0.64

141

987

Speech therapy

159

1223

1.30

2.70

1.5

1.4

2800.77

2618.24

e6/l

0.07

115

874

Sleep apnoea, including avohilmo

577

3255

1.15

2.69

1.5

2687.10

3574.24

e6/l

0.54

424

2358

Leisure time condition

675

1.41

2.69

1.4

1.5

10666.68

2193.08

e6/l

0.46

496

Other and unspecified injuries of lower leg

197

1.79

2.67

1.5

1.3

2150.86

2009.21

e6/l

0.06

140

Other disorders of bone

634

1.42

2.67

1.4

1837.36

2594.21

e6/l

0.64

469

Overexertion and strenuous or repetitive movements

327

1.60

2.65

1.6

1.4

2360.57

2302.87

e6/l

0.02

235

Disorders of muscles

359

1.57

2.64

1.4

4877.33

1879.88

e6/l

0.82

258

Carcinoma in situ of skin of lower limb, including hip

2.19

2.63

1.6

1.3

913.08

1345.80

e6/l

0.55

Coeliac disease

415

1.52

2.63

1.4

1731.13

2599.18

e6/l

1.09

299

Traumatic subdural haemorrhage

101

717

1.39

2.62

1.5

1.4

1284.32

1982.03

e6/l

1.11

496

Vasculitis limited to skin, not elsewhere classified

2.18

2.62

1.4

1670.33

1575.80

e6/l

0.04

Other surgical follow-up care

2.27

2.61

1.3

1913.18

1834.85

e6/l

0.03

Malignant neoplasm of renal pelvis

3.73

2.61

2.0

1.2

408.67

1726.11

e6/l

—

All anxiety disorders

232

1506

1.24

2.60

1.5

4423.56

3561.72

e6/l

0.20

173

1072

Carcinoma in situ of colon

2.94

2.60

1.5

1.3

338.20

2728.65

e6/l

—

Injury of unspecified body region

283

1.64

2.57

1.8

1.4

1830.00

1605.19

e6/l

0.10

202

Malignant neoplasm of other and unspecified parts of tongue

2.77

2.56

1.4

499.50

1666.28

e6/l

—

Focal epilepsy, strict definition

113

835

1.36

2.55

1.4

1.5

2465.11

2305.02

e6/l

0.12

604

Benign neoplasm: Skin of eyelid, including canthus

451

1.49

2.54

1.3

1.5

3002.20

2477.34

e6/l

0.16

331

Episodal and paroxysmal disorders

670

3024

1.14

2.51

1.5

2697.64

3388.68

e6/l

0.54

511

2145

Bipolar affective disorders

493

1.46

2.50

1.2

1.4

12171.82

2527.84

e6/l

0.81

352

Symptoms and signs involving speech and voice

185

1467

1.26

2.50

1.6

1.5

4628.43

2861.97

e6/l

0.48

137

1075

Malignant neoplasm of pancreas

325

1.58

2.50

1.2

1.4

2913.10

1746.27

e6/l

0.58

234

Type 1 diabetes, definitions combined

157

1.85

2.49

1.4

1564.55

2852.13

e6/l

1.50

109

Acute bronchiolitis

2.29

2.49

1.3

1.5

3408.83

4470.07

e6/l

0.17

Temporomandibular joint disorders, including avohilmo

1115

0.71

2.49

1.7

1.5

4001.32

3395.02

e6/l

0.12

797

Left hemicolectomy

102

2.09

2.49

1.4

1.3

1465.27

1266.10

e6/l

0.08

Osteoporosis with pathological fracture (FG)

286

1.62

2.49

1.4

3342.97

1831.40

e6/l

0.31

200

Benign neoplasm: Kidney

2.21

2.48

1.5

7006.85

1987.97

e6/l

0.79

Carcinoma in situ of skin of upper limb, including shoulder

116

2.02

2.48

1.5

1.3

1847.55

1361.46

e6/l

0.23

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

2.41

2.47

1.3

1.4

3833.00

2121.70

e6/l

—

Complications of other internal prosthetic devices, implants and grafts

144

1.89

2.47

1.3

2085.00

1538.82

e6/l

0.31

104

Inflammatory disorders of male genital organs, not elsewhere classified

2.59

2.46

1.8

1.3

342.00

1806.69

e6/l

—

Type 1 diabetes, strict (exclude DM2)

158

1.84

2.45

1.4

1564.55

2789.59

e6/l

1.40

109

Memory loss

480

1.47

2.45

1.7

1.5

853.35

1704.55

e6/l

3.03

350

Hidradenitis suppurativa

2.56

2.44

1.4

6719.38

2371.48

e6/l

—

Other necrotizing vasculopathies (FG)

272

1.63

2.44

1.7

1.4

1574.22

1673.16

e6/l

0.09

197

Dental caries 2, only avohilmo

230

2221

0.82

2.44

1.6

1.5

6998.36

3521.54

e6/l

0.51

159

1605

Adverse effects, not elsewhere classified

579

1.42

2.44

1.6

1.4

1365.36

2410.94

e6/l

2.08

425

Paracetamol of NSAID medication

111

408

1.37

2.43

1.4

1.5

1921.37

2285.15

e6/l

0.34

296

Olecranon bursitis

249

1.66

2.43

1.8

1.5

27349.63

1850.06

e6/l

0.58

181

Other spirochaetal diseases

1063

0.70

2.42

1.4

1.5

3927.02

2776.02

e6/l

0.24

770

Carcinoma in situ of other and unspecified digestive organs

117

1.99

2.42

1.5

1.3

529.58

1626.27

e6/l

2.51

Myeloproliferative diseases (CML excluded)

344

1.55

2.40

1.2

1.4

1913.03

1804.96

e6/l

0.07

250

Evidence of alcohol involvement determined by blood alcohol level

3.37

2.40

1.1

1.4

2103.33

2157.90

e6/l

—

Other specified and unspecified personality disorders

212

1.70

2.39

1.5

1.4

3236.85

2175.78

e6/l

0.34

147

Urticaria

122

923

1.32

2.37

1.6

1.4

2350.96

2546.04

e6/l

0.15

673

Social phobias

2.07

2.37

1.3

1.4

1946.17

2264.36

e6/l

0.12

Complications of labour and delivery

139

1005

0.77

2.36

1.4

3038.22

4065.33

e6/l

0.36

104

713

Hypothyroidism, strict autoimmune

410

2329

1.17

2.35

1.6

1.4

5297.11

2769.56

e6/l

0.50

292

1686

Benign neoplasm of bone and articular cartilage

161

1.81

2.35

1.4

1.5

1530.70

2902.73

e6/l

0.89

121

Alzheimer disease, including avohilmo

199

1777

0.81

2.35

1.4

1.5

3113.23

2319.71

e6/l

0.32

151

1273

Acute alcohol intoxication

150

1170

1.29

2.34

1.4

1.5

6982.97

2332.57

e6/l

0.62

118

825

Dental caries 3, only avohilmo

593

2665

1.14

2.34

1.5

2544.76

2837.42

e6/l

0.23

413

1936

Female genital prolapse

715

0.72

2.33

1.2

1.4

1556.36

3564.10

e6/l

1.10

506

Coxarthrosis

360

2076

1.18

2.33

1.5

1.4

1801.45

3402.90

e6/l

1.77

268

1499

Superficial injury of hip and thigh

653

1.38

2.31

1.6

1.5

1203.74

2109.57

e6/l

1.77

475

Dental caries 1, only avohilmo

575

2583

1.14

2.29

1.5

2514.79

2841.23

e6/l

0.26

398

1881

Lyme disease

1051

0.71

2.29

1.4

1.5

3927.02

2789.92

e6/l

0.24

760

Diseases of external ear

186

1494

1.25

2.28

1.5

7083.97

2331.99

e6/l

0.50

142

1081

Oesophagitis

223

1.67

2.28

1.6

1.3

1181.88

1895.93

e6/l

1.08

161

Other dorsopathies, not elsewhere classified

606

2821

1.13

2.27

1.5

2986.31

2994.01

e6/l

0.00

440

2033

Melanocytic naevi of trunk

406

1.48

2.26

1.5

1.4

1021.78

2336.38

e6/l

2.24

291

Pain in joint

321

1795

1.19

2.24

1.6

1.5

5908.50

3542.27

e6/l

0.60

218

1312

Fracture of neck

263

1.61

2.24

1.7

1.4

4040.37

1526.72

e6/l

0.43

190

Focal epilepsy, mode (most common among epilepsy diagnosis)

103

768

1.35

2.24

1.4

1.5

2223.55

2258.04

e6/l

0.03

558

Tonsillectomy and adenotomy

110

1013

0.76

2.23

1.4

1.5

3758.82

3211.28

e6/l

0.21

734

Polyarthritis, unspecified

135

1.87

2.23

1.6

1.4

2866.16

1904.56

e6/l

0.48

101

Open wound of forearm

343

1.52

2.21

1.6

1.4

1996.80

1808.40

e6/l

0.11

258

Other salmonella infections

107

1.98

2.21

1.3

2244.29

1718.06

e6/l

0.26

Cholecystectomy

422

3236

1.15

2.20

1.4

1.5

2408.67

2958.37

e6/l

0.39

308

2352

Aspergillosis

3.40

2.19

1.5

2176.00

1480.94

e6/l

—

Somnolence, stupor and coma

165

1.77

2.19

1.8

1.4

14662.78

1407.41

e6/l

0.51

116

Traumatic subarachnoid haemorrhage

136

1.85

2.18

1.5

1.4

868.47

1996.74

e6/l

1.71

Postprocedural endocrine and metabolic disorders, not elsewhere classified

320

1.54

2.18

1.5

1.4

1476.68

2865.69

e6/l

1.47

233

Erythema nodosum

2.26

2.18

1.5

1.3

2232.50

1804.80

e6/l

—

Autoimmune hyperthyroidism

158

1.78

2.17

1.3

1016.73

1974.00

e6/l

1.78

114

Rubella [German measles]

2.04

2.16

1.3

1.4

5026.29

1853.71

e6/l

0.32

Follow-up care involving plastic surgery

2.03

2.16

1.3

1150.71

2213.41

e6/l

1.13

Otitis externa

108

816

1.33

2.16

1.5

2814.51

2220.51

e6/l

0.32

593

Moderate visual impairment, binocular

130

1.86

2.13

1.5

1.3

1007.82

1121.09

e6/l

0.12

Burns and corrosions

461

1.44

2.13

1.4

1.5

4070.84

2749.27

e6/l

0.29

334

Acute alcohol intoxication, ICD10

101

758

1.34

2.12

1.4

1.5

9480.92

2323.71

e6/l

0.70

538

Corneal scars and opacities

2.07

2.12

1.3

1523.85

1834.02

e6/l

0.13

Event of undetermined intent

152

1.78

2.12

1.5

1.4

2168.24

1800.42

e6/l

0.30

108

Toxic effect of ethanol

2.06

2.11

1.3

1.4

2541.36

1836.28

e6/l

0.29

Melanoma in situ

190

1.70

2.11

1.7

1.4

1643.05

1719.12

e6/l

0.05

132

Personal history of malignant neoplasm

2.01

2.11

1.5

1.2

9337.46

2151.14

e6/l

0.43

Bacterial, viral and other infectious agents

236

1.62

2.10

1.7

1.4

1524.17

2603.68

e6/l

1.01

168

Disorders of sclera, cornea, iris and ciliary body

280

2365

1.19

2.10

1.4

1.5

2435.30

3061.35

e6/l

0.31

200

1714

Benign neoplasm: Oesophagus

2.94

2.08

1.9

1.2

1746.78

2127.84

e6/l

—

Non-selective monoamine reuptake inhibitors

227

1826

1.21

2.08

1.4

1.5

6311.04

2154.84

e6/l

0.52

167

1304

Functional dyspepsia

129

1005

1.29

2.08

1.4

2455.44

2697.82

e6/l

0.13

725

Benign neoplasm: Stomach

431

1.45

2.07

1.5

1404.07

2026.97

e6/l

0.85

317

Other otitis externa (chronic)

214

1.64

2.06

1.5

1.4

3669.81

1693.30

e6/l

0.41

145

Progressive vascular leukoencephalopathy

184

1.70

2.06

1.3

1942.63

1428.90

e6/l

0.24

135

Polymyalgia rheumatica

677

1.35

2.05

1.4

1.5

1329.58

1919.25

e6/l

1.25

492

Acute alcohol intoxication ICD-9

154

1.77

2.05

1.2

1.4

1126.71

1650.97

e6/l

0.78

103

Anomalies of dental arch relationship, including avohilmo

410

0.59

2.03

1.3

1.4

6211.74

2929.69

e6/l

0.45

296

Other peripheral vascular diseases

270

1.56

2.03

1.4

2844.96

1820.65

e6/l

0.68

193

Diseases of salivary glands

731

1.33

2.00

1.4

1423.45

2135.93

e6/l

1.25

529

Hydrocephalus

377

0.55

2.00

1.4

952.63

1556.48

e6/l

1.48

269

Special screening examination for other diseases and disorders

287

1.54

1.99

1.5

1.4

4067.05

2054.45

e6/l

0.33

195

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

240

1.60

1.99

1.6

1.5

756.50

1604.66

e6/l

3.25

178

Malignant neoplasm of endocrine gland

232

1.60

1.99

1.5

1.3

3149.62

1903.62

e6/l

0.35

164

Chronic conjunctivitis

2.16

1.99

1.3

1.4

1851.00

2077.88

e6/l

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

119

1.87

1.98

1.4

1.3

1350.19

1393.38

e6/l

0.03

Multiple myeloma

119

1.87

1.98

1.4

1.3

1350.19

1393.38

e6/l

0.03

Benign neoplasm of breast

217

1.62

1.96

1.2

1.6

5167.35

2452.68

e6/l

0.37

165

Recurring oral aphthae, including avohilmo

486

1.40

1.96

1.4

1.5

3070.57

2245.08

e6/l

0.34

354

Pain in thoracic spine

503

1.40

1.95

1.6

1.5

7611.06

2105.67

e6/l

1.35

368

Viral agents as the cause of diseases classified to other chapters

2.37

1.95

1.9

1.4

853.71

2412.67

e6/l

—

Ingrowing nail

134

1.80

1.95

1.8

1.4

1236.84

1963.76

e6/l

0.89

Family history of malignant neoplasm

249

1.57

1.95

1.4

3324.39

2895.26

e6/l

0.13

170

Nonalcoholic fatty liver disease

265

1.55

1.94

1.8

1.4

1268.97

2601.59

e6/l

1.32

191

Mental disorders, not otherwise specified

164

1.71

1.94

1.5

1.4

2584.93

3117.32

e6/l

0.16

111

Blood alcohol or alcohol intoxication level

2.46

1.93

1.2

1.3

1990.27

1824.78

e6/l

0.09

Use of donepezil

1241

0.76

1.93

1.3

1.5

3809.75

1901.34

e6/l

0.55

899

Embolic stroke

266

1.55

1.92

1.5

1.4

3650.08

1559.17

e6/l

0.47

190

Other disorders of ear

567

3370

1.12

1.91

1.5

2502.57

3215.38

e6/l

0.62

441

2401

Cachexia

3.27

1.90

2.0

1.3

11892.43

1781.35

e6/l

—

Other disorders of gingiva or/and edentulous alveolar ridge

173

1.69

1.90

1.4

1.5

1505.18

2142.83

e6/l

0.39

129

Benign neoplasm of other and unspecified endocrine glands

498

1.39

1.89

1.6

1.5

1271.32

2203.14

e6/l

1.30

358

Superficial injury of abdomen, lower back and pelvis

515

1.38

1.89

1.5

17626.63

2117.84

e6/l

0.60

373

Colorectal cancer

163

1324

1.23

1.88

1.4

1.5

1014.98

2356.94

e6/l

4.81

127

958

Other condition

465

1.40

1.88

1.6

1.5

1754.53

2237.34

e6/l

0.54

341

Varicose veins

396

2616

1.15

1.88

1.5

1.4

1552.01

2970.55

e6/l

3.44

290

1901

Benign neoplasm: Small intestine

174

1.68

1.87

1.7

1.3

1310.70

1699.71

e6/l

0.48

128

Pilonidal cyst

174

1.67

1.86

1.6

1.4

3386.90

3051.60

e6/l

0.12

119

Combinations of oral blood glucose lowering drugs

181

1489

1.22

1.85

1.4

1.5

1473.98

3147.61

e6/l

1.84

127

1098

Psoriasis vulgaris

100

767

1.31

1.85

1.6

1.5

5340.92

2394.90

e6/l

1.03

557

Dental pulpitis 4, only avohilmo

679

3194

1.11

1.85

1.5

2217.91

3074.03

e6/l

1.20

494

2321

Vitamin B12 deficiency anaemia

526

1.37

1.85

1.7

1.4

1264.15

2373.57

e6/l

1.49

386

Other maternal disorders predominantly related to pregnancy

111

896

0.78

1.85

1.4

3943.08

3853.67

e6/l

0.02

646

Pruritus

400

1.43

1.84

1.5

1.4

1874.18

2294.28

e6/l

0.17

292

therapeutic use

115

1.84

1.83

1.3

1.2

2135.93

1750.94

e6/l

0.17

Open wound of abdomen, lower back and pelvis

2.13

1.82

1.6

1.3

23449.00

1717.61

e6/l

—

Triptan medication for migraine, min. 3 purchases

109

1101

0.78

1.82

1.5

1.4

4930.52

3590.01

e6/l

0.35

798

Congenital malformations and deformations of the musculoskeletal system

159

1.69

1.82

1.5

2046.53

2377.64

e6/l

0.18

110

Cholera

145

1.74

1.82

1.9

1.3

622.07

2652.01

e6/l

1.46

101

Seronegative rheumatoid arthritis

494

1.38

1.81

1.5

1.4

5665.63

1844.14

e6/l

1.01

353

Other maltreatment syndromes

2.28

1.81

2.0

1.4

3843.57

1890.69

e6/l

—

Lower back pain or/and sciatica

585

3641

1.12

1.80

1.5

4256.33

3154.19

e6/l

0.52

443

2621

Inguinal hernia, bilateral

589

1.35

1.80

1.7

1.5

1228.59

2332.12

e6/l

1.54

423

Benign neoplasm: Choroid

153

1.71

1.80

1.5

1088.63

1807.96

e6/l

1.32

110

Malignant neoplasm of stomach

263

1.53

1.79

1.3

1.4

1436.59

1514.03

e6/l

0.08

189

Paralytic ileus

161

1.69

1.79

1.4

4642.89

1291.83

e6/l

0.75

105

Nummular dermatitis

353

1.45

1.78

1.6

1.4

2830.38

2019.28

e6/l

0.38

247

Benign neoplasm: Tongue

2.18

1.78

1.5

1.3

1046.75

2445.52

e6/l

—

Inguinal or femoral hernia, bilateral

599

1.34

1.77

1.7

1.5

1214.84

2318.88

e6/l

1.58

429

Certain conditions originating in the perinatal period

1.96

1.77

1.7

1.3

2442.44

4736.20

e6/l

—

Benign neoplasm: Descending colon

313

1.48

1.76

1.8

1.4

1362.79

1605.68

e6/l

0.42

221

Hypothermia

2.05

1.76

1.9

1.3

1143.44

1444.76

e6/l

—

Melanocytic naevi of lower limb, including hip

2.10

1.76

1.6

1.3

2560.13

2492.41

e6/l

—

Other mental disorders due to brain damage and dysfunction and to physical disease

574

1.35

1.76

1.4

1.5

3258.13

1541.14

e6/l

0.96

421

Schizoaffective disorder

177

1.64

1.76

1.3

1.4

2035.47

2247.91

e6/l

0.14

127

Disorders of male genital organs in diseases classified elsewhere

3.39

1.76

1.3

1.6

234.83

2345.82

e6/l

—

Alzheimer disease

176

1603

0.83

1.75

1.4

1.5

3346.21

1992.65

e6/l

0.57

131

1162

Burn and corrosion of trunk

1.99

1.75

1.0

1.3

1220.45

2245.85

e6/l

0.79

Chronic laryngitis and laryngotracheitis

609

1.33

1.75

1.5

1.4

2223.98

1929.98

e6/l

0.19

439

Malignant neoplasm of liver and intrahepatic bile ducts

178

1.65

1.74

1.8

1.5

827.33

1542.62

e6/l

2.03

129

Anxiety disorders, excluding more controls

400

2332

1.14

1.73

1.5

4145.03

2111.62

e6/l

1.37

307

1658

Other injuries of upper limb, level unspecified

2.70

1.73

1.4

1.2

1349.50

1883.78

e6/l

—

Otalgia

233

1.55

1.73

1.4

1.3

4901.65

1990.19

e6/l

0.75

165

Other disorders of lacrimal gland

168

1383

1.22

1.73

1.5

1842.73

2788.59

e6/l

0.86

131

992

Visual disturbances

250

2134

1.17

1.72

1.4

1.5

1698.61

2632.66

e6/l

1.65

180

1538

Ankle and foot

3.89

1.72

1.2

1.1

1433.20

889.25

e6/l

—

Burns and corrosions of external body surface, specified by site

340

1.45

1.70

1.3

1.4

5022.68

1900.82

e6/l

0.65

243

L04AC Interleukin inhibitors

1.92

1.70

1.4

1.3

7266.91

2285.93

e6/l

0.41

Conjunctivitis (acute, non atopic)

116

917

1.26

1.68

1.4

1.5

3640.10

2533.54

e6/l

0.23

666

Achalasia of cardia

2.20

1.68

1.8

1.3

1580.14

1731.00

e6/l

—

Benign neoplasm: Adrenal gland

300

1.47

1.68

1.8

1.5

1146.88

1847.80

e6/l

0.73

216

Colorectal adenocarcinoma

136

1100

1.24

1.67

1.4

1.5

1032.56

2368.56

e6/l

4.12

103

792

False labour

242

0.60

1.67

1.2

1.4

3094.94

6731.01

e6/l

0.79

169

Leukaemia of unspecified cell type

3.20

1.67

1.7

1.2

1949.33

2633.00

e6/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

1.87

1.66

1.7

1.5

625.36

1991.42

e6/l

3.03

Rheumatic valve diseases

112

1.80

1.65

1.5

1.3

1200.83

1384.53

e6/l

0.10

Myalgia

772

1.28

1.65

1.5

3144.77

2966.73

e6/l

0.03

561

Malignant neoplasm of corpus uteri

301

1.47

1.65

1.3

1.4

920.55

2127.91

e6/l

2.02

223

Dementia

255

2050

0.86

1.65

1.3

1.5

3161.86

2262.87

e6/l

0.46

192

1475

Other diseases of jaws

228

1.54

1.65

1.6

1.4

780.60

2260.77

e6/l

1.85

175

Iridocyclitis in diseases classified elsewhere

2.27

1.64

1.9

1.4

1226.67

1675.45

e6/l

—

Ptosis of eyelid

495

1.36

1.64

1.5

1985.96

2338.32

e6/l

0.27

361

Other bursopathies

555

1.34

1.64

1.6

1.4

3485.98

1706.58

e6/l

0.52

403

Acute gastritis

310

1.46

1.63

1.7

1.4

1576.14

1654.57

e6/l

0.06

228

Retinal detachment with retinal break

599

1.32

1.63

1.3

1.5

12507.60

1912.00

e6/l

0.46

433

Pneumoconiosis due to dust containing silica

3.67

1.63

1.2

1.4

4313.40

2742.67

e6/l

—

Other aneurysm

237

1.53

1.63

1.6

1.4

1234.04

2032.14

e6/l

1.16

167

Headache

260

1868

1.16

1.62

1.5

1.4

6743.15

2850.18

e6/l

1.04

197

1333

Abnormal findings on examination of urine, without diagnosis

166

1.64

1.62

1.4

1252.95

1811.20

e6/l

0.50

121

Ethmoidectomy

451

0.64

1.62

1.4

1.5

2329.13

2383.23

e6/l

0.02

326

Other problems related to primary support group, including family circumstances

192

1.58

1.61

1.5

1.4

17821.12

2889.39

e6/l

0.68

138

Lesion of radial nerve

113

1.78

1.61

1.5

1.3

1196.42

1746.17

e6/l

0.57

Rheumatic fever incl heart disease

151

1.67

1.60

1.6

1.4

1453.00

1320.27

e6/l

0.09

104

Hypertrophic disorders of skin

128

1.73

1.60

1.5

1.3

370.13

2114.84

e6/l

6.12

Eustachian salpingitis and obstruction

128

1.72

1.60

1.6

1.4

1136.76

2600.56

e6/l

2.85

Conductive and sensorineural hearing loss

519

3231

1.11

1.60

1.5

2478.46

3159.20

e6/l

0.56

423

2300

Malignant neoplasm of thyroid gland

214

1.55

1.59

1.5

1.3

1678.62

1908.54

e6/l

0.23

149

FESS (DNB20)

425

0.63

1.59

1.3

1.5

2464.59

2342.00

e6/l

0.04

311

Other vitreous opacities

136

1.70

1.59

1.2

1.4

10377.29

1958.01

e6/l

0.44

Superficial injury of ankle and foot

287

1.47

1.59

1.5

15004.57

2536.71

e6/l

0.44

203

Other specified disorders of external ear

167

1.63

1.59

1.6

1.5

2358.05

1609.22

e6/l

0.74

116

Endometriosis

730

0.78

1.58

1.5

1.4

3527.56

3556.32

e6/l

0.01

517

Single spontaneous delivery

118

784

0.80

1.57

1.4

2974.83

4797.31

e6/l

0.54

575

Contact with heat and hot substances

152

1.65

1.56

1.5

1.4

3966.58

2102.10

e6/l

0.26

107

Hypertrophic scar

114

1.76

1.56

1.6

1.3

387.73

1877.81

e6/l

5.47

Erosion of teeth, including avohilmo

507

1.34

1.56

1.5

1637.42

2508.11

e6/l

1.26

383

Dementia, including avohilmo

275

2184

0.87

1.55

1.3

1.5

2980.24

2279.47

e6/l

0.37

210

1575

Adenomyosis (Endometriosis of uterus)

494

0.67

1.55

1.5

1.4

1549.45

3529.83

e6/l

0.78

349

Unspecified dementia

688

0.73

1.55

1.2

1.5

1829.04

1363.62

e6/l

0.24

497

Crohn's disease NAS

161

1.62

1.52

1.7

1.4

3733.00

2071.73

e6/l

0.43

111

Urethral stricture

307

1.44

1.52

1.6

1.4

1809.43

1869.13

e6/l

0.03

227

Renal cell carcinoma of kidney

185

1.58

1.52

1.4

2125.08

1458.48

e6/l

0.31

135

Carcinoma in situ of colon

2.19

1.51

1.5

1.2

338.20

1539.15

e6/l

—

Other diseases of lip and oral mucosa

660

1.29

1.50

1.6

1.4

1939.49

2041.46

e6/l

0.07

489

Muscle strain

1.91

1.49

1.8

1.3

3028.56

1962.59

e6/l

—

Open wound of hip and thigh

1.91

1.49

2.1

1.3

3188.80

2109.70

e6/l

—

Mixed hyperlipidaemia

170

1.60

1.49

1.6

1.4

534.43

1680.53

e6/l

2.85

129

Voice disturbances

133

1089

1.22

1.49

1.6

1.5

6172.16

2673.05

e6/l

0.75

795

Benign neoplasm of middle ear and respiratory system

226

1.51

1.49

1.4

1.5

2682.00

1743.68

e6/l

0.30

161

Adhesive capsulitis of shoulder

724

1.27

1.47

1.4

6970.54

2028.91

e6/l

0.45

513

Benign neoplasm: Oesophagus

2.40

1.46

1.9

1.3

1746.78

1587.08

e6/l

—

Nonorganic sleeping disorders, excluding more controls

514

1.33

1.46

1.6

1.5

6132.83

2293.12

e6/l

0.49

371

Sleep disorders

663

1.28

1.45

1.6

1.5

5197.90

2378.07

e6/l

0.44

487

Other and unspecified urticaria

593

1.30

1.45

1.7

1.5

1875.97

2140.47

e6/l

0.30

439

Benign neoplasm: Other and unspecified parts of mouth

1.89

1.45

1.7

1.5

7896.38

2293.62

e6/l

—

Oral leukoplakia and related diseases

220

1.51

1.44

1.5

1.3

2835.41

1771.10

e6/l

0.32

151

Alzheimer’s disease, wide definition

137

1383

0.83

1.43

1.4

1.5

3228.18

1972.64

e6/l

0.41

1005

Schizophrenia

516

1.32

1.43

1.3

1.5

7195.76

2589.12

e6/l

0.63

373

Keratitis

168

1414

1.19

1.43

1.4

1.5

3054.65

2638.93

e6/l

0.11

116

1010

Type 1 diabetes, strict definition, subgroup 1

1.92

1.42

1.3

1.4

1929.00

3745.17

e6/l

—

Hypothyroidism, other/unspecified

503

3001

1.11

1.42

1.5

1.4

4584.16

2867.94

e6/l

0.40

363

2172

KRA_PSY_EATING, excluding more controls

1.91

1.42

1.3

1.5

1344.11

1796.65

e6/l

—

Cramp and spasm

141

1.64

1.42

1.7

1.4

4258.06

1632.65

e6/l

0.43

100

Biological medication for rheuma

379

1.37

1.41

1.5

8447.44

2264.65

e6/l

1.25

266

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

178

1.54

1.41

1.2

1.6

23071.05

2661.10

e6/l

0.77

120

Unspecified mental disorder

171

1443

1.19

1.41

1.4

1.5

7204.89

2321.11

e6/l

1.01

120

1050

Uterine polyps

314

0.60

1.41

1.2

1.4

2931.57

3994.88

e6/l

0.19

230

Carcinoma in situ of other and unspecified genital organs

2.27

1.40

1.9

1.1

767.56

1460.79

e6/l

—

Total colectomy

126

1.68

1.40

1.1

1.3

3953.64

1842.01

e6/l

0.56

Total colectomy operation

126

1.68

1.40

1.1

1.3

3953.64

1842.01

e6/l

0.56

Maternal care related to the fetus and amniotic cavity and possible delivery problems

518

0.76

1.40

1.5

1.4

2065.24

4577.30

e6/l

1.43

375

Disorders of lacrimal system

211

1814

1.16

1.39

1.5

1755.85

2912.60

e6/l

1.43

164

1302

Type 1 diabetes, strict definition

1.85

1.39

1.3

1.4

1929.00

3722.30

e6/l

—

Benign neoplasm: Pancreas

1.95

1.39

1.7

1.5

2537.00

1892.07

e6/l

—

Other specified and unspecified disorders of eye and adnexa

119

1.69

1.38

1.1

1.3

1373.80

1812.33

e6/l

—

Other epidermal thickening

158

1.59

1.38

1.2

1.3

1109.50

1809.06

e6/l

0.78

107

Other/unspecified dorsalgia

196

1669

1.17

1.37

1.5

1859.92

2350.43

e6/l

0.52

144

1197

Divergent concomitant strabismus

206

1.51

1.37

1.1

1.4

2736.75

2678.59

e6/l

0.02

144

Kela-code for severe mental illness

158

1328

1.19

1.37

1.4

1.5

7522.32

2352.78

e6/l

1.02

114

971

Injury of muscle and tendon at shoulder and upper arm level

158

1873

0.84

1.37

1.5

1926.12

2835.61

e6/l

1.01

113

1368

Dental pulpitis 1, only avohilmo

671

3213

1.09

1.37

1.5

2250.45

3058.43

e6/l

1.10

487

2337

Chronic rhinitis, nasopharyngitis and pharyngitis

143

1192

1.20

1.36

1.7

1.5

3256.17

2743.38

e6/l

0.29

103

858

Neurotic, stress-related and somatoform disorders

404

2575

1.12

1.36

1.5

4129.91

3577.52

e6/l

0.20

309

1836

Convalescence

135

1.64

1.36

1.3

1063.85

1964.22

e6/l

1.17

Female infertility

477

0.75

1.35

1.3

1.4

2108.21

4372.12

e6/l

0.73

346

Motorcycle rider injured in other and unspecified transport accidents

112

1.70

1.35

2.0

1.4

2542.00

2067.71

e6/l

—

Artificial joint operation, meniscal resection

486

3564

0.91

1.35

1.5

2059.40

3342.01

e6/l

2.09

361

2583

Other and specified injuries of hip and thigh

1.88

1.35

1.6

1.3

555.13

1372.09

e6/l

—

Benign neoplasm: Brain, supratentorial

0.00

1.34

0.0

1.3

—

1670.82

—

Postmenopausal bleeding

101

689

0.80

1.34

1.5

1.4

2560.15

3604.43

e6/l

0.36

487

Benign neoplasm: Caecum

505

1.31

1.33

1.6

1.4

2969.92

1681.35

e6/l

0.34

365

Endometriosis of pelvic peritoneum

377

0.65

1.33

1.2

1.4

2498.63

4806.74

e6/l

0.58

276

Superficial injury of lower leg

103

833

1.24

1.33

1.5

1.4

1585.40

2490.00

e6/l

1.59

603

Anogenital herpesviral [herpes simplex] infection

1.78

1.33

1.4

1174.44

2655.39

e6/l

—

Malignant neoplasm of colon

798

1.24

1.32

1.4

1.5

1117.85

1743.02

e6/l

2.23

580

Malignant melanoma of skin

541

1.30

1.32

1.5

1739.31

1737.98

e6/l

0.00

396

Wet age-related macular degeneration

129

1050

1.21

1.32

1.3

1.5

1131.39

2156.37

e6/l

2.06

759

Psoriasis

141

1179

1.20

1.31

1.5

4664.54

2293.12

e6/l

1.10

853

Bilateral sagittal split ramus osteotomy operation

0.00

1.31

0.0

1.4

—

1878.44

—

Tinnitus

1021

0.79

1.31

1.6

1.5

2957.04

2845.32

e6/l

0.04

721

Panniculitis, unspecified

2.52

1.31

1.3

1.2

1754.17

1533.11

e6/l

—

Other and unspecified nerve root and plexus disorders, also in other diseases

683

0.75

1.30

1.6

1.5

2201.82

2453.86

e6/l

0.17

486

Eating disorders

168

1.55

1.30

1.3

1.4

4327.45

2572.92

e6/l

0.26

119

Benign neoplasm: Parotid gland

326

1.39

1.30

1.7

1.4

2372.10

1564.99

e6/l

0.56

237

Nontoxic multinodular goitre

102

827

1.24

1.30

1.4

2535.80

2914.49

e6/l

0.13

601

Sensorineural hearing loss

500

3183

1.10

1.29

1.5

2492.46

3175.08

e6/l

0.55

413

2268

Other disorders of the musculoskeletal system and connective tissue

605

1.28

1.4

1.5

2024.60

2130.21

e6/l

0.08

437

Disorders of vitreous body and globe

291

2513

1.13

1.28

1.4

1.5

2826.09

3204.14

e6/l

0.15

212

1834

Fall on same level involving ice and snow

290

2568

1.13

1.28

1.5

2264.68

3285.98

e6/l

0.94

199

1863

Hyperaldosteronism

1.73

1.27

1.5

1.4

871.50

1903.23

e6/l

—

Speech disturbances, not elsewhere classified

396

1.34

1.27

1.5

1.4

1110.40

1590.94

e6/l

1.03

290

Other sleep disorders

448

1.32

1.27

1.4

1.5

2363.95

2169.99

e6/l

0.11

316

Ventral hernia

134

1120

1.20

1.27

1.5

2786.40

2541.49

e6/l

0.08

101

798

Other specified/unspecified hearing loss

379

1.35

1.27

1.4

2181.08

1671.28

e6/l

0.47

269

Nontraumatic intracranial haemmorrhage

135

1129

1.20

1.27

1.5

4240.14

2156.88

e6/l

0.46

805

Iridocyclitis

112

920

1.22

1.26

1.5

1518.85

2503.06

e6/l

2.24

667

Other lesions of median nerve

107

1.69

1.26

1.6

1.4

1920.33

1350.61

e6/l

0.41

Other specific joint derangements/joint disorders

362

2174

1.12

1.26

1.6

1.4

4823.31

3822.23

e6/l

0.25

255

1555

Other and unspecified mood [affective] disorders

107

1.69

1.25

1.3

10204.17

2187.16

e6/l

—

Other abnormal products of conception

300

0.69

1.25

1.5

1.4

2260.76

3901.99

e6/l

0.63

224

Benign neoplasm of ovary

554

1.28

1.25

1.3

1.4

3047.31

3437.12

e6/l

0.09

402

Herpesviral [herpes simplex] infections

397

1.34

1.25

1.6

1.5

1724.77

2170.47

e6/l

0.28

295

Delivery

123

785

0.83

1.24

1.4

3057.54

4797.31

e6/l

0.53

575

Benign neoplasm of urinary organs

195

1.50

1.24

1.3

5359.70

1758.74

e6/l

0.89

139

Speech and linguistic disorders, excluding more controls

123

1.61

1.23

1.0

1.4

22758.75

1625.06

e6/l

0.63

Superficial injury of thorax

591

1.27

1.23

1.5

2947.93

2068.02

e6/l

0.38

436

Parkinson's disease, strict definition

822

0.78

1.23

1.5

1844.05

2020.09

e6/l

0.13

596

Postmenopausal osteoporosis with pathological fracture

237

1.44

1.23

1.4

4138.23

1353.32

e6/l

0.45

180

Mixed and other personality disorders

155

1.55

1.22

1.2

1.4

61611.50

2353.49

e6/l

0.70

103

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

1.98

1.22

1.3

1.5

5267.40

2425.38

e6/l

—

Appendectomy

285

2436

1.13

1.22

1.5

1960.95

3945.46

e6/l

2.68

201

1756

Noninflammatory disorders of female genital tract

124

751

0.83

1.22

1.4

2878.17

3685.79

e6/l

0.23

530

Other/unspecified reactive arthropathies

196

1.48

1.21

1.6

1.4

2131.39

1957.16

e6/l

0.12

132

Respiratory tuberculosis, not confirmed

221

1.46

1.21

1.5

1.4

1704.14

1650.97

e6/l

0.05

161

Other neurotic disorders

180

1.51

1.21

1.4

1.3

3532.67

1618.30

e6/l

0.92

122

Follicular cysts of skin and subcutaneous tissue

718

1.24

1.20

1.4

1.5

6392.73

2398.66

e6/l

0.50

526

Tumor necrosis factor alpha inhibitors

331

1.36

1.20

1.6

1.5

7898.83

2357.24

e6/l

1.00

233

Migraine

114

1167

0.83

1.19

1.6

1.4

3122.50

2903.82

e6/l

0.09

807

Leukaemia of unspecified cell type

2.33

1.19

1.7

1.3

1949.33

1858.44

e6/l

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

515

3111

1.09

1.18

1.5

4499.20

2828.70

e6/l

0.40

374

2247

Malignant neoplasm of rectum

480

1.30

1.18

1.5

1.4

872.69

1764.25

e6/l

3.56

341

Carcinoma in situ of skin of ear and external auricular canal

1.80

1.18

1.6

1.3

2682.00

1506.74

e6/l

—

Nontoxic goitre/thyroid nodule

149

1267

1.18

1.3

1.4

3036.80

2681.33

e6/l

0.13

111

904

Prepatellar bursitis

165

1.52

1.18

1.6

1.5

1373.60

1923.06

e6/l

0.50

125

Benign neoplasm: Skin, unspecified

1.78

1.17

1.4

1.5

772.00

2270.95

e6/l

—

Heartburn

350

1.35

1.17

1.6

1.4

4628.89

1887.17

e6/l

0.44

257

Labour and delivery complicated by fetal stress [distress]

159

0.59

1.16

1.4

4411.11

5281.40

e6/l

—

109

Disorders of vitreous body

280

2441

1.12

1.15

1.4

1.5

2859.07

2894.96

e6/l

0.01

202

1781

Dental operations, only avohilmo

507

2375

1.09

1.15

1.6

1.5

2476.96

2881.89

e6/l

0.31

360

1716

Cardiac murmurs and other cardiac sounds

196

1.47

1.15

1.3

1.4

2131.62

2490.35

e6/l

0.20

142

Degenerative diseases of the nervous system

206

1773

0.87

1.15

1.4

1.5

3544.01

1986.11

e6/l

0.82

154

1271

Subarachnoid haemorrhage

474

1.29

1.14

1.6

1.5

2969.81

1873.13

e6/l

0.45

341

Anxiety disorders

409

2632

1.10

1.14

1.5

1.4

4106.06

3537.52

e6/l

0.21

311

1880

Orchitis and epididymitis

448

1.30

1.13

1.6

1934.93

2095.19

e6/l

0.10

316

Other and unspecified glaucoma

335

1.35

1.13

1.5

1.4

1183.10

1935.83

e6/l

0.84

236

Parkinson's disease

877

0.80

1.12

1.4

1.5

3041.38

1959.29

e6/l

0.39

630

Salpingitis and oophoritis

484

1.28

1.12

1.4

2978.09

2427.55

e6/l

0.13

352

MS-disease / Multiple Sclerosis

143

1.54

1.11

1.4

1510.27

3290.89

e6/l

0.94

Crushed, pushed or stepped on by crowd or human stampede

127

1.58

1.11

1.4

1920.46

1958.98

e6/l

0.02

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

192

1.46

1.11

1.4

1.5

1293.45

1965.54

e6/l

0.82

137

Myocardial infarction, with ST-elevation

131

1110

1.18

1.10

1.5

812.28

1999.08

e6/l

4.27

800

Other diseases of blood and blood-forming organs

268

1.39

1.10

1.3

1.4

1800.90

1729.68

e6/l

0.04

185

Undefined dementia

692

0.78

1.10

1.2

1.4

1786.32

1687.02

e6/l

0.04

500

Abnormal findings in secretions and smears from cervix uteri vagina vulva

871

0.82

1.09

1.4

5898.61

3455.97

e6/l

0.26

638

Spontaneous abortion

100

822

0.83

1.09

1.3

1.4

10938.89

2702.37

e6/l

0.85

606

Suppurative and unspecified otitis media

115

853

1.20

1.09

1.5

5970.32

2576.73

e6/l

0.51

607

Disorders of psychological development

163

1.48

1.09

1.0

1.5

19064.85

2926.05

e6/l

0.59

106

Benign neoplasm of major salivary glands

425

1.30

1.08

1.6

1.4

2241.59

2142.86

e6/l

0.05

309

Abnormal involuntary movements

523

1.27

1.07

1.3

1.5

3415.91

2116.37

e6/l

0.43

377

Degenerative macular diseases

613

1.24

1.06

1.6

1.5

947.52

1983.43

e6/l

3.21

441

Dental caries 1 and operation codes, only avohilmo

114

684

0.84

1.06

1.4

1.5

1896.75

2836.05

e6/l

0.94

522

Exclusions for E4_PCOS_BROAD

559

1.25

1.06

1.5

7460.71

2573.66

e6/l

0.44

403

Use of galantamine

419

0.71

1.06

1.2

1.4

1360.19

1797.80

e6/l

0.49

306

Anterior Iridocyclitis

804

1.21

1.05

1.4

1.5

1549.37

2410.33

e6/l

1.69

591

Fenamates

536

0.79

1.05

1.5

2453.41

1656.88

e6/l

0.37

374

Use of biperiden

162

1.49

1.04

1.2

1.4

5673.42

1816.17

e6/l

0.67

112

Alzheimer’s disease (Late onset)

131

1313

0.85

1.04

1.4

1.5

3352.38

1928.72

e6/l

0.44

962

Exposure to excessive heat of man-made origin

2.30

1.04

1.0

1.3

695.40

2765.60

e6/l

—

Postprocedural musculoskeletal disorders, not elsewhere classified

306

1.35

1.03

1.3

1.4

1868.48

1769.78

e6/l

0.06

224

Arthropathy in ulcerative colitis

2.29

1.03

1.2

10168.20

1178.00

e6/l

—

Parkinson's disease, including avohilmo

922

0.81

1.03

1.5

2920.82

1932.00

e6/l

0.37

664

Dental caries 2

259

2275

0.89

1.03

1.6

1.5

6570.58

3541.96

e6/l

0.47

173

1653

Superficial injuries involving multiple body regions

1.84

1.03

1.4

1720.33

1612.07

e6/l

—

Rotator cuff syndrome

368

2487

1.10

1.02

1.5

1.4

4163.02

2713.45

e6/l

0.46

281

1782

Cervicalgia

105

880

1.20

1.02

1.4

1.5

2741.09

2604.33

e6/l

0.04

635

Seborrhoeic dermatitis

394

1.30

1.02

1.4

2855.55

2367.10

e6/l

0.12

282

Use of antiglaucoma preparations and miotics

421

1.29

1.01

1.6

1.5

1480.40

2024.69

e6/l

0.41

302

Oral leukoplakia and related diseases, including avohilmo

342

1.32

1.01

1.5

1.4

2913.29

2134.23

e6/l

0.29

248

Other and unspecified disorders of vitreous body

176

1998

0.87

1.01

1.4

1.5

2220.71

2951.27

e6/l

0.44

127

1449

Demyelinating diseases of the central nervous system

188

1.44

1.01

1.3

1.4

38741.39

3034.97

e6/l

0.45

128

Benign leiomyoma with endometriosis

541

0.76

1.01

1.4

3305.54

3311.49

e6/l

0.00

394

Other and unspecified visual disturbances

351

1.31

1.01

1.4

1.5

1892.29

1665.73

e6/l

0.23

251

Generalized anxiety disorder

273

1.36

1.00

1.4

13680.46

3423.04

e6/l

0.42

185

Special screening examination for infectious and parasitic diseases

420

1.25

0.99

1.3

1.4

5273.20

2608.35

e6/l

1.05

277

Deficiency of other B group vitamins

1.72

0.99

1.3

1356.38

1180.69

e6/l

—

Other disorders of eyelid

278

2418

1.11

0.99

1.4

1.5

1946.88

2540.65

e6/l

0.74

191

1738

Other osteochondropathies

206

1.41

0.98

1.5

2595.74

2011.02

e6/l

0.13

143

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

2.19

0.98

1.4

1.3

4117.00

1874.13

e6/l

—

Mandibular retrognathia AND surgery (BSSRO)

0.00

0.97

0.0

1.3

—

2169.89

—

Female infertility, cervigal, vaginal, other or unspecified origin

467

0.79

0.97

1.2

1.4

2262.82

4417.38

e6/l

0.66

339

Use of levodopa decarboxylase inhibitor

771

0.80

0.97

1.5

1729.56

1687.72

e6/l

0.03

561

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

503

0.75

0.96

1.5

4409.03

1968.37

e6/l

0.36

364

Pustulosis palmaris et plantaris

108

1.58

0.96

1.4

1.3

5395.13

1909.21

e6/l

—

Lesion of lateral popliteal nerve

182

1.43

0.96

1.9

1.4

1480.83

1680.47

e6/l

0.15

128

Polycystic ovarian syndrome, consortium definition

250

1348

1.12

0.96

1.4

3895.87

3273.75

e6/l

0.15

194

958

Leiomyoma of uterus

246

1249

1.12

0.96

1.4

2052.27

3377.45

e6/l

1.08

181

912

Tooth eruption problems

172

1.44

0.95

1.3

1.4

8319.00

3474.88

e6/l

0.36

114

Erectile dysfunction

506

1.25

0.95

1.5

860.96

1783.82

e6/l

2.93

366

Benign lipomatous neoplasm of other sites/unspecified

399

1.28

0.94

1.4

1529.69

1717.33

e6/l

0.25

296

Benign neoplasm of meninges

421

0.73

0.94

1.3

1.5

1650.42

2292.33

e6/l

0.52

311

Endometriosis ASRM stages 1,2

352

0.71

0.94

1.2

1.4

2498.63

2739.87

e6/l

0.12

257

Other and/or unspecified nontoxic goitre

303

1.32

0.93

1.5

1.4

1873.04

2146.08

e6/l

0.17

218

Other strabismus

649

1.22

0.93

1.6

1.5

3178.21

2289.26

e6/l

0.48

470

Dislocation, sprain and strain of joints and ligaments of knee

195

2041

0.89

0.93

1.4

1.5

5611.90

3847.24

e6/l

0.23

141

1472

Inflammatory bowel disease, strict (require KELA)

756

0.81

0.92

1.4

1.5

2685.65

2558.67

e6/l

0.08

541

conjunctival haemorrhage

330

1.31

0.92

1.4

1308.55

1600.23

e6/l

0.31

238

Aneurysms, operations, SAH

725

1.20

0.92

1.5

7045.48

2152.98

e6/l

0.53

535

Speech and linguistic disorders

136

1.48

0.92

1.0

1.4

22758.75

1894.87

e6/l

0.62

Burns and corrosions confined to eye and internal organs

1.83

0.92

2.0

1.4

1624.00

1878.09

e6/l

—

Pregnancy with abortive outcome

200

1180

0.89

0.92

1.5

1.4

6139.77

2579.14

e6/l

0.53

139

866

Carcinoma in situ of skin of trunk

159

1.46

0.92

1.6

1.4

1432.20

1487.74

e6/l

0.04

113

Mood disorders, excluding more controls

494

2784

1.08

0.92

1.5

4814.01

2133.70

e6/l

1.80

365

1981

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

126

1.52

0.91

1.2

1.3

1190.25

1832.74

e6/l

0.56

Dental caries 3 and operation codes, only avohilmo

129

753

0.86

0.91

1.4

1.5

1900.40

2761.92

e6/l

0.93

567

Disorders of orbit

118

1.53

0.91

1.3

1638.60

1671.36

e6/l

—

Dental caries 2 and operation codes

253

2229

0.90

0.91

1.5

6695.22

3593.62

e6/l

0.47

169

1617

Other specified/unspecified bacterial intestinal infections

244

1.36

0.91

1.6

1.4

1471.32

1815.06

e6/l

0.31

173

Unspecified lump in breast

455

1.25

0.90

1.4

2384.53

2333.28

e6/l

0.02

332

Chronic iridocyclitis

151

1.46

0.90

1.3

1242.36

1695.85

e6/l

0.25

102

Nonorganic sleeping disorders

554

1.23

0.90

1.6

1.4

6132.82

2340.25

e6/l

0.48

401

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

176

1.42

0.90

1.5

1.6

1229.22

2697.28

e6/l

1.09

131

Maternal care for known or suspected abnormality of pelvic organs

258

0.72

0.90

1.5

1.3

2620.94

4716.80

e6/l

0.62

178

Thyroiditis, ILD-related definition

340

1.30

0.90

1.4

2004.97

2441.86

e6/l

0.29

247

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

2.09

0.90

1.5

1.2

818.00

2125.30

e6/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

367

1.28

0.89

1.7

1.4

2334.45

1724.39

e6/l

0.40

267

Faecal incontinence

323

1.30

0.89

1.4

2995.33

2025.77

e6/l

0.25

228

Colon adenocarcinoma

646

1.21

0.89

1.4

1.5

1147.60

1844.99

e6/l

1.96

470

Bronchitis, not specified as acute or chronic

332

1.30

0.89

1.5

1945.40

1614.30

e6/l

0.29

243

IBD patients in KELA-register

751

0.81

0.88

1.4

1.5

2685.65

2588.86

e6/l

0.06

536

Corneal ulcer

656

1.21

0.88

1.4

1.5

2075.98

2571.03

e6/l

0.30

473

Encephalopathy

2.02

0.87

1.2

1.3

2002.83

1212.45

e6/l

—

Crohn's disease of small intestine

169

1.42

0.87

1.5

1.3

2031.33

1942.46

e6/l

0.04

117

Early syphilis

2.01

0.87

1.5

1.4

2278.67

2481.05

e6/l

—

Thyroiditis

203

1.38

0.87

1.4

2556.37

2574.21

e6/l

0.01

142

Benign neoplasm: Connective and other soft tissue of head, face and neck

2.01

0.87

1.7

1.1

721.67

3293.72

e6/l

—

Idiopathic urticaria

2.01

0.87

1.0

1.3

1407.67

2238.24

e6/l

—

Eating disorder

1.61

0.87

1.3

1.4

1344.11

3389.02

e6/l

—

Injury of muscle and tendon at wrist and hand level

505

0.77

0.87

1.4

1.5

1733.57

2660.80

e6/l

1.02

358

Other degenerative diseases of the nervous system

170

1137

1.14

0.87

1.3

1.5

9581.96

2456.01

e6/l

0.70

125

790

Acute upper respiratory infections

594

3481

1.07

0.86

1.5

1.4

2555.62

3437.76

e6/l

1.00

461

2492

Primary open-angle glaucoma

174

1910

0.89

0.86

1.4

1.5

5192.45

2200.06

e6/l

0.40

130

1366

Etanercept

128

1.49

0.86

1.6

1.4

12373.64

2284.18

e6/l

0.85

Acute and subacute iridocyclitis

750

1.19

0.85

1.4

1.5

1494.99

2506.65

e6/l

2.14

547

Other psoriatic arthropathies

352

1.28

0.85

1.5

3074.11

2286.81

e6/l

0.23

259

Benign neoplasm: Rectosigmoid junction

187

1.40

0.85

1.4

867.67

1749.58

e6/l

2.62

137

Benign neoplasm: Anus and anal canal

112

1.53

0.85

1.5

1.3

2743.67

1549.25

e6/l

0.38

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

198

1739

1.12

0.85

1.4

1956.68

3416.46

e6/l

1.69

138

1252

Residual foreign body in soft tissue

145

1.45

0.85

1.6

1.4

2849.00

1805.82

e6/l

0.51

103

Thyrotoxicosis with diffuse goitre

424

1.25

0.84

1.4

1.5

1671.98

2239.16

e6/l

0.58

313

Vasomotor and allergic rhinitis

104

1194

0.86

0.84

1.5

2272.22

2900.64

e6/l

0.35

856

Ulcerative colitis (strict definition, all Crohn cases excluded)

468

0.77

0.83

1.3

1.5

2077.82

2511.35

e6/l

0.33

340

Allergic conjunctivitis

206

1818

1.12

0.83

1.4

1983.82

3361.76

e6/l

1.65

145

1312

Femoral hernia

188

1.39

0.83

1.3

1.4

1300.38

1679.00

e6/l

0.53

138

Diseases of inner ear

257

2768

0.91

0.83

1.4

1.5

2276.91

3091.39

e6/l

0.80

191

1998

Effects of foreign body entering through natural orifice

973

0.84

0.83

1.4

1.5

2232.17

2331.26

e6/l

0.06

704

Impotence

266

1.32

0.82

1.6

2001.04

1629.56

e6/l

0.28

188

Allergic rhinitis

759

0.82

1.5

2046.67

2729.92

e6/l

0.66

555

Arthropathic psoriasis

399

1.26

0.82

1.5

2781.65

2290.19

e6/l

0.15

295

Benign neoplasm: Cerebral meninges

376

0.74

0.82

1.4

1644.73

2251.65

e6/l

0.44

279

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

109

939

1.16

0.81

1.6

1.4

2027.87

2440.92

e6/l

0.24

686

Glucosamine medication

278

2430

0.91

0.81

1.4

1.5

1676.20

2573.17

e6/l

1.38

203

1746

Follow-up examination after treatment for malignant neoplasms

481

1.23

0.80

1.6

1.5

2756.06

1868.14

e6/l

0.24

317

Bell's palsy

445

1.24

0.80

1.3

1.4

3215.10

2126.14

e6/l

0.40

316

Arthropathies

492

2332

1.07

0.80

1.6

1.4

2529.09

3768.22

e6/l

1.07

356

1671

Sequelae of injuries of lower limb

294

1.30

0.79

1.4

2292.19

2412.74

e6/l

0.06

212

Disorders of ocular muscles, binocular movement, accommodation and refraction

186

1651

1.12

0.79

1.5

6613.17

2685.34

e6/l

0.55

129

1189

Other and unspecified nail disorders

1.67

0.79

1.5

1.2

2208.00

2232.68

e6/l

—

Dorsopathies

590

2825

1.07

0.78

1.5

2910.93

2994.35

e6/l

0.05

444

2034

Coxibs

196

933

1.12

0.78

1.5

1705.80

1791.61

e6/l

0.10

131

668

Bullous disorders

251

1.32

0.78

1.6

1.4

1511.35

1580.90

e6/l

0.05

186

Pustular psoriasis

131

1.46

0.78

1.4

8639.56

1950.11

e6/l

—

Intracerebral haemorrhage

684

1.19

0.78

1.5

4959.63

1716.81

e6/l

0.44

493

280

0.71

0.78

1.6

1.3

858.58

2457.17

e6/l

1.42

207

Hypothyroidism, strict autoimmune, 3 medication purchases required

448

2845

1.07

0.77

1.5

1.4

4966.75

2765.09

e6/l

0.46

317

2048

Conjunctivitis

311

2490

1.09

0.77

1.4

1.5

2698.74

3456.83

e6/l

0.37

227

1779

Chondropathies

511

1.22

0.77

1.5

1965.40

2490.39

e6/l

0.28

376

Neuromuscular dysfunction of bladder

376

1.25

0.77

1.6

1.4

1878.36

1964.79

e6/l

0.06

273

Melanocytic naevi

121

1057

1.15

0.76

1.5

2156.73

2301.26

e6/l

0.06

757

Other general symptoms and signs

122

1.46

0.76

2.1

1.3

1572.42

2264.84

e6/l

0.51

Allergic urticaria

226

1.33

0.76

1.5

1.4

4388.60

2182.45

e6/l

0.59

162

Medial epicondylitis

1.52

0.75

2.0

1.3

1049.22

1820.17

e6/l

—

Psoriatic arthropathies, ICD10

359

1.26

0.75

1.5

3074.11

2270.40

e6/l

0.23

264

Carcinoma in situ of other and unspecified sites

192

1.36

0.75

1.5

1539.95

1623.87

e6/l

0.06

138

Ulcerative enterocolitis

1.61

0.75

1.2

1.3

2509.86

1958.70

e6/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

486

1.22

0.75

1.5

1.4

872.05

1817.50

e6/l

3.88

348

Ankylosing spondylitis

315

1.27

0.74

1.5

1689.52

1969.32

e6/l

0.26

223

Dislocation, sprain and strain of joints and ligaments of elbow

141

1.42

0.74

1.3

3023.27

2300.50

e6/l

0.21

Strabismus

105

909

1.15

0.74

1.5

8669.11

2407.39

e6/l

0.56

666

Other shoulder lesions

289

1.28

0.73

1.9

1.4

1794.93

1750.49

e6/l

0.04

208

Benign neoplasm: Cerebral meninges

210

1.34

0.73

1.4

1.6

1644.73

2299.88

e6/l

0.38

155

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

591

0.81

0.73

1.3

1.5

2452.91

2678.18

e6/l

0.15

418

Congenital malformations of eye, ear, face and neck

133

1.43

0.73

1.2

1.3

3496.27

2302.58

e6/l

0.43

Cystitis

471

2692

1.07

0.73

1.5

3558.74

2982.87

e6/l

0.20

331

1992

Abrasion of teeth

691

0.85

0.73

1.4

2330.79

2487.95

e6/l

0.12

522

Polycystic ovarian syndrome, broad definition

1.52

0.72

1.1

1.5

41796.43

4222.62

e6/l

—

Disorders of breast

165

1369

1.12

0.72

1.4

3068.44

3191.60

e6/l

0.04

120

986

Female infertility, associated with anovulation

1.62

0.71

1.3

1.4

47489.17

3146.58

e6/l

—

Organic, including symptomatic, mental disorders

353

2363

1.08

0.71

1.4

1.5

3873.24

2245.81

e6/l

0.95

272

1714

Other disorders of pigmentation

151

1.40

0.71

1.5

1.4

1008.81

1669.31

e6/l

0.71

101

Artrosis, including avohilmo

466

2730

0.94

0.71

1.5

2265.85

3545.29

e6/l

1.46

334

1990

Psoriatic and enteropathic arthropathies

426

1.22

0.70

1.5

1.4

4134.09

2114.07

e6/l

0.71

310

Benign neoplasm: Kidney

126

1.43

0.70

1.5

1.4

7006.85

1611.15

e6/l

0.87

Papulosquamous disorders

192

1737

1.11

0.70

1.5

3749.76

2698.48

e6/l

0.49

133

1258

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

509

1.20

0.69

1.5

1.4

856.57

1792.77

e6/l

4.01

363

Ankylosing spondylitis, ICD10

283

1.27

0.69

1.6

1.4

1802.90

2391.34

e6/l

0.42

204

Other disorders of breast

328

1.25

0.69

1.2

1.4

1879.03

2003.90

e6/l

0.11

239

Toxic effects of substances chiefly nonmedicinal as to source

355

1.24

0.69

1.4

1.5

3937.39

1820.68

e6/l

0.51

249

Acute myeloid leukaemia, helper endpoint

1.86

0.68

1.8

1.1

3746.80

1827.53

e6/l

—

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

1.86

0.68

1.8

1.1

3746.80

1827.53

e6/l

—

Otosclerosis

319

0.75

0.68

1.4

1.5

1570.58

2202.13

e6/l

0.49

235

Carpal tunnel syndrome

309

2581

1.08

0.68

1.5

1.4

3773.37

3504.05

e6/l

0.08

243

1845

Nystagmus and other irregular eye movements

1.86

0.68

1.4

1.3

1252.80

4492.19

e6/l

—

Dyshidrosis [pompholyx]

1.86

0.68

2.6

1.3

762.00

1715.29

e6/l

—

Other orthopaedic follow-up care

161

1.37

0.68

1.1

1.3

1571.59

1730.25

e6/l

0.11

108

Irregular menses

877

0.87

0.67

1.6

1.4

7323.82

3651.51

e6/l

0.42

631

Parkinson's disease, strict definition, excluding more controls

742

0.84

0.66

1.5

1844.05

1764.75

e6/l

0.07

507

Other congenital malformations of the digestive system

110

1.45

0.66

1.3

813.00

2486.33

e6/l

2.27

Perforation of tympanic membrane

384

1.23

0.66

1.5

1.4

3165.44

1683.13

e6/l

1.19

277

Other meningitis

1.79

0.66

1.4

1425.80

1501.75

e6/l

—

Hemiplegia

188

1.33

0.66

1.5

1.3

1792.90

1573.62

e6/l

0.14

131

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

105

1195

0.88

0.66

1.5

4578.36

2247.65

e6/l

1.00

859

Pedal cyclist injured in other and unspecified transport accidents

373

0.78

0.66

1.7

1.4

2950.91

2096.23

e6/l

0.25

273

Pedal cyclist injured in transport accident

767

0.85

0.66

1.5

15702.66

2540.54

e6/l

0.48

553

Pain associated with micturition

430

1.21

0.65

1.7

1.4

1280.02

2605.26

e6/l

1.86

315

Pediculosis, acariasis and other infestations

145

1.38

0.65

1.4

6793.92

1764.47

e6/l

0.48

102

Carcinoma in situ, bladder

180

1.34

0.65

1.5

1428.39

1623.23

e6/l

0.13

127

Blepharochalasis

161

1451

1.11

0.65

1.4

1.5

1771.04

2786.67

e6/l

1.05

106

1039

Injuries involving multiple body regions

103

1.46

0.65

1.5

1.3

1784.56

1856.18

e6/l

—

Dislocation, sprain and strain of joints and ligaments at neck level

394

0.79

0.64

1.5

4667.70

2429.68

e6/l

0.38

280

Lesion of ulnar nerve

560

1.18

0.64

1.5

1.4

5686.86

2482.08

e6/l

0.83

397

Alzheimer disease, excluding more controls

106

804

0.88

0.64

1.3

1.5

4881.00

1705.46

e6/l

0.93

550

Stomatitis and related lesions

269

1.27

0.63

1.6

1.5

4013.63

2338.16

e6/l

0.34

197

Correction of physiology of bite - demanding therapy visit

146

1.37

0.63

1.4

8174.53

3184.01

e6/l

0.30

100

Ulcerative colitis (strict definition, require KELA)

547

0.82

0.63

1.3

1.5

2452.91

2643.56

e6/l

0.12

395

Primary open-angle glaucoma, strict

139

1546

0.90

0.63

1.4

1.5

1761.22

2345.74

e6/l

0.66

102

1111

Crohn's disease of large intestine

112

1.43

0.63

1.6

1.3

4896.30

1780.83

e6/l

—

Persistent mood disorders

709

1.16

0.63

1.6

1.5

2818.95

2334.88

e6/l

0.25

515

Retinal breaks without detachment

663

1.16

0.63

1.6

1.5

1788.30

2059.66

e6/l

0.27

475

Insomnia

469

1.20

0.63

1.5

1.4

7314.47

2405.32

e6/l

0.50

336

Adalimumab

190

1.32

0.62

1.4

11343.14

2298.80

e6/l

0.68

130

Autonomic disorders

1.56

0.62

1.3

1.2

2644.67

1321.52

e6/l

—

Haemangioma and lymphangioma, any site

306

1.24

0.62

1.5

1.4

2339.68

2370.90

e6/l

0.01

217

Unattended death

1.68

0.61

1.2

1.1

816.20

1184.78

e6/l

—

Enthesopathies of lower limb, excluding foot

836

0.86

0.61

1.6

1.5

3324.61

2017.52

e6/l

0.28

593

Benign neoplasm of meninges

244

1.27

0.61

1.3

1.6

1650.42

2339.24

e6/l

0.46

176

Hallux rigidus

663

0.84

0.61

1.6

1.4

2611.49

2851.41

e6/l

0.08

480

Monoamine oxidase A inhibitors

471

1.19

0.61

1.3

1.4

19725.05

2010.61

e6/l

0.51

334

Spondylopathies (FG)

471

1.19

0.60

1.5

1830.87

2352.48

e6/l

0.53

345

Benign neoplasm: Tongue

1.48

0.60

1.5

1.3

1046.75

1838.45

e6/l

—

Atopic dermatitis, strict definition with reimbursement

681

1.15

0.60

1.7

1.4

2605.39

2662.29

e6/l

0.03

490

Postdysenteric arthropathy

0.00

0.60

0.0

1.4

—

1236.58

—

Other intracranial haemorrhages

174

1.33

0.60

1.6

1.4

743.17

1731.30

e6/l

2.50

127

LSIL lesion of the vagina

0.00

0.60

0.0

1.0

—

1342.20

—

Benign neoplasm: Brain, supratentorial

0.00

0.60

0.0

1.1

—

3225.42

—

Supervision of high-risk pregnancy

168

1.26

0.60

1.4

1.3

6451.81

7544.89

e6/l

0.08

122

Cervical root disorders

0.00

0.59

0.0

1.5

—

885.43

—

Pemphigoid

131

1.38

0.59

1.8

1.4

1203.25

1336.46

e6/l

0.07

Benign neoplasm of male genital organs

1.54

0.59

1.2

1.5

1550.18

2224.46

e6/l

0.33

Seborrhoeic keratosis

121

1081

1.12

0.59

1.4

1.5

7377.65

2242.65

e6/l

0.54

776

Other congenital malformations

183

1.31

0.59

1.3

1.4

3824.82

2085.46

e6/l

0.39

127

Internal derangement of knee

160

1757

0.91

0.59

1.5

1.4

1934.21

3679.39

e6/l

1.46

106

1258

Benign neoplasm: Skin of ear and external auricular canal

114

1.41

0.59

1.4

516.20

1936.24

e6/l

—

Acetic acid derivatives and related substances

196

932

1.10

0.58

1.5

1977.63

1780.91

e6/l

0.23

132

667

Any dementia

246

1873

0.92

0.58

1.3

1.5

3177.45

2293.72

e6/l

0.43

185

1342

Parkinson's disease, excluding more controls

789

0.86

0.58

1.4

1.5

3041.38

1712.51

e6/l

0.52

537

Gestational diabetes (for exclusion)

322

0.81

0.58

1.7

1.4

9084.57

4885.78

e6/l

0.39

238

Haemangioma, any site

291

1.24

0.58

1.4

2385.08

2411.67

e6/l

0.01

204

Other noninflammatory disorders of vulva and perineum

246

1.26

0.58

1.4

3724.37

4885.21

e6/l

0.15

180

Sicca syndrome [Sjögren]

282

1.24

0.58

1.6

1.5

2780.71

2394.99

e6/l

0.07

198

Other disorders of penis

447

1.19

0.57

1.8

1.6

1714.25

2094.93

e6/l

0.43

318

Other acquired deformities of musculoskeletal system and connective tissue

141

1.35

0.56

1.4

2333.71

1828.41

e6/l

0.17

Foreign body on external eye

506

0.83

0.56

1.5

2628.23

2282.64

e6/l

0.12

360

Drug-induced adrenocortical insufficiency

1.63

0.55

2.0

1.2

428.50

1594.65

e6/l

—

Entropion and trichiasis of eyelid

467

1.18

0.55

1.3

1.5

2583.24

1632.65

e6/l

0.49

344

Pregnancy examination and test

108

0.69

0.55

1.8

1.2

1442.00

6831.36

e6/l

—

Scleritis and episcleritis

159

1.32

0.55

1.5

1.3

2569.73

3058.38

e6/l

0.17

107

Benign paroxysmal vertigo

120

1334

0.90

0.55

1.3

1.5

2002.59

2602.71

e6/l

0.47

957

Pneumoconiosis due to asbestos and other mineral fibres

142

1.35

0.54

1.6

1.4

1143.71

1915.35

e6/l

0.94

103

Ectopic pregnancy

384

0.81

0.54

1.3

1.4

2440.60

2127.51

e6/l

0.16

276

Propionic acid derivatives

171

941

0.91

0.54

1.5

2253.78

1809.59

e6/l

0.29

120

673

Ulcerative colitis

103

919

1.12

0.53

1.3

1.5

2066.76

2348.18

e6/l

0.23

664

Malignant neoplasm of testis

1.54

0.53

1.8

1.5

2658.17

1829.85

e6/l

—

Reactive arthropathies, FINNGEN

232

1.25

0.52

1.6

1.4

2131.39

2072.28

e6/l

0.04

171

Pollen allergy

312

0.79

0.52

1.5

1.4

2392.12

2831.71

e6/l

0.17

212

Meniscus derangement

289

2112

0.94

0.52

1.4

1942.94

3602.38

e6/l

1.80

208

1521

Hypertrophy of breast

381

0.81

0.51

1.3

1.4

7389.76

2300.27

e6/l

0.58

279

Disorders of conjunctiva

368

2907

1.06

0.51

1.4

1.5

2549.64

3673.06

e6/l

0.70

271

2083

Menorrhagia

120

737

0.90

0.51

1.5

1.4

1888.29

3525.81

e6/l

0.78

519

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

522

0.84

0.51

1.3

1.5

2522.06

2708.41

e6/l

0.12

376

Psoriatic arthropathies

388

1.19

0.51

1.5

1.4

3074.11

2134.61

e6/l

0.29

288

Maternal care for other known or suspected fetal problems

167

0.77

0.51

1.9

1.4

2482.27

6300.71

e6/l

0.79

114

Vestibular neuronitis

358

0.81

0.51

1.4

3666.00

1716.80

e6/l

0.59

269

Somatoform disorder

518

1.16

0.51

1.4

1.5

6737.17

2167.16

e6/l

0.89

372

Pathological resorption of teeth

1.47

0.50

1.6

1.4

7399.40

1963.17

e6/l

—

Coxarthrosis, primary

386

3169

1.06

0.50

1.5

1675.11

2857.12

e6/l

1.91

293

2297

Benign neoplasm of mouth and pharynx

444

1.17

0.50

1.5

1.4

2876.71

2078.04

e6/l

0.29

325

Metatarsalgia

315

1.21

0.50

1.5

1.4

5398.33

1724.63

e6/l

0.53

229

Viral warts

288

1.22

0.50

1.4

1610.35

2392.74

e6/l

0.70

214

Excessive, frequent and irregular menstruation

122

751

0.90

0.49

1.4

3545.67

3685.79

e6/l

0.03

530

Lichen ruber planus, wide definition including periferal and oral lichen planus

840

0.88

0.49

1.6

1.4

1536.36

2282.26

e6/l

1.40

609

Alzheimer’s disease (Atypical or mixed), excluding more controls

440

0.84

0.49

1.3

1.5

2226.12

1493.01

e6/l

0.85

315

Other joint disorders

460

2327

1.05

0.49

1.6

1.4

2785.30

3768.27

e6/l

0.68

319

1670

Other abnormal uterine and vaginal bleeding

105

672

1.12

0.49

1.4

5470.62

3574.07

e6/l

0.23

470

Dysplasia of cervi uteri

452

0.85

0.49

1.2

1.4

8911.12

4517.55

e6/l

0.28

331

Chronic sinusitis

192

1777

1.08

0.48

1.7

1.5

2678.88

3456.57

e6/l

0.37

127

1286

Superficial injury of forearm

280

1.22

0.48

1.2

1.5

26216.19

2283.33

e6/l

0.46

205

Other intervertebral disc disorders

475

2767

1.05

0.48

1.5

3120.24

2949.74

e6/l

0.09

348

1995

Nasal polyp

954

0.89

0.48

1.5

3672.85

2223.10

e6/l

0.69

693

Impingement syndrome of shoulder

121

1098

1.10

0.48

1.3

1.4

3714.23

2979.54

e6/l

0.16

791

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

217

1.25

0.48

1.4

1293.43

3116.88

e6/l

1.61

157

Polyp of the female genital tract

112

722

0.90

0.47

1.5

1.4

2551.18

3554.93

e6/l

0.38

511

Other disorders of male genital organs

128

1.33

0.47

1.6

1173.20

1662.92

e6/l

—

Endometriosis of ovary

516

0.85

0.47

1.8

1.4

5318.97

4275.96

e6/l

0.14

370

Benign leiomyoma with endometriosis

345

1.19

0.47

1.4

3305.54

2239.51

e6/l

0.34

261

Other diseases of spinal cord

102

1.38

0.47

1.6

1.3

2213.78

1715.06

e6/l

—

Peritonsillar abscess

656

0.87

0.47

1.5

1.4

3623.53

2374.64

e6/l

0.62

468

Fissure and fistula of anal and rectal regions

111

1004

1.11

0.47

1.5

2090.57

2324.75

e6/l

0.23

723

Obstructed labour due to maternal pelvic abnormality

376

0.82

0.47

1.5

1.4

1878.21

3275.78

e6/l

0.54

272

Injuries to the neck

767

1.12

0.47

1.5

3746.61

2325.65

e6/l

0.39

557

Other symptoms and signs involving the nervous and musculoskeletal systems

188

1743

1.08

0.46

1.5

5968.25

2675.54

e6/l

0.36

161

1252

Budesonide

411

1.17

0.46

1.4

1455.08

2140.48

e6/l

1.19

298

Other disorders of bone density and structure

1.43

0.46

1.1

1.2

1275.43

1519.36

e6/l

—

Alzheimer’s disease (Atypical or mixed)

556

0.86

0.46

1.3

1.4

2106.03

1373.10

e6/l

0.92

408

Primary angle-closure glaucoma

219

1.24

0.45

1.3

1.4

788.82

1557.57

e6/l

2.03

158

Postpartum haemorrhage

307

0.82

0.45

1.3

1.4

2946.50

5081.32

e6/l

0.57

222

Other diseases of gallbladder

183

1.26

0.45

1.6

1.3

1880.22

1678.67

e6/l

0.16

133

Other specified/unspecified soft tissue disorders

183

1.26

0.45

1.2

1.3

1489.71

2169.22

e6/l

0.43

129

Spirochaetal infections, other/unspecified

330

0.82

0.44

1.5

3061.61

2237.75

e6/l

0.21

243

Flat foot [pes planus] (acquired)

330

0.82

0.44

1.4

5588.11

1993.48

e6/l

0.42

244

Pedestrian injured in transport accident

242

0.78

0.44

1.6

1.4

1568.79

1649.09

e6/l

0.06

172

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

320

1.19

0.44

1.5

4409.03

2085.27

e6/l

0.34

238

Ovarian cyst

116

738

0.91

0.44

1.5

1.4

1577.70

3534.87

e6/l

1.10

522

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

148

1.29

0.43

1.5

1.4

769.17

1544.11

e6/l

1.59

104

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

1.62

0.43

1.0

1.2

1587.60

1770.58

e6/l

—

Pain and other conditions associated with female genital organs and menstrual cycle

398

0.84

0.43

1.3

1.4

1249.87

5131.05

e6/l

1.31

286

Stenosis and insufficiency of lacrimal passages

382

0.84

0.42

1.7

1.4

1516.40

2107.05

e6/l

0.44

279

Benign neoplasm of bone and articular cartilage

239

1.22

0.42

1.4

1530.70

2505.17

e6/l

0.78

167

Transport accidents

192

1587

1.07

0.42

1.6

1.4

7626.71

2911.19

e6/l

0.49

143

1144

Migraine with aura

542

0.87

0.41

1.4

2670.86

2466.30

e6/l

0.14

379

Other disorders of conjunctiva

651

1.12

0.41

1.4

1.5

1768.05

2113.91

e6/l

0.22

483

HSIL lesion of the vulva

1.52

0.41

1.6

1.2

1760.40

1053.50

e6/l

—

Other keratitis

360

1.17

0.41

1.3

1.4

2645.00

2297.69

e6/l

0.09

257

Any dementia, excluding more controls

231

1706

0.94

0.41

1.3

1.5

3345.89

1735.69

e6/l

1.00

174

1217

Spermatocele

445

0.85

0.41

1.4

1.5

2861.27

1718.52

e6/l

0.76

315

Other retinal artery occlusion

105

1.34

0.41

1.1

1.4

721.67

1520.95

e6/l

—

Deep bite that required surgery

0.00

0.41

0.0

1.3

—

2925.13

—

Other disorders of binocular vision

0.00

0.41

0.0

1.1

—

1022.50

—

Benign mammary dysplasia

463

1.15

0.41

1.3

1.4

2127.58

2173.45

e6/l

0.03

339

Complications associated with artificial fertilization

0.00

0.41

0.0

1.4

—

2994.78

—

Acute nasopharyngitis (common cold)

312

1.18

0.41

1.5

1.4

1353.34

3513.13

e6/l

1.60

219

Other disorders of eye and adnexa

454

1.15

0.41

1.3

1.5

2793.34

2157.63

e6/l

0.21

335

1.39

0.40

2.3

1.5

5018.33

2670.97

e6/l

—

Persons encountering health services in circumstances related to reproduction

166

1210

0.93

0.40

1.5

1.4

3633.70

3899.19

e6/l

0.09

110

889

Other diseases of peritoneum

141

1.28

0.40

1.1

1.3

1228.64

1593.20

e6/l

0.41

Other enthesopathy of foot (+metatarsalgia)

324

1.17

0.40

1.5

1.4

5398.33

1714.64

e6/l

0.53

236

Cicatricial alopecia [scarring hair loss]

0.00

0.40

0.0

1.2

—

2013.00

—

Short Achilles tendon (acquired)

1.31

0.39

2.4

1.2

1854.38

1710.50

e6/l

—

Sequelae of injuries of upper limb

306

1.18

0.39

1.8

1.5

1737.45

2481.16

e6/l

0.67

218

Inflammatory bowel disease

129

1190

1.08

0.39

1.4

1.5

2182.52

2202.79

e6/l

0.02

854

Melanocytic naevi of lower limb, including hip

106

1.32

0.39

1.6

1.3

2560.13

1938.50

e6/l

—

Atopic dermatitis, strict definition

632

1.12

0.39

1.7

1.4

2610.84

2969.86

e6/l

0.20

458

Graves disease, strict definition

242

1.20

0.38

1.3

1.4

1935.46

2815.03

e6/l

0.61

170

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

302

0.83

0.38

1.5

1.4

1229.22

2184.91

e6/l

0.96

217

Maternal care for known or suspected fetal abnormality and damage

142

1.25

0.38

1.3

1.4

1294.62

6721.43

e6/l

1.05

Outcome of delivery

120

0.77

0.38

1.2

4354.56

6184.70

e6/l

—

Hyperplasia of prostate

277

1497

1.06

0.37

1.5

2790.55

3423.17

e6/l

0.31

206

1082

Acute myeloid leukaemia

1.36

0.37

1.8

1.2

3746.80

1636.92

e6/l

—

Dentofacial anomalies [including malocclusion]

780

0.90

0.37

1.6

1.5

3766.66

2786.90

e6/l

0.18

575

Disorders of oesophagus in diseases classified elsewhere

1.39

0.37

1.5

1.3

1960.60

1820.90

e6/l

—

Other headache syndromes

149

1599

0.93

0.36

1.5

8736.46

2759.81

e6/l

1.09

106

1128

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

336

1.16

0.36

1.4

801.84

1723.21

e6/l

2.52

242

Other/unspecified synovitis and tenosynovitis

440

1.14

0.36

1.4

2979.93

2040.11

e6/l

0.27

319

Ulcerative colitis, NAS

478

1.13

0.36

1.3

1.5

2222.57

2308.04

e6/l

0.04

349

Benign lipomatous neoplasm

124

1339

0.93

0.36

1.5

2465.01

2551.61

e6/l

0.03

960

Hallux valgus (acquired)

150

1165

0.93

0.36

1.5

1.4

2691.86

3077.36

e6/l

0.14

105

837

Benign neoplasm: Skin of other and unspecified parts of face

479

1.13

0.35

1.4

1.5

988.86

2166.82

e6/l

3.24

352

Benign neoplasm: Other and unspecified parts of mouth

117

1.29

0.35

1.7

1.3

7896.37

1940.61

e6/l

—

Injury of eye and orbit

459

0.87

0.35

1.6

1.4

1000.46

2666.50

e6/l

3.55

325

Crohn disease

395

1.14

0.34

1.5

3330.35

2383.02

e6/l

0.38

282

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.37

0.34

1.7

1.3

721.67

1886.88

e6/l

—

Endometriosis ASRM stages 3,4

606

0.89

0.34

1.7

1.4

4608.28

3264.13

e6/l

0.24

439

Other/unspecified enthesopathies, not elsewhere classified

351

0.85

0.34

1.5

1.4

1256.00

2125.04

e6/l

1.08

257

Cervicocranial syndrome

372

0.86

0.33

1.6

1.5

2221.62

1777.77

e6/l

0.39

269

Deviated nasal septum

176

1656

1.06

0.33

1.5

6449.13

3443.37

e6/l

0.62

129

1203

Visual field defects

369

1.14

0.32

1.4

1363.97

1809.74

e6/l

0.48

262

Achilles tendinitis

413

0.87

0.32

1.4

1.5

6138.35

1997.33

e6/l

0.42

287

Plantar fascial fibromatosis

322

1.15

0.32

1.5

1.4

2239.04

1749.41

e6/l

0.36

231

Lumbar disc prolapse

303

2518

0.96

0.32

1.5

3435.73

2803.99

e6/l

0.28

216

1824

Astigmatism

164

1.22

0.32

1.5

1570.29

1837.62

e6/l

0.12

118

Foreign body in alimentary tract

192

1.20

0.32

1.4

1970.14

1913.88

e6/l

0.02

139

Early lumbar disc prolapse operation

176

0.79

0.32

1.3

1.5

4659.00

4342.43

e6/l

—

126

Other and unspecified mononeuropathies, also in other diseases

101

1.29

0.31

1.4

1.2

1462.00

1649.17

e6/l

—

Other benign neoplasms of connective and other soft tissue

370

1.14

0.31

1.5

1.4

1235.35

2143.90

e6/l

1.34

271

Disorders of optic nerve and visual pathways

305

0.85

0.31

1.3

1.4

1221.00

2365.99

e6/l

1.24

215

Glaucoma suspect

176

1863

0.94

0.31

1.4

1.5

5444.39

2311.02

e6/l

0.42

132

1333

Nonsuppurative otitis media

509

1.10

0.30

1.4

1.5

2762.29

2544.68

e6/l

0.12

366

Extrapyramidal and movement disorders

188

1985

0.95

0.30

1.4

1.5

3464.96

2548.84

e6/l

0.46

140

1430

Inflammatory disease of uterus

283

0.85

0.30

1.4

2498.87

2555.42

e6/l

0.02

212

Sciatica+with lumbago

244

2208

1.05

0.30

1.5

4774.51

2716.65

e6/l

0.68

181

1593

Malignant neoplasm of bladder

438

1.12

0.30

1.3

1.5

1073.35

1900.83

e6/l

1.41

311

Heterophoria

212

1.18

0.30

1.4

3985.56

2150.56

e6/l

0.39

150

Other appendicitis

282

0.85

0.29

1.9

1.5

1058.12

2357.16

e6/l

1.78

205

Other arthrosis

300

2056

1.04

0.29

1.5

1.4

2915.86

3380.52

e6/l

0.23

218

1478

Lichen planus, including avohilmo

734

0.91

0.29

1.4

1.5

1400.91

2229.73

e6/l

1.63

537

HSIL lesion of the cervix uteri

250

1.16

0.29

1.2

1.4

14180.83

3013.72

e6/l

0.47

173

Disorders of vestibular function (Vertigo)

223

2322

0.95

0.28

1.4

1.5

2281.02

2662.14

e6/l

0.36

164

1668

Lichen planus

523

0.90

0.28

1.4

1.5

1128.16

2069.11

e6/l

1.92

392

Gonarthrosis

367

2184

0.96

0.28

1.5

1.4

1956.41

3505.22

e6/l

1.78

275

1577

Acute pharyngitis

315

1.14

0.28

1.5

1.4

2270.29

2443.26

e6/l

0.10

217

Rosacea

366

1.12

0.26

1.6

1.5

2000.97

2169.70

e6/l

0.10

266

Diseases of the ear and mastoid process

612

3183

0.97

0.26

1.5

4976.60

3132.55

e6/l

0.56

451

2257

Vascular dementia (undefined)

244

0.85

0.26

1.3

1.4

1520.69

1318.48

e6/l

0.10

182

Ménière disease

414

1.11

0.26

1.3

1.5

2239.64

2094.18

e6/l

0.09

314

Glaucoma, exfoliation

624

0.91

0.26

1.4

1.5

11395.47

1717.45

e6/l

0.46

445

Mixed conductive and sensorineural hearing loss

587

1.09

0.26

1.3

1.5

1524.26

2167.94

e6/l

0.76

419

Dislocation, sprain and strain of joint and ligaments of hip

132

1.21

0.25

1.6

1.4

787.45

1398.64

e6/l

1.04

Other secondary gonarthrosis

224

0.85

0.25

1.2

1.4

2034.46

1702.44

e6/l

0.17

158

Status post-ami

443

0.91

0.25

1.4

1.5

695.31

2489.02

e6/l

1.82

325

Medical treatment for female infertility

234

0.85

0.25

1.2

1.5

1370.47

4944.63

e6/l

1.23

160

conjunctival degenerations and deposits

1.20

0.25

1.2

1.3

2181.33

1991.54

e6/l

—

Myopia

273

1.14

0.25

1.4

1.5

1552.72

2926.86

e6/l

1.17

196

Oter anti-inflammatory and antirheumatic agents, non-steroids

170

896

1.05

0.25

1.4

1.5

1937.55

1691.93

e6/l

0.21

123

643

Diseases of appendix

326

3075

0.97

0.25

1.5

2766.34

3660.99

e6/l

0.41

231

2227

Acne

114

1.23

0.25

1.4

1.5

2014.33

3749.35

e6/l

—

Benign neoplasm: Pancreas

105

1.24

0.25

1.7

1.4

2537.00

1526.61

e6/l

—

Foreign body entering into or through eye or natural orifice

264

1.14

0.24

1.6

1.5

1424.29

1808.09

e6/l

0.46

191

Reactive arthropathies

340

1.12

0.24

1.5

1.4

2471.00

1992.05

e6/l

0.39

255

Spontaneous rupture of synovium and tendon

321

1.12

0.24

1.4

3175.52

1690.38

e6/l

0.75

231

Lateral epicondylitis

434

0.90

0.24

1.9

1.4

1947.38

2215.63

e6/l

0.28

320

Redundant prepuce, phimosis and paraphimosis

895

1.07

0.24

1.6

1.5

4680.79

2445.33

e6/l

0.76

630

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

152

1.19

0.23

1.7

1.4

625.36

1617.61

e6/l

3.07

106

Maternal care for other conditions predominantly related to pregnancy

261

0.87

0.23

1.7

1.4

4522.33

5259.92

e6/l

0.09

192

Postpartum hemorraghe, all women as controls

326

0.89

0.23

1.3

1.4

2946.50

5237.44

e6/l

0.66

236

Multiple delivery

179

0.84

0.23

1.4

1891.60

4693.82

e6/l

—

127

Mouth breathing

174

1819

0.96

0.23

1.4

1.5

2420.28

3457.32

e6/l

0.73

127

1307

Vertical strabismus

1.24

0.23

1.7

1.3

955.57

1657.86

e6/l

—

Striking against or struck by other objects

122

1154

1.06

0.23

1.4

1.5

2495.46

2422.02

e6/l

0.05

828

Glaucoma

349

2969

1.03

0.22

1.4

1.5

3519.41

2645.98

e6/l

0.20

261

2143

Urolithiasis

176

1839

0.96

0.22

1.7

1.5

2114.77

2776.36

e6/l

0.39

123

1340

Otitis media, unspecified

213

0.86

0.22

1.4

2078.17

2404.24

e6/l

0.11

146

Medical abortion

204

1156

0.96

0.22

1.5

1.4

6282.72

2494.47

e6/l

0.60

143

845

Cholesteatoma of middle ear

252

0.87

0.21

1.2

1.4

15797.93

1731.62

e6/l

0.68

184

Vascular syndromes of brain in cerebrovascular disorders

248

1.13

0.21

1.5

898.90

1702.72

e6/l

1.59

181

D07AA Corticosteroids, weak (group I)

440

0.91

0.21

1.3

1.4

1914.93

2282.67

e6/l

0.23

316

Neuroendocrine tumor and carcinoma of rectum

0.00

0.21

0.0

1.1

—

676.83

—

Sudden idiopathic hearing loss

449

1.09

0.21

1.6

1.4

2604.27

2014.45

e6/l

0.44

328

Presbycusis

911

0.94

0.21

1.4

1220.70

1820.79

e6/l

0.97

639

Acute inflammation of orbit

0.00

0.21

0.0

1.4

—

921.17

—

Open bite that required surgery (Lefort1 or BSSRO)

0.00

0.21

0.0

1.7

—

1794.40

—

Other disorders of breast and lactation associated with childbirth

0.00

0.21

0.0

1.1

—

2925.67

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

0.00

0.21

0.0

1.3

—

2113.14

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

0.21

0.0

1.3

—

2184.14

—

Contact with other specified venomous animals

0.00

0.21

0.0

1.2

—

1606.83

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.21

0.0

1.2

—

2088.86

—

Carcinoma in situ of cervix uteri, endocervix

0.00

0.21

0.0

1.1

—

1292.20

—

HSIL lesion of the cervix uteri, vagina or vulva

315

1.11

0.21

1.3

1.4

11564.10

2810.57

e6/l

0.46

226

Deforming dorsopathies

120

1139

1.05

0.21

1.5

3252.92

2524.71

e6/l

0.30

816

Benign neoplasm of eye and adnexa

421

1.09

0.21

1.5

1.4

2056.44

2121.69

e6/l

0.04

304

Endometriosis of fallopian tube

0.00

0.21

0.0

1.1

—

1792.67

—

Disorders in reading

0.00

0.21

0.0

1.3

—

4096.88

—

5-aminosalicylic acid

667

0.93

0.20

1.4

2815.66

2311.47

e6/l

0.40

478

Other peripheral vertigo

387

0.90

0.20

1.4

1.5

3281.53

1709.74

e6/l

0.73

282

Chromophobe cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

0.00

0.20

0.0

1.1

—

4803.33

—

Disorder of pancreatic internal secretion, other and/or unspecified

0.00

0.20

0.0

1.3

—

2502.67

—

Injury of muscle and tendon at lower leg level

625

0.93

0.20

1.5

2001.52

2443.09

e6/l

0.35

447

Other/unspecified enthesopathies of lower limb, excluding foot

202

1.14

0.20

2.0

1.4

969.24

1528.51

e6/l

0.60

139

Anankastic personality disorder

1.23

0.20

1.7

1.3

2102.17

2216.67

e6/l

—

Other and unspecified psoriasis

250

1.12

0.19

1.5

2599.86

1764.76

e6/l

0.21

181

Alzheimer’s disease, wide definition, excluding more controls

103

739

0.95

0.19

1.4

1.5

3866.95

1628.45

e6/l

0.64

506

Haemorrhoids and perianal venous thrombosis

160

1533

1.04

0.19

1.5

1760.53

2652.51

e6/l

0.94

125

1114

Suggestive for eosinophilic asthma

365

1.10

0.19

1.5

1.4

3532.23

1882.13

e6/l

0.83

265

Diplopia

539

1.08

0.19

1.5

1526.61

1884.55

e6/l

0.34

394

Early lumbar disc prolapse, operated

165

0.85

0.19

1.3

1.5

4659.00

2705.71

e6/l

—

115

Vasomotor rhinitis (mode)

270

0.89

0.19

1.8

1.4

3164.21

2419.25

e6/l

0.14

195

Supervision of normal pregnancy

167

0.89

0.19

1.4

1.3

8087.79

8377.07

e6/l

0.02

122

Migraine with aura and triptan purchases

249

0.88

0.19

1.4

3232.00

2718.50

e6/l

0.21

169

Carcinoma in situ of breast, intraductal

270

1.11

0.18

1.2

1.4

3782.79

2354.70

e6/l

0.35

201

Persistent delusional disorders

270

1.11

0.18

1.6

1.4

2569.33

1513.78

e6/l

0.48

194

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

143

0.84

0.18

2.3

1.4

1552.29

3358.25

e6/l

—

102

Use of ropinirole

164

0.85

0.18

1.2

1.4

3348.89

1660.47

e6/l

—

117

Intermittent heterotropia

100

1.20

0.18

1.8

1.4

1867.14

2148.87

e6/l

—

Depression

442

2973

1.02

0.18

1.5

1.4

4058.43

3298.10

e6/l

0.30

328

2139

Inflammatory diseases of prostate (prostatitis)

746

1.06

0.17

1.7

1.5

1554.16

2030.63

e6/l

0.59

531

Appendicitis, broad definition

325

3050

0.97

0.17

1.5

2766.34

3682.47

e6/l

0.42

231

2210

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

142

0.84

0.17

2.3

1.3

1552.29

3680.97

e6/l

—

100

Benign neoplasm: Skin of ear and external auricular canal

184

0.87

0.17

1.4

516.20

1696.63

e6/l

—

132

Primary coxarthrosis, bilateral

162

1681

0.96

0.17

1.4

1.5

1701.98

2595.93

e6/l

0.94

129

1206

Viral infections of the central nervous system

205

1.12

0.17

1.5

1.3

3824.06

1769.14

e6/l

0.46

144

Hypermetropia

205

1.12

0.17

1.6

1.4

9450.15

1800.68

e6/l

0.47

142

Diseases of tongue

253

1.11

0.17

1.8

1.5

2280.59

2146.21

e6/l

0.05

191

Depression or dysthymia

388

2120

1.02

0.16

1.6

1.5

2789.72

2201.17

e6/l

0.43

285

1511

Restless leg syndrome

474

0.93

0.16

1.4

5586.22

1907.53

e6/l

0.68

342

Acute appendicitis, with complications

856

1.05

0.16

1.6

1.5

5025.61

2257.31

e6/l

0.39

626

Hypertrophy of breast in women and men

535

0.93

0.16

1.4

1.5

4972.86

2151.14

e6/l

0.56

389

Non-allergic asthma

349

0.92

0.15

1.6

1.4

2134.64

2265.71

e6/l

0.06

254

Disorders of refraction and accommodation

776

1.05

0.15

1.5

1.4

3358.63

2382.26

e6/l

0.20

562

Other extrapyramidal and movement disorders in other diseases

107

1024

1.05

0.15

1.4

1.5

3912.11

1843.60

e6/l

0.90

734

Artificial joint re-operation

322

1.09

0.15

1.7

1.4

3153.05

1565.89

e6/l

1.01

235

Other disorders of patella

546

1.06

0.15

1.6

1.4

8607.66

2257.76

e6/l

0.51

398

Pre-eclampsia or poor fetal growth

542

0.94

0.14

1.6

1.4

1694.33

3211.92

e6/l

1.02

382

Obstructed labour due to malposition and malpresentation of fetus

279

0.91

0.14

1.4

2850.10

5404.76

e6/l

0.60

199

Vascular dementia (subcortical)

169

1.13

0.14

1.4

1318.90

1594.79

e6/l

—

124

Atopic dermatitis

163

1435

0.97

0.14

1.7

1.5

2348.59

3405.83

e6/l

0.80

120

1024

Biomechanical lesions, not elsewhere classified

170

1.12

0.13

1.4

2543.33

1646.60

e6/l

0.46

114

Other disorders of bladder

627

1.05

0.13

1.8

1.5

1600.84

1882.12

e6/l

0.26

458

Cerebral aneurysm, nonruptured

325

1.08

0.13

1.2

1.4

12209.70

2458.59

e6/l

0.49

234

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

109

918

1.04

0.13

1.5

1.4

1811.45

3815.20

e6/l

1.37

658

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

897

0.96

0.12

1.6

1.5

1449.33

2731.15

e6/l

3.10

647

Lichen sclerosus et atrophicus

314

0.92

0.12

1.6

1.4

1393.64

2370.50

e6/l

1.04

231

Bitten or struck by other mammals

277

1.08

0.12

1.8

1.4

1775.05

2823.40

e6/l

0.68

192

Other acute skin changes due to ultraviolet radiation

127

0.87

0.12

1.5

1.3

1322.83

1557.08

e6/l

—

L02BB Anti-androgens

610

1.05

0.12

1.4

1.5

1292.96

1757.02

e6/l

0.75

426

Gestational [pregnancy-induced] hypertension

443

1.06

0.11

1.4

2003.91

2565.32

e6/l

0.52

322

Impacted cerumen

454

1.06

0.11

1.5

3023.10

1966.11

e6/l

0.29

330

Sequelae of infectious and parasitic diseases

271

0.92

0.11

1.4

5086.70

1660.70

e6/l

0.56

188

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

201

1.09

0.11

1.3

1.4

1641.56

2108.08

e6/l

0.38

144

Foreign body or object entering through skin

178

0.90

0.11

1.2

1.5

2841.64

1931.93

e6/l

0.61

128

Complications predominantly related to the puerperium

484

1.05

0.11

1.5

1.4

4158.28

2226.39

e6/l

0.34

349

Postpartum hemorraghe, parous women as controls

273

0.93

0.11

1.3

1.4

2946.50

3019.98

e6/l

0.03

202

L02BX Other hormone antagonists and related agents

332

0.93

0.11

1.5

1508.92

1826.77

e6/l

0.34

240

Other fall from one level to another

877

1.04

0.11

1.7

1.5

2202.01

2323.07

e6/l

0.10

629

Gonarthrosis [arthrosis of knee](FG)

421

2517

0.98

0.11

1.5

1.4

1934.18

3557.58

e6/l

2.10

313

1825

Other diseases of hard tissues of teeth

292

2137

1.02

0.10

1.5

1.4

3427.79

3055.55

e6/l

0.18

210

1564

Nontoxic single thyroid nodule

249

0.92

0.10

1.4

1.5

6041.24

2377.51

e6/l

0.33

176

Brachial plexus disorders

218

0.92

0.10

1.4

2282.43

2944.40

e6/l

0.28

149

Spondylosis

289

2522

0.98

0.10

1.4

1.5

2646.46

2722.84

e6/l

0.05

197

1818

Injuries to the wrist and hand

474

3481

0.99

0.10

1.5

6586.32

2958.65

e6/l

0.83

343

2524

Other noninflammatory disorders of uterus, except cervix

670

0.97

0.10

1.4

2133.77

3529.98

e6/l

0.55

471

Examination and encounter for administrative purposes

166

0.90

0.09

2.1

1.4

1530.00

1160.95

e6/l

—

Ulcerative proctitis

166

0.90

0.09

1.5

1.4

3277.80

1842.08

e6/l

—

118

Preparation and fitting of bite rail to mouth

361

0.94

0.09

1.4

1.5

6068.50

2431.86

e6/l

0.45

256

Trigger finger

516

1.05

0.09

1.8

1.4

2779.65

2118.37

e6/l

0.25

371

Arthrosis

400

2231

0.99

0.09

1.5

1.4

2236.86

3520.29

e6/l

1.25

291

1610

Other/unspecified disorders of vestibular function

145

0.90

0.09

1.5

1.4

1034.13

1606.59

e6/l

—

100

Vascular dementia

545

0.96

0.09

1.3

1.5

2790.20

1407.21

e6/l

0.48

396

Fall on and from ladder

340

1.06

0.09

1.5

1.4

1520.35

1784.60

e6/l

0.22

246

Pregnancy hypertension

792

0.97

0.09

1.5

1.4

1922.75

3996.66

e6/l

1.17

571

Conductive hearing loss, unspecified

309

0.94

0.09

1.6

1.4

4441.61

2266.96

e6/l

0.37

224

TMD related operations

458

1.05

0.09

1.4

1.5

4892.03

2395.25

e6/l

0.38

334

Diabetes mellitus in pregnancy

247

0.94

0.09

1.7

1.4

7633.82

4044.77

e6/l

0.35

180

Complications following abortion and ectopic and molar pregnancy

1.14

0.09

1.5

1.2

1051.50

1930.94

e6/l

—

Ectropion of eyelid

233

1.07

0.09

1.4

1196.83

1571.46

e6/l

0.37

169

Other disorders of prostate

194

1.08

0.09

2.0

1.5

1597.67

1702.46

e6/l

0.05

140

Migraine without aura and triptan purchases

237

0.93

0.09

1.5

1.4

4354.18

2908.74

e6/l

0.61

164

Calculus of lower urinary tract

282

1.06

0.09

1.4

4965.86

1858.27

e6/l

0.60

205

Open wound of wrist and hand

176

1779

0.98

0.08

1.5

9556.44

2886.44

e6/l

0.63

128

1297

Superficial injury of wrist and hand

573

0.96

0.08

1.4

1.5

24037.77

2523.56

e6/l

0.69

410

Excessive attrition of teeth

141

747

1.02

0.08

1.5

1.4

3634.31

2405.03

e6/l

0.50

111

567

Allergic contact dermatitis

410

1.05

0.08

1.3

1.4

3174.60

2367.98

e6/l

0.36

299

Hereditary corneal dystrophies

117

1.11

0.08

1.2

1.3

1247.57

1897.05

e6/l

—

Mood disorders

501

3254

1.01

0.08

1.5

4782.08

3165.11

e6/l

0.79

370

2344

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

962

1.03

0.08

1.6

1.5

2094.74

2806.40

e6/l

0.64

688

Other hammer toe(s) (acquired)

811

0.97

0.08

1.5

1.4

3257.29

3139.34

e6/l

0.03

574

Pedal cyclist injured in noncollision transport accidents

358

0.95

0.08

1.3

1.5

26027.04

2252.11

e6/l

0.46

262

Synovial cyst of popliteal space [Baker]

303

1.06

0.07

1.7

1.4

5217.86

1739.15

e6/l

0.42

221

Temporomandibular joint disorders

429

0.96

0.07

1.7

1.4

5185.41

3235.85

e6/l

0.24

317

All dysplastic lesions of the cervix uteri, vagina or vulva

487

1.04

0.07

1.3

1.4

9473.98

2390.65

e6/l

0.51

361

Impacted teeth

200

0.93

0.07

1.4

14281.79

2628.91

e6/l

0.66

136

Embedded and impacted teeth

330

0.95

0.07

1.4

1.5

8917.26

2906.57

e6/l

0.66

227

Puerperal sepsis

323

1.05

0.07

1.5

1.4

5409.42

2321.36

e6/l

0.36

233

malignant neoplasm of male genital organs

317

1986

1.01

0.07

1.5

1859.68

2857.88

e6/l

0.88

231

1461

Unspecified urinary incontinence

337

0.95

0.07

1.7

1.4

1244.26

2226.25

e6/l

1.46

246

Calculus of kidney and ureter

162

1650

0.98

0.07

1.7

1.5

1658.22

2297.76

e6/l

0.85

115

1203

Other predominantly sexually transmitted diseases, not elsewhere classified

304

1.05

0.07

1.4

4269.19

2915.13

e6/l

0.57

210

Recurrent dislocation and subluxation of joint

157

1.08

0.07

1.2

1.4

1548.73

2233.59

e6/l

0.57

113

Pre-eclampsia or eclampsia

442

1.04

0.07

1.7

1.4

1506.49

2594.09

e6/l

1.25

312

Injury of muscle and tendon at hip and thigh level

326

0.95

0.07

2.1

1.5

887.80

2456.37

e6/l

2.82

235

Preterm labour and delivery

549

0.96

0.07

1.3

1.4

2051.00

2918.32

e6/l

0.48

395

Malignant neoplasm of prostate

309

1975

0.99

0.06

1.5

1838.27

2859.28

e6/l

0.89

225

1454

Radiculopathy

828

1.03

0.06

1.4

1.5

4608.27

1860.01

e6/l

0.79

585

Benign neoplasm of breast

366

0.96

0.06

1.2

1.4

5167.35

2189.15

e6/l

0.42

271

Selective serotonin reuptake inhibitors

559

2968

0.99

0.06

1.5

5667.93

2568.30

e6/l

0.89

409

2157

Other disorders of cornea

374

1.04

0.06

1.3

1.4

8940.54

2109.78

e6/l

0.57

281

Benign neoplasm: Choroid

246

1.06

0.06

1.5

1.4

1088.63

1660.60

e6/l

1.31

171

Antenatal screening

172

0.95

0.06

1.3

6810.91

8209.76

e6/l

0.10

125

Fibromyalgia

203

0.94

0.06

1.4

1.3

19651.56

1996.39

e6/l

—

144

Trochanteric bursitis

503

1.03

0.06

1.3

1.4

5022.94

3287.41

e6/l

0.21

362

Endometriosis diagnosis and infertility diagnosis occurring together

162

0.93

0.06

1.3

1.4

1953.67

3480.88

e6/l

—

115

Other diseases of upper respiratory tract

651

3369

1.01

0.06

1.5

1.4

2438.85

3052.63

e6/l

0.70

470

2444

Scoliosis

233

0.94

0.05

1.5

1.4

2392.79

2184.77

e6/l

0.09

163

Rheumatism, unspecified

486

0.97

0.05

1.4

1798.30

3451.51

e6/l

0.62

350

Superficial injury of shoulder and upper arm

405

1.04

0.05

1.3

1.4

17984.13

2209.76

e6/l

0.64

296

Diseases of middle ear and mastoid

211

1706

1.01

0.05

1.4

1.5

5310.77

2847.27

e6/l

0.63

160

1224

Disorders of synovium and tendon

237

2111

1.01

0.05

1.6

1.4

3724.63

2779.30

e6/l

0.49

181

1512

Mood [affective] disorders

497

3246

1.01

0.04

1.5

4637.44

3199.87

e6/l

0.66

366

2340

Haemorrhage in early pregnancy

551

0.97

0.04

1.2

1.4

2595.49

3379.03

e6/l

0.31

402

Paralytic strabismus

302

0.96

0.04

1.4

21286.21

1600.14

e6/l

0.51

221

Other disorders of the genitourinary system

516

1.03

0.04

1.5

1.4

1656.00

2248.48

e6/l

0.66

376

Inflammatory diseases of female pelvic organs

183

1363

1.01

0.04

1.5

1.4

4921.54

3230.17

e6/l

0.32

134

980

Other enthesopathies

119

1173

1.01

0.04

1.7

1.5

2783.07

3003.26

e6/l

0.06

840

Polyarthrosis

935

0.98

0.03

1.5

1.4

2465.92

3033.15

e6/l

0.25

667

Ocular pain

210

0.95

0.03

1.5

1.4

4801.25

2651.01

e6/l

0.28

143

Recurrent or chronic depression

129

944

0.99

0.03

1.5

3635.77

2265.45

e6/l

0.91

664

Tongue abnormality

230

1.04

0.03

1.8

1.3

2368.21

1654.20

e6/l

0.35

163

Migraine without aura

359

1.03

0.03

1.5

1.4

3653.04

2824.87

e6/l

0.45

246

Spondylolisthesis/Spondylolysis

757

1.02

0.03

1.5

3472.07

2813.77

e6/l

0.16

540

Glaucoma-related operations

280

0.96

0.03

1.3

1.4

693.56

1511.40

e6/l

3.30

207

Chronic suppurative otitis media, including avohilmo

290

1.03

0.03

1.6

1.4

1133.18

1888.39

e6/l

1.35

211

Diseases of male genital organs

330

1658

1.01

0.03

1.5

2636.01

3702.05

e6/l

0.68

235

1190

Use of pramipexole

104

1027

1.01

0.03

1.5

1778.32

2073.67

e6/l

0.37

748

Disturbances of smell and taste

122

1.07

0.02

1.2

1.3

3061.50

1720.12

e6/l

—

Endovascular or surgical operations to intracerebral aneurysms

241

1.04

0.02

1.4

3920.95

1817.76

e6/l

0.63

168

Benign neoplasm: Skin, unspecified

132

1.06

0.02

1.4

1.3

772.00

1747.29

e6/l

—

Cervicobrachial syndrome

831

0.99

0.02

1.4

1.5

3385.26

1937.91

e6/l

0.48

589

Oxicams

161

908

1.01

0.02

1.5

3979.68

1768.01

e6/l

0.87

121

651

Benign neoplasm: Skin of eyelid, including canthus

660

1.02

0.02

1.3

1.5

3002.20

2206.55

e6/l

0.29

484

All dysplastic lesions of the cervix uteri

388

0.98

0.02

1.3

1.4

11468.81

2787.71

e6/l

0.47

281

Contact with machinery

481

1.02

0.02

1.6

1.5

1643.03

2009.34

e6/l

0.30

341

Chronic suppurative otitis media

262

1.03

0.02

1.6

1.4

1263.42

1683.23

e6/l

0.58

190

Benign neoplasm of middle ear and respiratory system

332

1.02

0.01

1.4

2682.00

1674.55

e6/l

0.33

233

Rash and other nonspecific skin eruption

372

1.02

0.01

1.7

1.4

2511.32

1808.81

e6/l

0.58

267

Neuralgia and neuritis, unspecified

163

1.04

0.01

1.2

1.4

2022.55

1597.60

e6/l

0.27

113

Ganglion

692

1.01

0.01

1.6

1.4

5500.24

3089.59

e6/l

0.48

494

Arthropod-borne viral fevers and viral haemorrhagic fevers

377

0.98

0.01

1.3

1.4

1013.61

1958.16

e6/l

2.25

270

Acute appendicitis, no complications

216

2145

1.00

0.01

1.5

1987.32

4007.71

e6/l

2.31

153

1551

Other and unspecified acute skin changes due to ultraviolet radiation

106

0.94

0.01

1.6

1.3

1369.40

1565.07

e6/l

—

Crohn disease (strict definition, require KELA, min 2 HDR)

134

1.05

0.00

1.6

1.4

3710.25

1910.60

e6/l

—

Pre-eclampsia

394

1.02

0.00

1.7

1.4

1551.65

2673.58

e6/l

1.12

284

Coxarthrosis, primary, with hip surgery

288

2735

1.00

0.00

1.5

1641.09

2480.60

e6/l

1.36

226

1959

Acute appendicitis

306

2887

1.00

0.00

1.5

2883.41

3700.85

e6/l

0.33

217

2094

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

323

0.99

0.00

1.5

1.4

6139.52

2423.65

e6/l

0.36

240

Otitis externa, unspecified

338

1.01

0.00

1.3

1.4

4345.61

2347.80

e6/l

0.42

243

Other hearing loss

174

1715

1.00

0.00

1.5

1982.81

2519.55

e6/l

0.47

135

1204

Crohn disease (strict definition, require KELA)

135

1.04

0.00

1.6

1.4

3710.25

1896.40

e6/l

—

Other endocrine disorders

111

1.04

0.00

1.3

1.4

901.67

2352.22

e6/l

—

Chalazion

408

1.00

0.00

1.7

1.5

1666.88

2457.02

e6/l

0.76

299

Macular hole

261

1.00

0.00

1.4

1.5

1371.94

1720.67

e6/l

0.40

186

Car occupant injured in other and unspecified transport accidents

595

1.01

0.00

1.6

1.5

3578.21

2238.62

e6/l

0.34

431

Contact with and exposure to communicable diseases

647

1.00

0.00

1.6

1.5

9291.92

2920.84

e6/l

0.43

467

Alzheimer’s disease (Late onset), excluding more controls

105

702

1.00

0.00

1.4

1.5

3776.95

1520.87

e6/l

0.65

484

Colonic or urogenital fistula

118

1175

1.00

0.00

1.5

2015.62

2470.85

e6/l

0.56

846

Anti-inflammatory and antirheumatic products, non-steroids

187

941

1.00

0.00

1.4

1.5

1863.66

1809.59

e6/l

0.06

135

673

Other Crohn's disease

156

1.03

0.00

1.4

5682.36

1884.72

e6/l

0.62

104

Presbyopia

164

0.98

0.00

1.6

1.3

1713.67

2968.56

e6/l

—

112

Other and unspecified abdominal hernia

176

1.02

0.00

1.6

1.4

1323.75

1748.78

e6/l

0.29

130

Other disorders of optic [2nd] nerve and visual pathways

206

1.02

0.00

1.3

1.4

906.87

1772.69

e6/l

1.49

141

Cervical disc disorders

183

1831

1.00

0.00

1.5

2128.96

2851.37

e6/l

0.67

142

1321

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

148

1.01

0.00

1.7

1.4

3332.22

1968.73

e6/l

—

103

Herpesviral keratitis and keratoconjunctivitis

162

0.99

0.00

1.5

1.4

1231.91

1712.77

e6/l

0.37

112

Other benign neoplasms of skin

186

1856

1.00

0.00

1.4

1.5

1775.92

2728.75

e6/l

0.91

143

1343

LSIL lesion of the cervix uteri, vagina or vulva

241

1.00

0.00

1.3

1.4

18573.06

2822.45

e6/l

0.46

170

Mucosal proctocolitis

379

1.00

0.00

1.4

1.5

2095.90

2516.45

e6/l

0.30

273

Disturbances of skin sensation

891

1.00

0.00

1.7

1.5

1747.52

2262.01

e6/l

1.03

634

Other abnormal findings of blood chemistry

153

0.98

0.00

1.4

4741.20

1681.12

e6/l

—

115

Polypectomy (DHB20)

273

0.99

0.00

1.7

1.5

2868.56

1889.27

e6/l

0.29

198

Normotensive glaucoma

413

0.99

0.00

1.4

743.94

2058.83

e6/l

3.63

295

Irritable bowel syndrome

935

0.99

0.00

1.5

1081.68

2746.24

e6/l

1.60

673

Long labour

317

0.99

0.00

1.4

2346.08

5197.18

e6/l

0.89

228

Pediculosis and phthiriasis

0.00

0.0

1.3

—

695.57

—

Thyrotoxicosis factitia

0.00

0.0

1.0

—

700.40

—

Dementia in other diseases classified elsewhere

230

1.00

0.00

1.3

1.4

1298.82

1422.57

e6/l

0.13

167

Atrophic disorders of skin

450

1.00

0.00

1.6

1.4

1130.89

2233.19

e6/l

2.09

321

Toxic effect of carbon monoxide

0.96

0.00

1.0

1.3

1931.00

1752.71

e6/l

—

Acne vulgaris

0.93

0.00

1.1

1.4

2215.43

2486.11

e6/l

—

Benign neoplasm of male genital organs

110

1.00

0.00

1.2

1.5

1550.18

1833.00

e6/l

0.13

Benign neoplasm: Female genital organ, unspecified

0.00

0.0

1.0

—

1194.80

—

Other female pelvic inflammatory diseases

440

1.00

0.00

1.4

1324.06

3814.27

e6/l

1.00

319

Sunburn

0.00

0.0

1.2

—

925.20

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Leukocytes [#/volume] in Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS